data_6vh8_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6vh8 _Structure_validation_residue.Date_analyzed 2020-10-02 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.29 30.32 9.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.925 . . . . 0.0 111.743 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.2 m -54.48 122.94 41.31 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 124.311 1.044 . . . . 0.0 109.066 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.73 -25.12 61.39 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 123.046 2.498 . . . . 0.0 113.808 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -151.84 169.03 23.25 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 32.7 t -167.74 165.55 14.13 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.8 m -151.88 166.41 31.55 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.687 0.676 . . . . 0.0 109.724 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -70.03 -20.42 63.26 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.73 -34.84 34.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.453 0.644 . . . . 0.0 110.035 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -130.71 90.31 2.89 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.549 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.47 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 31.9 pt -91.23 -5.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.541 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.47 0.21 35.06 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.427 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.8 -24.4 63.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -129.98 85.06 2.26 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.54 133.1 11.36 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.579 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 74.01 -27.07 0.19 Allowed 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.574 1.95 . . . . 0.0 114.478 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -117.35 -39.41 3.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.3 m -127.02 175.26 8.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -139.82 141.62 36.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.2 p -108.32 148.18 30.43 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.379 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.555 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 3.7 p -110.42 108.05 58.42 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 123.76 5.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.045 1.83 . . . . 0.0 111.518 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.2 pt? -154.93 100.19 2.35 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.172 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.0 Cg_exo -81.38 -60.53 0.04 OUTLIER 'Cis proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.792 -0.92 . . . . 0.0 113.368 -2.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.37 -46.21 14.51 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 CA-C-O 121.174 0.511 . . . . 0.0 109.958 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.24 161.75 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -159.85 -179.72 34.84 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.916 -1.135 . . . . 0.0 111.5 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.0 161.25 13.73 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 t -105.28 130.27 53.45 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -122.4 125.5 26.49 Favored Pre-proline 0 N--CA 1.422 -1.853 0 CA-C-O 121.177 0.513 . . . . 0.0 110.338 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -87.5 125.99 2.18 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 122.012 1.808 . . . . 0.0 109.777 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 C--N 1.31 -1.109 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.738 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.434 -1.252 0 CA-C-O 120.364 0.126 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 59.44 15.57 4.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.702 1.201 . . . . 0.0 113.383 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.481 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 10.6 t -141.92 132.5 12.87 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.99 -55.8 1.18 Allowed 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.942 2.428 . . . . 0.0 114.848 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -138.21 -179.8 6.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.18 0.514 . . . . 0.0 112.228 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 40.4 t -159.35 167.93 27.63 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.408 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 65.7 p -160.19 176.82 11.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.68 -38.32 77.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -70.42 -55.49 8.91 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB3' ' CD2' ' A' ' 16' ' ' LEU . 32.5 mmt180 -109.54 89.18 2.93 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.291 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.537 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 5.8 pt -98.83 -9.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.467 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.48 73.54 Favored Glycine 0 C--N 1.316 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.979 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 13' ' ' ARG . 4.2 mm? -80.24 -32.66 38.38 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.654 -0.321 . . . . 0.0 111.611 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 6' ' ' SER . 69.3 m -133.36 109.49 9.39 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.321 0.581 . . . . 0.0 110.019 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -145.93 159.81 28.01 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 175.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.3 t70 77.01 -35.1 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.802 1.641 . . . . 0.0 112.633 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 18' ' ' GLY . 53.5 mttp -113.37 -50.53 2.85 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.953 -175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.7 m -132.71 145.17 50.82 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -99.84 139.77 35.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.12 127.79 53.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 120.945 0.402 . . . . 0.0 111.917 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.53 106.54 56.59 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.198 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 22.3 Cg_exo -68.47 128.25 16.93 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.828 2.352 . . . . 0.0 111.983 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.91 89.56 38.33 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.12 0.486 . . . . 0.0 112.091 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -92.9 -13.77 20.53 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.527 -1.03 . . . . 0.0 110.674 -8.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 44.1 mm -106.85 -57.5 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.316 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 88.1 m-85 -96.86 146.76 24.63 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.78 162.4 27.04 Favored Glycine 0 N--CA 1.416 -2.693 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.418 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.19 156.67 16.22 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.43 121.69 35.08 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.15 126.66 26.93 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.424 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -64.96 116.49 3.86 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.262 1.975 . . . . 0.0 110.439 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--N 1.319 -0.755 0 C-N-CA 124.354 1.061 . . . . 0.0 112.791 -176.796 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.13 28.97 18.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.034 0.921 . . . . 0.0 110.493 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 p -102.8 129.12 26.4 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.04 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.35 -24.21 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.905 1.736 . . . . 0.0 111.128 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -165.79 172.48 11.67 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.1 t -153.01 156.64 39.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 p -150.11 169.12 22.01 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 28' ' ' ILE . 2.3 pt? -70.45 -24.04 62.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.428 0.558 . . . . 0.0 110.247 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -82.11 -47.5 12.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.399 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -108.25 91.64 3.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt -100.01 -5.52 9.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 O-C-N 123.691 0.619 . . . . 0.0 109.458 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.8 -13.41 56.42 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.866 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.13 -26.57 64.01 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.425 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 55.8 m -141.71 90.31 2.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.471 0.653 . . . . 0.0 110.426 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.22 126.47 4.2 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 176.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 t70 72.71 -23.18 0.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.244 1.418 . . . . 0.0 112.595 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.507 ' H ' ' C ' ' A' ' 18' ' ' GLY . 41.4 mmtm -90.54 -38.48 13.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 3.9 p -170.48 171.48 6.47 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 m -120.86 139.98 52.41 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.671 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 30.0 p -100.53 144.75 29.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.529 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 40.3 t -106.22 95.22 10.87 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 4.2 Cg_exo -76.48 118.31 4.85 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.945 2.43 . . . . 0.0 111.325 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.8 100.02 4.68 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -83.58 -33.54 2.69 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.052 -4.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.402 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 61.9 mt -102.42 -56.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.594 -174.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -101.15 162.29 13.0 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.631 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -164.46 177.23 40.18 Favored Glycine 0 N--CA 1.418 -2.552 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.481 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.96 156.38 16.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 124.044 0.496 . . . . 0.0 110.564 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 80.7 m -101.44 121.77 42.55 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.191 0.519 . . . . 0.0 110.722 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.19 130.22 23.23 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.27 149.4 85.76 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 122.367 2.045 . . . . 0.0 111.661 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--N 1.298 -1.632 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.133 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 120.384 0.135 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.65 34.65 22.26 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.489 0.715 . . . . 0.0 112.587 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 p -83.91 118.24 70.81 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.17 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -72.24 -30.42 13.05 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.378 1.385 . . . . 0.0 108.806 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -169.11 173.35 6.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.4 t -165.48 162.62 19.4 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.3 m -149.12 167.45 25.87 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.521 0.6 . . . . 0.0 110.362 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -68.21 -26.7 65.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.851 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -83.0 -35.96 25.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.318 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -122.36 88.64 2.97 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt -101.12 -1.16 9.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.27 53.96 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.626 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.43 -40.57 74.98 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -133.76 138.87 46.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.299 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -153.61 146.18 14.26 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 75.3 -33.12 0.23 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.63 1.972 . . . . 0.0 113.48 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 18' ' ' GLY . 45.6 mttm -113.78 -44.95 3.13 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -172.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -129.35 154.16 47.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.267 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -126.84 147.47 50.03 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.546 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 26.6 p -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.113 -1.035 . . . . 0.0 113.107 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.481 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.7 p -115.36 112.81 43.54 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-N 114.392 -1.277 . . . . 0.0 107.942 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -85.47 132.84 4.39 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.359 2.039 . . . . 0.0 112.538 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -151.97 99.87 2.9 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.2 Cg_exo -78.6 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 124.407 -1.08 . . . . 0.0 112.116 -4.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.84 -51.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.48 139.56 30.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.009 0.433 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -153.12 -177.49 26.73 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.4 mt -112.12 165.49 12.09 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 117.716 0.758 . . . . 0.0 110.743 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 m -89.19 135.8 33.37 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.304 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.35 128.95 24.69 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.71 123.97 11.01 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.086 1.857 . . . . 0.0 111.715 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 CA--C 1.484 -1.579 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.812 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.25 1.101 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 59.42 21.92 10.34 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.725 1.21 . . . . 0.0 111.127 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -80.16 126.84 78.48 Favored Pre-proline 0 N--CA 1.426 -1.649 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.32 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -74.03 -27.31 12.11 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.125 1.884 . . . . 0.0 111.846 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 45.7 p90 -164.62 179.6 6.53 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 18.5 t -174.24 162.11 3.61 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.3 p -156.88 -179.77 8.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -75.48 -20.19 58.93 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.647 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.42 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 58.1 m-85 -86.24 -34.78 20.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 5.5 mpt_? -121.37 87.42 2.75 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.508 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 36.4 pt -97.02 -7.6 9.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.875 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.66 -19.15 62.44 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.163 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.94 -37.84 87.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.252 0.549 . . . . 0.0 110.094 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.09 -23.16 35.89 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.914 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . 45.33 56.56 6.15 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.434 -1.257 . . . . 0.0 115.793 171.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 71.9 -23.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.183 1.393 . . . . 0.0 113.672 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 18' ' ' GLY . 36.8 mtmm -81.65 -28.74 33.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 111.27 -176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 60.7 m -133.65 169.21 17.35 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.369 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -131.22 124.43 30.58 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.6 p -94.14 138.04 32.64 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.635 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -98.99 107.31 43.2 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.1 Cg_exo -79.09 127.91 7.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.713 2.276 . . . . 0.0 111.322 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.8 pt? -134.16 90.21 26.37 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.874 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.6 Cg_endo -90.78 -21.68 9.32 Favored 'Cis proline' 0 C--N 1.357 1.015 0 C-N-CA 124.399 -1.084 . . . . 0.0 111.704 -7.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 49.1 mm -108.85 -57.28 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.183 0.516 . . . . 0.0 110.296 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 58.9 t80 -88.45 146.15 25.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.46 -169.03 15.46 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.67 -1.729 . . . . 0.0 113.722 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.2 t -99.05 120.25 39.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -111.17 132.7 21.6 Favored Pre-proline 0 C--O 1.257 1.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.585 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.0 Cg_endo -54.51 119.62 6.7 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.172 2.582 . . . . 0.0 112.074 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 C--N 1.301 -1.531 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.641 -176.396 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.2 m . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 60.88 18.62 8.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.102 0.961 . . . . 0.0 113.319 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -54.33 125.49 51.31 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.307 0.643 . . . . 0.0 109.307 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.44 -44.4 14.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.751 2.301 . . . . 0.0 113.36 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.82 145.74 51.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 t -158.29 163.46 37.35 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.0 m -151.37 178.6 9.11 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -77.22 -22.66 51.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 109.707 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -81.14 -45.21 16.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.908 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -112.52 89.06 2.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.877 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.5 pt -95.99 -5.97 9.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.698 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.19 6.92 32.88 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.53 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.97 -14.17 56.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.251 0.548 . . . . 0.0 110.081 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -134.43 107.59 7.67 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -112.48 100.03 1.1 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.864 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 t70 74.25 -29.47 0.2 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.293 2.237 . . . . 0.0 113.518 171.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 18' ' ' GLY . 47.1 mmtm -77.75 -50.11 13.04 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.811 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.3 m -130.75 171.06 13.54 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -133.81 144.03 48.74 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -98.33 144.83 27.31 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.494 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.558 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.3 p -108.31 100.48 37.59 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.262 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 10.0 Cg_exo -72.77 128.86 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.618 2.212 . . . . 0.0 111.339 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -135.99 89.5 20.48 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-O 120.897 0.38 . . . . 0.0 112.02 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.2 Cg_endo -89.45 -19.39 15.19 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.479 -1.05 . . . . 0.0 111.405 -7.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 70.6 mt -107.77 -59.68 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.98 146.18 24.08 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.32 178.24 32.92 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.922 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.37 165.03 12.98 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 124.15 0.559 . . . . 0.0 110.49 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 19.3 t -103.23 112.46 25.34 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.07 137.69 27.78 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.302 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.96 113.76 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.126 1.217 . . . . 0.0 109.321 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 C--N 1.301 -1.513 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.113 -176.164 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 74.03 -0.42 3.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.548 1.539 . . . . 0.0 110.471 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -85.95 118.0 69.71 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.616 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.64 -26.58 9.8 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.86 1.706 . . . . 0.0 112.383 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -157.92 -179.94 8.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.9 t -166.91 169.82 12.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.9 m -155.91 171.31 20.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.07 -24.36 61.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.364 0.602 . . . . 0.0 111.667 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -85.89 -59.11 2.4 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -81.48 80.08 7.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.9 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.13 -2.78 9.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.627 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.38 4.44 72.6 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.609 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.28 -31.69 33.54 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.902 -0.175 . . . . 0.0 111.316 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -114.11 105.5 13.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -124.81 127.01 6.2 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.099 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.0 t70 76.94 -36.21 0.25 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 126.851 2.06 . . . . 0.0 113.074 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 18' ' ' GLY . 47.1 mmtm -97.39 -40.83 8.51 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.46 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 62.3 m -139.4 168.69 19.26 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.047 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 m -135.97 148.92 48.68 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -106.58 143.62 34.43 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.018 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.22 102.41 18.1 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.8 Cg_exo -73.67 126.27 10.68 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.615 2.21 . . . . 0.0 112.691 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.404 HD11 ' O ' ' A' ' 26' ' ' LEU . 1.2 pp -156.88 97.27 2.11 Favored Pre-proline 0 N--CA 1.425 -1.701 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.692 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -81.85 -62.09 0.03 OUTLIER 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.097 -3.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.17 -43.6 14.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.979 0.418 . . . . 0.0 110.481 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -83.5 154.77 23.7 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -137.46 156.07 23.33 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.608 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.414 ' O ' HD12 ' A' ' 31' ' ' LEU . 4.1 pp -85.79 139.96 30.87 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.2 t -91.98 119.72 31.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -112.03 130.79 22.9 Favored Pre-proline 0 C--O 1.25 1.084 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.791 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 18.7 Cg_endo -58.31 126.55 21.8 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.686 2.257 . . . . 0.0 112.226 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--N 1.306 -1.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.216 -178.856 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t70 69.82 28.87 4.21 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.535 1.534 . . . . 0.0 108.811 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -97.56 109.55 50.98 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.852 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -73.14 -24.47 16.99 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.826 1.684 . . . . 0.0 112.142 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -157.49 -179.87 8.59 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.2 t -160.27 169.34 23.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 m -155.7 169.55 24.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 28' ' ' ILE . 2.2 pt? -71.32 -30.15 65.88 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.06 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.44 -16.97 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.079 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -125.29 78.97 1.76 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.5 pt -99.71 -1.25 10.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.435 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.04 -15.81 69.96 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.69 -44.61 81.29 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -126.87 89.91 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.583 0.706 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -139.99 136.72 7.94 Favored Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t70 74.87 -25.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.242 1.417 . . . . 0.0 113.498 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 18' ' ' GLY . 54.5 mttp -113.55 -39.44 4.07 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -174.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 p -148.86 169.66 20.02 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -122.53 144.4 49.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.8 139.83 52.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.782 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.12 107.9 60.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.576 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 57.5 Cg_endo -75.81 134.78 16.87 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.646 2.231 . . . . 0.0 112.246 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -150.09 90.95 4.33 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.797 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -86.0 -40.41 0.64 Allowed 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.619 -0.992 . . . . 0.0 111.829 -7.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.46 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 48.7 mm -98.48 -53.91 7.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.76 138.87 46.75 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.449 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -136.26 156.72 23.14 Favored Glycine 0 N--CA 1.41 -3.062 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.596 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.5 143.0 27.91 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.6 t -98.23 146.01 26.05 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.89 129.04 7.12 Favored Pre-proline 0 N--CA 1.425 -1.683 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.0 116.84 4.71 Favored 'Trans proline' 0 C--O 1.254 1.313 0 C-N-CA 121.8 1.667 . . . . 0.0 109.361 172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.734 -177.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 17.68 9.13 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.73 1.212 . . . . 0.0 113.893 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.4 m -148.07 137.96 12.52 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.17 -60.03 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.561 2.174 . . . . 0.0 112.043 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -139.38 175.35 9.63 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 p -129.72 -165.47 1.53 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 m -148.5 163.92 35.76 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.95 -23.87 67.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.704 0.764 . . . . 0.0 110.848 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -80.78 -54.31 5.72 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.054 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -105.36 90.19 3.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.656 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 pt -97.21 -4.23 9.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.41 -5.19 41.83 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.199 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.47 -40.45 70.26 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.42 85.71 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.352 0.596 . . . . 0.0 109.919 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.97 126.45 4.06 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 67.41 -6.58 0.62 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.684 1.194 . . . . 0.0 112.416 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' GLY . 54.0 mttp -101.81 -55.94 2.39 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.815 0.846 . . . . 0.0 109.229 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -147.66 -179.92 7.22 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 130.75 53.76 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.2 p -121.13 129.78 53.44 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.925 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.97 118.68 62.41 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.455 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.7 Cg_exo -76.81 120.61 5.55 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.256 1.97 . . . . 0.0 111.823 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 2.0 pt? -150.63 101.12 3.1 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.786 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -83.67 -57.0 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.652 -0.978 . . . . 0.0 111.897 -3.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.05 -44.17 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -83.69 151.88 25.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -126.34 144.65 15.24 Favored Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 119.07 -1.538 . . . . 0.0 114.055 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.4 127.22 33.05 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.04 116.47 30.33 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.58 132.58 23.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.79 113.36 3.18 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.847 1.698 . . . . 0.0 110.094 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.452 -177.716 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 70.94 14.14 6.93 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 125.233 1.413 . . . . 0.0 109.535 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 m -108.4 115.99 57.15 Favored Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.182 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.93 -22.13 17.7 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.826 1.684 . . . . 0.0 109.905 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -169.94 -179.94 3.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.8 t -152.47 164.04 38.35 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 m -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.19 -26.51 64.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.071 0.462 . . . . 0.0 111.137 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -105.54 1.14 27.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -140.1 78.92 1.68 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.33 -4.34 9.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.111 0.482 . . . . 0.0 110.378 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.66 -12.23 73.76 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.203 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.39 -46.66 79.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 m -85.94 94.4 9.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -79.66 69.13 3.08 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.435 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 70.84 -21.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.328 1.851 . . . . 0.0 112.772 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.2 mttt -65.76 -34.13 77.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.215 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 71.1 m -138.5 -179.94 6.1 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.328 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 m -124.67 146.88 48.88 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -116.83 133.11 56.41 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.506 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.6 p -97.91 113.62 63.98 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.017 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 96.1 Cg_endo -88.42 148.09 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.787 2.325 . . . . 0.0 112.188 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.3 pt? -142.85 88.01 8.65 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.181 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -91.22 -18.68 13.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.09 -1.212 . . . . 0.0 111.597 -9.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.9 mt -108.47 -46.59 7.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.214 0.53 . . . . 0.0 111.357 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -99.54 146.7 26.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 25' ' ' PRO . . . -160.12 -168.8 22.58 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.597 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.0 156.21 23.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.64 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 6.5 t -101.26 141.02 34.75 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.9 134.58 15.98 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -67.87 140.28 50.14 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.748 1.632 . . . . 0.0 109.551 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--N 1.304 -1.373 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -176.2 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 16.5 t70 59.67 20.03 8.69 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.274 1.43 . . . . 0.0 110.762 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -82.86 112.65 39.5 Favored Pre-proline 0 N--CA 1.424 -1.748 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 5' ' ' ASP . 23.1 Cg_exo -64.07 -49.41 3.85 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 121.971 1.781 . . . . 0.0 108.745 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -146.04 165.8 27.99 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.58 154.02 31.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.3 m -144.7 175.37 10.22 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.49 -23.27 62.64 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.38 0.61 . . . . 0.0 110.302 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -85.37 -56.9 3.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.03 79.74 6.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.023 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.8 pt -92.63 -13.92 8.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.796 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.15 -5.3 33.32 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.574 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.34 -24.33 50.78 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.524 -0.398 . . . . 0.0 110.13 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -115.61 87.35 2.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -91.69 94.68 1.96 Allowed Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.73 -0.748 . . . . 0.0 114.316 -172.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 74.11 -31.2 0.21 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.398 1.879 . . . . 0.0 114.051 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' GLY . 56.1 mmtt -90.54 -26.09 19.91 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.518 -174.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 32.8 m -137.54 165.06 27.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -136.45 141.62 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.1 p -103.33 135.73 44.4 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.357 0.599 . . . . 0.0 111.155 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.616 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 58.6 t -98.39 105.72 31.2 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.499 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.9 Cg_exo -78.21 135.79 13.9 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.73 2.286 . . . . 0.0 112.458 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -146.24 93.23 5.09 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-O 120.948 0.404 . . . . 0.0 112.074 177.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.5 Cg_exo -87.36 -27.64 5.06 Favored 'Cis proline' 0 C--N 1.354 0.865 0 C-N-CA 124.562 -1.016 . . . . 0.0 111.651 -7.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.499 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 48.1 mm -100.77 -57.32 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -100.6 158.33 16.02 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.22 -163.02 11.85 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.238 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 pp -101.3 154.39 18.82 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.76 0.329 . . . . 0.0 110.537 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -102.54 125.14 49.16 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.5 135.48 23.64 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.8 126.1 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.328 2.018 . . . . 0.0 111.128 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -175.013 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.5 m . . . . . 0 CA--C 1.509 -0.598 0 CA-C-O 120.818 0.342 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 61.16 20.98 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.093 0.957 . . . . 0.0 112.269 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 t -120.59 121.28 29.21 Favored Pre-proline 0 N--CA 1.423 -1.816 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.71 -39.48 8.76 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.682 1.588 . . . . 0.0 110.884 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -170.62 164.07 8.24 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.7 -173.28 4.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -155.77 172.68 17.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.46 -27.4 68.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.932 0.787 . . . . 0.0 112.353 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 91.6 m-85 -81.54 -21.36 38.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 9.4 mpt_? -130.74 82.15 2.04 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.64 -5.21 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.759 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -8.06 47.55 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.872 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.74 -34.03 77.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.834 0.35 . . . . 0.0 110.287 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.3 m -127.04 102.21 6.88 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.162 0.506 . . . . 0.0 110.855 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -136.45 146.61 18.58 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 74.84 -27.27 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 113.443 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 18' ' ' GLY . 49.8 mttm -119.68 -43.83 2.57 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -172.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 63.6 m -135.88 165.56 25.34 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -125.53 141.26 52.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m -90.37 123.32 34.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.844 0.354 . . . . 0.0 110.922 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.91 100.16 19.26 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 9.8 Cg_exo -73.37 123.88 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.785 2.323 . . . . 0.0 111.678 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -135.43 89.68 22.1 Favored Pre-proline 0 N--CA 1.417 -2.124 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.6 Cg_exo -88.03 -27.64 4.7 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.498 -1.043 . . . . 0.0 111.998 -6.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.0 mt -110.4 -48.43 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 O-C-N 122.191 -0.318 . . . . 0.0 111.258 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -75.27 144.51 42.48 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 25' ' ' PRO . . . -124.18 148.25 16.73 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 119.468 -1.349 . . . . 0.0 113.931 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.95 140.0 34.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.0 t -94.99 114.92 26.79 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.35 130.17 23.11 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.164 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.604 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 19.9 Cg_endo -61.04 118.1 4.94 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.81 2.34 . . . . 0.0 110.503 177.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--N 1.304 -1.393 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.42 -175.831 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.433 -1.278 0 CA-C-O 120.345 0.117 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 65.09 26.8 12.52 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.744 0.783 . . . . 0.0 109.593 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 m -114.81 109.42 47.57 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.211 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.72 -29.95 18.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.546 1.498 . . . . 0.0 111.138 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -163.06 -179.98 7.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 38.9 t -154.82 173.07 16.97 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 p -150.08 168.47 23.82 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.18 -25.22 60.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.38 0.61 . . . . 0.0 109.978 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -78.63 -46.57 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -118.45 95.48 4.89 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.941 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.631 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 32.6 pt -93.32 -3.92 10.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 0.7 22.27 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.648 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.21 -30.53 66.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -94.08 122.87 37.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -88.8 53.76 4.03 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.63 -174.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 70.43 -18.47 0.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.642 1.577 . . . . 0.0 113.604 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 18' ' ' GLY . 56.7 mtpt -84.77 -17.86 36.9 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.993 0.902 . . . . 0.0 111.092 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 60.5 m -136.51 153.29 51.06 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.668 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 m -125.28 142.57 51.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 29.5 p -108.53 156.32 19.64 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.63 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.628 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 7.5 p -120.5 118.48 30.95 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -80.96 124.08 4.85 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 121.902 1.735 . . . . 0.0 111.428 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -139.8 92.12 10.15 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.863 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.5 Cg_exo -87.57 -35.9 1.14 Allowed 'Cis proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.73 -0.946 . . . . 0.0 112.973 -5.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mm -100.13 -52.6 8.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.118 0.485 . . . . 0.0 110.295 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -101.44 150.2 23.28 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -154.03 -174.22 23.93 Favored Glycine 0 N--CA 1.415 -2.745 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.855 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.26 153.47 18.01 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.133 -0.534 . . . . 0.0 109.585 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 27.1 t -109.66 131.09 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.61 134.94 25.2 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 21.6 Cg_endo -63.15 124.63 14.25 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.225 1.95 . . . . 0.0 110.224 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 . . . . . 0 C--N 1.304 -1.382 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.641 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.434 -1.23 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 70.18 0.09 3.01 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.255 1.422 . . . . 0.0 113.008 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 m -68.3 121.46 80.49 Favored Pre-proline 0 N--CA 1.427 -1.615 0 C-N-CA 123.725 0.81 . . . . 0.0 108.871 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -72.67 -26.73 15.95 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.214 1.943 . . . . 0.0 112.569 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.78 -179.69 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 t -175.33 158.15 2.29 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 m -148.51 169.9 19.25 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 12' ' ' PHE . 3.3 pp -66.47 -24.45 66.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.633 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.401 ' N ' HD13 ' A' ' 11' ' ' LEU . 75.4 m-85 -78.81 -64.72 1.11 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.96 87.35 5.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.537 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 pt -92.71 -3.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.409 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.7 -0.44 87.79 Favored Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.476 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.29 -34.66 78.86 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.196 0.522 . . . . 0.0 110.115 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 57.4 m -97.64 116.5 29.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.21 128.45 5.8 Favored Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.177 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 79.07 -38.01 0.2 Allowed 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 127.023 2.129 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -119.87 -22.35 6.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -132.6 164.38 26.81 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.953 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -136.74 137.16 39.6 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 27.2 p -95.59 142.83 27.46 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.05 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.43 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 61.6 t -105.11 101.41 30.19 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 14.7 Cg_exo -69.25 128.01 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.501 2.134 . . . . 0.0 110.773 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.1 pp -134.42 88.49 29.66 Favored Pre-proline 0 N--CA 1.423 -1.813 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -87.88 -21.97 12.07 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.626 -8.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.5 -57.42 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.717 0.294 . . . . 0.0 110.772 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.62 145.84 24.12 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -148.79 -175.19 21.07 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 118.427 -1.844 . . . . 0.0 114.553 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.4 151.44 21.52 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.09 -1.055 . . . . 0.0 109.222 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.2 119.84 39.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.58 139.1 29.3 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.1 118.61 5.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.292 1.995 . . . . 0.0 109.897 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 121.076 0.465 . . . . 0.0 109.971 -174.321 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 20' ' ' LYS . 61.9 m . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 53.7 34.01 17.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.57 1.148 . . . . 0.0 111.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.4 m -83.85 121.26 75.93 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.651 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.05 -33.15 32.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 111.34 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -143.79 166.11 25.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.785 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 46.1 t -156.24 167.24 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -147.06 168.59 21.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.4 -26.23 64.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.514 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -81.82 -53.17 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.647 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -96.22 85.29 3.95 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.481 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.401 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 26.0 pt -99.68 -6.34 9.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.435 0.635 . . . . 0.0 109.504 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.43 -15.69 59.58 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.56 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.31 -36.87 84.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.776 0.798 . . . . 0.0 109.828 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -111.39 13.2 21.54 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.715 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -40.77 96.27 0.01 OUTLIER Glycine 0 N--CA 1.466 0.681 0 C-N-CA 125.364 1.459 . . . . 0.0 115.618 -173.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t70 71.09 -19.98 0.23 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.497 2.319 . . . . 0.0 113.177 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 18' ' ' GLY . 30.8 mmtp -79.26 -50.96 10.1 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.712 0.805 . . . . 0.0 111.23 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.5 m -128.76 -179.12 4.9 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -123.72 137.68 54.66 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.1 p -118.57 147.55 43.58 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.166 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 43.5 t -112.67 99.29 47.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 21.8 Cg_exo -70.86 122.99 9.34 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.567 2.178 . . . . 0.0 110.574 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -132.0 92.65 29.04 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-O 120.97 0.414 . . . . 0.0 111.961 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 94.7 Cg_endo -92.28 -7.76 38.08 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.057 -1.226 . . . . 0.0 111.737 -6.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 73.1 mt -121.09 -49.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.998 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.69 148.34 26.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -155.42 -175.84 26.92 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.685 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.58 165.15 11.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.5 t -114.65 136.0 53.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 130.3 22.95 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.932 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.64 131.28 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.577 1.518 . . . . 0.0 109.842 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--N 1.298 -1.662 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.372 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.497 -1.085 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.1 t70 73.89 6.0 4.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.857 1.663 . . . . 0.0 111.887 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -148.31 133.48 9.24 Favored Pre-proline 0 C--N 1.289 -2.031 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.29 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.46 -45.51 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.256 1.971 . . . . 0.0 111.411 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -117.96 171.49 8.04 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.502 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 43.3 t -166.81 175.6 7.66 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.2 m -147.11 165.11 30.95 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.86 -28.11 67.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.144 0.497 . . . . 0.0 110.774 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.85 -31.49 40.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.386 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -126.24 88.13 2.79 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.544 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 23.2 pt -99.43 -0.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.601 0.715 . . . . 0.0 110.799 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -8.09 87.17 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.33 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.45 -51.88 63.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.1 m -64.77 127.16 30.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.865 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -75.03 40.88 1.23 Allowed Glycine 0 CA--C 1.535 1.344 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.1 t70 71.07 -25.76 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.546 1.938 . . . . 0.0 114.145 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 18' ' ' GLY . 48.0 mttp -88.02 1.46 54.15 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.328 1.061 . . . . 0.0 110.201 -176.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.69 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 58.6 m -144.1 155.43 43.95 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -130.39 147.92 52.15 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.1 p -103.04 144.85 30.74 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.61 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 42.5 t -105.13 100.23 23.87 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.43 118.78 5.01 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.479 2.119 . . . . 0.0 111.787 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -139.42 97.57 8.38 Favored Pre-proline 0 N--CA 1.416 -2.134 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -84.91 -26.49 7.5 Favored 'Cis proline' 0 C--N 1.35 0.637 0 C-N-CA 124.551 -1.02 . . . . 0.0 111.618 -6.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -111.34 -54.95 4.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -93.2 151.47 19.8 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -158.32 176.17 35.33 Favored Glycine 0 C--N 1.28 -2.567 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.78 155.78 18.01 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.298 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -98.58 119.54 37.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.39 127.5 26.77 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.69 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.8 Cg_endo -61.23 134.18 50.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.482 2.122 . . . . 0.0 112.708 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--N 1.306 -1.302 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.768 176.878 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.442 -0.862 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 61.66 30.81 18.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.435 1.094 . . . . 0.0 112.099 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.3 m -132.98 116.68 14.63 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.19 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.88 -35.1 27.97 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.71 2.274 . . . . 0.0 113.224 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.69 160.15 28.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.1 m -130.63 -177.76 4.49 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -142.94 170.35 15.86 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt -51.9 -43.44 63.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.488 0.661 . . . . 0.0 111.167 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -84.51 -37.8 20.84 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.081 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.9 88.02 2.64 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.195 0.521 . . . . 0.0 110.642 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.7 pt -109.29 -0.39 9.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.74 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.04 2.73 68.33 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.183 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.4 -27.52 69.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.333 0.587 . . . . 0.0 109.876 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -121.35 90.6 3.35 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -85.93 86.73 1.55 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.624 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t70 73.69 -20.88 0.28 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.631 1.972 . . . . 0.0 113.4 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.3 mttt -60.29 -39.91 88.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.721 0.772 . . . . 0.0 109.31 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.613 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.9 m -153.6 179.03 9.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -122.72 133.77 54.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.7 m -82.3 129.34 34.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 96.5 44.29 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 10.4 Cg_exo -74.86 129.48 12.51 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.26 2.64 . . . . 0.0 112.828 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.3 pt? -153.75 105.71 2.51 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.301 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.37 -29.29 5.5 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.603 -0.999 . . . . 0.0 111.619 -7.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt -110.94 -54.59 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -87.96 144.28 26.63 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.966 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -132.22 167.81 22.81 Favored Glycine 0 N--CA 1.402 -3.596 0 C-N-CA 119.546 -1.311 . . . . 0.0 114.666 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 mt -92.38 160.78 14.94 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 42.3 t -117.57 118.01 30.98 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.85 134.31 26.17 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.998 -176.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 42.6 Cg_endo -74.17 136.56 22.42 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.086 1.858 . . . . 0.0 112.744 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.696 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 34' ' ' PRO . 59.4 m . . . . . 0 C--O 1.238 0.453 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 64.03 21.36 12.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.663 1.22 . . . . 0.0 109.24 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -105.24 113.09 64.87 Favored Pre-proline 0 N--CA 1.429 -1.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.978 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.39 -37.3 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.768 1.645 . . . . 0.0 111.718 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.18 -179.81 7.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.2 t -160.94 162.16 31.89 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.0 m -154.64 169.91 22.77 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 28' ' ' ILE . 2.3 pt? -72.86 -22.7 60.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.549 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -88.71 -14.02 38.24 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.694 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -136.22 79.61 1.78 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.1 pt -102.81 -4.24 9.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.19 0.519 . . . . 0.0 110.92 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.55 -0.95 64.29 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.247 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.39 -27.68 67.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.958 0.503 . . . . 0.0 110.427 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.49 128.66 55.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.46 103.14 0.39 Allowed Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.069 -177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.9 t70 76.94 -31.29 0.18 Allowed 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.67 1.988 . . . . 0.0 114.27 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -101.88 -42.06 6.27 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.487 0.661 . . . . 0.0 111.488 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.3 m -116.29 161.9 18.31 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.963 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -139.22 143.87 38.23 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 p -113.72 158.44 20.91 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.625 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.2 p -119.83 106.21 41.93 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.869 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.12 115.45 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.287 1.992 . . . . 0.0 110.357 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -133.36 98.34 15.41 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.252 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -89.09 -20.44 13.53 Favored 'Cis proline' 0 C--N 1.353 0.787 0 C-N-CA 124.724 -0.948 . . . . 0.0 111.785 -7.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.421 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 45.7 mm -108.72 -58.26 3.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.269 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.17 156.94 16.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -162.87 -176.69 35.19 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -106.4 155.84 19.14 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -103.32 130.47 50.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.42 136.87 29.57 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.472 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 28.7 Cg_endo -65.38 115.57 3.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.391 2.061 . . . . 0.0 109.912 175.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 C--N 1.304 -1.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.223 -174.657 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.74 -0.59 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.633 1.173 . . . . 0.0 112.943 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.7 m -118.69 133.72 23.58 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.608 -0.682 . . . . 0.0 110.862 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.91 -36.69 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.799 2.332 . . . . 0.0 112.361 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -147.18 160.56 42.31 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.8 p -139.88 -168.31 2.48 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.0 p -141.97 166.25 25.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.88 -21.76 64.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.447 0.642 . . . . 0.0 110.996 175.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -76.49 -59.77 2.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.35 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.45 92.04 4.03 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.341 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.5 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 37.9 pt -91.6 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.25 -7.39 57.13 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.636 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.73 -25.67 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.55 0.69 . . . . 0.0 109.524 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 52.9 m -98.1 100.18 11.48 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -71.97 72.93 0.87 Allowed Glycine 0 C--N 1.312 -0.765 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 -170.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 72.31 -33.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.653 2.381 . . . . 0.0 113.909 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 18' ' ' GLY . 68.1 mttm -83.19 -22.69 33.12 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-O 122.207 1.004 . . . . 0.0 110.2 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 1.6 p -124.21 149.33 46.51 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.716 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.9 m -112.14 154.33 25.64 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.398 1.079 . . . . 0.0 108.629 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 61.0 m -88.28 129.14 35.45 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.24 95.64 8.5 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.95 124.3 4.39 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.899 1.733 . . . . 0.0 112.048 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.5 89.82 21.56 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.039 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -87.82 -29.94 3.15 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 124.309 -1.121 . . . . 0.0 111.191 -7.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 52.6 mt -110.1 -49.4 6.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.919 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -71.73 132.08 44.02 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.54 16.57 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.993 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -117.53 150.2 39.35 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.0 m -78.11 113.48 16.09 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.516 0.51 . . . . 0.0 110.394 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.69 134.96 20.23 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.15 112.99 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.694 1.596 . . . . 0.0 110.666 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.053 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.443 -0.806 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 67.26 29.22 7.73 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.559 1.171 . . . . 0.0 109.566 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 m -91.58 116.04 65.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.129 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.36 -47.85 3.95 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.697 2.264 . . . . 0.0 113.099 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -145.21 -179.75 6.84 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 16.3 t -156.17 162.75 40.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.0 p -145.09 170.29 16.49 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.72 -20.04 64.38 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.629 0.728 . . . . 0.0 110.534 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.22 -59.08 2.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.865 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.84 90.73 4.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.444 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.519 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 38.0 pt -100.38 -0.14 10.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 109.643 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.86 64.92 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.243 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.85 -33.59 75.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 m -128.72 83.84 2.19 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -110.31 99.55 1.19 Allowed Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.939 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 72.63 -22.92 0.21 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.147 1.779 . . . . 0.0 112.685 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 18' ' ' GLY . 97.8 mttt -79.77 -29.96 40.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.548 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 p -163.0 177.75 8.92 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.044 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -134.49 148.71 50.61 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.6 p -124.7 139.86 53.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -113.84 102.7 55.06 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.47 142.34 65.01 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.897 2.398 . . . . 0.0 110.88 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -149.33 92.22 4.31 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-O 120.706 0.289 . . . . 0.0 111.75 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.0 Cg_exo -87.62 -28.48 4.2 Favored 'Cis proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.592 -1.003 . . . . 0.0 111.95 -6.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.1 mt -101.99 -47.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -109.05 154.02 22.82 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.36 177.51 33.33 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.772 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.6 163.97 12.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -108.3 140.22 41.88 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.05 138.85 24.25 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.63 132.06 45.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.89 1.727 . . . . 0.0 109.421 173.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 C--N 1.297 -1.684 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -173.894 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.4 155.33 66.59 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.5 2.134 . . . . 0.0 110.712 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -119.34 145.55 46.07 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.557 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.3 m -92.98 -65.13 1.02 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.29 30.32 9.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.925 . . . . 0.0 111.743 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.2 m -54.48 122.94 41.31 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 124.311 1.044 . . . . 0.0 109.066 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.73 -25.12 61.39 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 123.046 2.498 . . . . 0.0 113.808 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -151.84 169.03 23.25 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 32.7 t -167.74 165.55 14.13 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.8 m -151.88 166.41 31.55 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.687 0.676 . . . . 0.0 109.724 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -70.03 -20.42 63.26 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.73 -34.84 34.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.453 0.644 . . . . 0.0 110.035 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -130.71 90.31 2.89 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.549 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.47 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 31.9 pt -91.23 -5.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.541 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.47 0.21 35.06 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.427 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.8 -24.4 63.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -129.98 85.06 2.26 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.54 133.1 11.36 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.579 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 74.01 -27.07 0.19 Allowed 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.574 1.95 . . . . 0.0 114.478 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -117.35 -39.41 3.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.3 m -127.02 175.26 8.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -139.82 141.62 36.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.2 p -108.32 148.18 30.43 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.379 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.555 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 3.7 p -110.42 108.05 58.42 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 123.76 5.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.045 1.83 . . . . 0.0 111.518 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.2 pt? -154.93 100.19 2.35 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.172 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.0 Cg_exo -81.38 -60.53 0.04 OUTLIER 'Cis proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.792 -0.92 . . . . 0.0 113.368 -2.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.37 -46.21 14.51 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 CA-C-O 121.174 0.511 . . . . 0.0 109.958 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.24 161.75 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -159.85 -179.72 34.84 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.916 -1.135 . . . . 0.0 111.5 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.0 161.25 13.73 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 t -105.28 130.27 53.45 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -122.4 125.5 26.49 Favored Pre-proline 0 N--CA 1.422 -1.853 0 CA-C-O 121.177 0.513 . . . . 0.0 110.338 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -87.5 125.99 2.18 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 122.012 1.808 . . . . 0.0 109.777 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.53 -34.03 35.88 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.422 -1.857 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.43 178.274 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 C--O 1.222 -0.351 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.29 141.57 82.52 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 122.965 2.444 . . . . 0.0 113.004 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -105.07 152.23 23.01 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -84.13 -40.54 18.11 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.807 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 59.44 15.57 4.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.702 1.201 . . . . 0.0 113.383 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.481 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 10.6 t -141.92 132.5 12.87 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.99 -55.8 1.18 Allowed 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.942 2.428 . . . . 0.0 114.848 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -138.21 -179.8 6.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.18 0.514 . . . . 0.0 112.228 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 40.4 t -159.35 167.93 27.63 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.408 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 65.7 p -160.19 176.82 11.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.68 -38.32 77.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -70.42 -55.49 8.91 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB3' ' CD2' ' A' ' 16' ' ' LEU . 32.5 mmt180 -109.54 89.18 2.93 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.291 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.537 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 5.8 pt -98.83 -9.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.467 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.48 73.54 Favored Glycine 0 C--N 1.316 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.979 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 13' ' ' ARG . 4.2 mm? -80.24 -32.66 38.38 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.654 -0.321 . . . . 0.0 111.611 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 6' ' ' SER . 69.3 m -133.36 109.49 9.39 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.321 0.581 . . . . 0.0 110.019 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -145.93 159.81 28.01 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 175.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.3 t70 77.01 -35.1 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.802 1.641 . . . . 0.0 112.633 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 18' ' ' GLY . 53.5 mttp -113.37 -50.53 2.85 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.953 -175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.7 m -132.71 145.17 50.82 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -99.84 139.77 35.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.12 127.79 53.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 120.945 0.402 . . . . 0.0 111.917 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.53 106.54 56.59 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.198 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 22.3 Cg_exo -68.47 128.25 16.93 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.828 2.352 . . . . 0.0 111.983 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.91 89.56 38.33 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.12 0.486 . . . . 0.0 112.091 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -92.9 -13.77 20.53 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.527 -1.03 . . . . 0.0 110.674 -8.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 44.1 mm -106.85 -57.5 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.316 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 88.1 m-85 -96.86 146.76 24.63 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.78 162.4 27.04 Favored Glycine 0 N--CA 1.416 -2.693 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.418 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.19 156.67 16.22 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.43 121.69 35.08 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.15 126.66 26.93 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.424 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -64.96 116.49 3.86 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.262 1.975 . . . . 0.0 110.439 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.12 -35.76 67.44 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 124.354 1.061 . . . . 0.0 112.791 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 C--N 1.304 -1.372 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.865 177.737 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.475 ' H1 ' HD13 ' A' ' 1' ' ' LEU . 5.3 mp . . . . . 0 C--O 1.238 0.471 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -64.2 136.31 51.1 Favored 'Trans proline' 0 CA--C 1.507 -0.844 0 C-N-CA 122.38 2.053 . . . . 0.0 110.892 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -108.92 167.51 10.03 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.0 m -88.4 -52.71 5.04 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.1 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.13 28.97 18.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.034 0.921 . . . . 0.0 110.493 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 p -102.8 129.12 26.4 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.04 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.35 -24.21 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.905 1.736 . . . . 0.0 111.128 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -165.79 172.48 11.67 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.1 t -153.01 156.64 39.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 p -150.11 169.12 22.01 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 28' ' ' ILE . 2.3 pt? -70.45 -24.04 62.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.428 0.558 . . . . 0.0 110.247 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -82.11 -47.5 12.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.399 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -108.25 91.64 3.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt -100.01 -5.52 9.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 O-C-N 123.691 0.619 . . . . 0.0 109.458 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.8 -13.41 56.42 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.866 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.13 -26.57 64.01 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.425 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 55.8 m -141.71 90.31 2.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.471 0.653 . . . . 0.0 110.426 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.22 126.47 4.2 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 176.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 t70 72.71 -23.18 0.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.244 1.418 . . . . 0.0 112.595 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' H ' ' C ' ' A' ' 18' ' ' GLY . 41.4 mmtm -90.54 -38.48 13.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 3.9 p -170.48 171.48 6.47 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 m -120.86 139.98 52.41 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.671 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 30.0 p -100.53 144.75 29.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.529 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 40.3 t -106.22 95.22 10.87 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 4.2 Cg_exo -76.48 118.31 4.85 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.945 2.43 . . . . 0.0 111.325 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.8 100.02 4.68 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -83.58 -33.54 2.69 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.052 -4.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.402 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 61.9 mt -102.42 -56.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.594 -174.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -101.15 162.29 13.0 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.631 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -164.46 177.23 40.18 Favored Glycine 0 N--CA 1.418 -2.552 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.481 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.96 156.38 16.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 124.044 0.496 . . . . 0.0 110.564 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 80.7 m -101.44 121.77 42.55 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.191 0.519 . . . . 0.0 110.722 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.19 130.22 23.23 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.27 149.4 85.76 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 122.367 2.045 . . . . 0.0 111.661 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -99.13 -1.16 40.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.133 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.432 -1.359 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.445 175.733 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.4 155.84 55.1 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 122.641 2.227 . . . . 0.0 112.645 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -116.99 178.19 4.44 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m -98.25 -47.09 5.59 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.799 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.65 34.65 22.26 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.489 0.715 . . . . 0.0 112.587 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 p -83.91 118.24 70.81 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.17 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -72.24 -30.42 13.05 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.378 1.385 . . . . 0.0 108.806 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -169.11 173.35 6.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.4 t -165.48 162.62 19.4 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.3 m -149.12 167.45 25.87 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.521 0.6 . . . . 0.0 110.362 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -68.21 -26.7 65.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.851 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -83.0 -35.96 25.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.318 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -122.36 88.64 2.97 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt -101.12 -1.16 9.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.27 53.96 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.626 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.43 -40.57 74.98 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -133.76 138.87 46.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.299 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -153.61 146.18 14.26 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 75.3 -33.12 0.23 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.63 1.972 . . . . 0.0 113.48 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 18' ' ' GLY . 45.6 mttm -113.78 -44.95 3.13 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -172.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -129.35 154.16 47.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.267 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -126.84 147.47 50.03 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.546 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 26.6 p -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.113 -1.035 . . . . 0.0 113.107 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.481 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.7 p -115.36 112.81 43.54 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-N 114.392 -1.277 . . . . 0.0 107.942 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -85.47 132.84 4.39 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.359 2.039 . . . . 0.0 112.538 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -151.97 99.87 2.9 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.2 Cg_exo -78.6 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 124.407 -1.08 . . . . 0.0 112.116 -4.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.84 -51.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.48 139.56 30.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.009 0.433 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -153.12 -177.49 26.73 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.4 mt -112.12 165.49 12.09 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 117.716 0.758 . . . . 0.0 110.743 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 m -89.19 135.8 33.37 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.304 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.35 128.95 24.69 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.71 123.97 11.01 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.086 1.857 . . . . 0.0 111.715 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -83.61 -36.0 24.23 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.417 -2.076 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.63 -179.649 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.408 ' H2 ' HD23 ' A' ' 1' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -52.09 135.34 51.89 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 123.122 2.548 . . . . 0.0 112.465 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -123.88 -171.34 2.3 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 m -85.67 -58.47 2.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 59.42 21.92 10.34 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.725 1.21 . . . . 0.0 111.127 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -80.16 126.84 78.48 Favored Pre-proline 0 N--CA 1.426 -1.649 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.32 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -74.03 -27.31 12.11 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.125 1.884 . . . . 0.0 111.846 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 45.7 p90 -164.62 179.6 6.53 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 18.5 t -174.24 162.11 3.61 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.3 p -156.88 -179.77 8.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -75.48 -20.19 58.93 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.647 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.42 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 58.1 m-85 -86.24 -34.78 20.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 5.5 mpt_? -121.37 87.42 2.75 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.508 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 36.4 pt -97.02 -7.6 9.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.875 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.66 -19.15 62.44 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.163 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.94 -37.84 87.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.252 0.549 . . . . 0.0 110.094 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.09 -23.16 35.89 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.914 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . 45.33 56.56 6.15 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.434 -1.257 . . . . 0.0 115.793 171.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 71.9 -23.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.183 1.393 . . . . 0.0 113.672 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 18' ' ' GLY . 36.8 mtmm -81.65 -28.74 33.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 111.27 -176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 60.7 m -133.65 169.21 17.35 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.369 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -131.22 124.43 30.58 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.6 p -94.14 138.04 32.64 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.635 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -98.99 107.31 43.2 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.1 Cg_exo -79.09 127.91 7.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.713 2.276 . . . . 0.0 111.322 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.8 pt? -134.16 90.21 26.37 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.874 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.6 Cg_endo -90.78 -21.68 9.32 Favored 'Cis proline' 0 C--N 1.357 1.015 0 C-N-CA 124.399 -1.084 . . . . 0.0 111.704 -7.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 49.1 mm -108.85 -57.28 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.183 0.516 . . . . 0.0 110.296 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 58.9 t80 -88.45 146.15 25.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.46 -169.03 15.46 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.67 -1.729 . . . . 0.0 113.722 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.2 t -99.05 120.25 39.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -111.17 132.7 21.6 Favored Pre-proline 0 C--O 1.257 1.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.585 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.0 Cg_endo -54.51 119.62 6.7 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.172 2.582 . . . . 0.0 112.074 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -88.91 -34.84 16.8 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.641 -176.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.432 -1.373 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.622 175.408 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.8 139.37 79.83 Favored 'Trans proline' 0 C--O 1.25 1.089 0 C-N-CA 123.678 2.919 . . . . 0.0 111.767 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -129.62 126.84 39.35 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.132 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.2 m -128.38 -50.44 1.29 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 60.88 18.62 8.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.102 0.961 . . . . 0.0 113.319 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -54.33 125.49 51.31 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.307 0.643 . . . . 0.0 109.307 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.44 -44.4 14.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.751 2.301 . . . . 0.0 113.36 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.82 145.74 51.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 t -158.29 163.46 37.35 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.0 m -151.37 178.6 9.11 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -77.22 -22.66 51.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 109.707 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -81.14 -45.21 16.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.908 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -112.52 89.06 2.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.877 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.5 pt -95.99 -5.97 9.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.698 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.19 6.92 32.88 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.53 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.97 -14.17 56.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.251 0.548 . . . . 0.0 110.081 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -134.43 107.59 7.67 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -112.48 100.03 1.1 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.864 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 t70 74.25 -29.47 0.2 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.293 2.237 . . . . 0.0 113.518 171.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 18' ' ' GLY . 47.1 mmtm -77.75 -50.11 13.04 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.811 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.3 m -130.75 171.06 13.54 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -133.81 144.03 48.74 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -98.33 144.83 27.31 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.494 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.558 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.3 p -108.31 100.48 37.59 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.262 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 10.0 Cg_exo -72.77 128.86 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.618 2.212 . . . . 0.0 111.339 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -135.99 89.5 20.48 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-O 120.897 0.38 . . . . 0.0 112.02 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.2 Cg_endo -89.45 -19.39 15.19 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.479 -1.05 . . . . 0.0 111.405 -7.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 70.6 mt -107.77 -59.68 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.98 146.18 24.08 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.32 178.24 32.92 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.922 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.37 165.03 12.98 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 124.15 0.559 . . . . 0.0 110.49 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 19.3 t -103.23 112.46 25.34 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.07 137.69 27.78 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.302 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.96 113.76 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.126 1.217 . . . . 0.0 109.321 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -86.35 -6.69 58.88 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.113 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--N 1.276 -2.599 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.706 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.439 ' H3 ' HD11 ' A' ' 1' ' ' LEU . 6.3 mp . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.55 169.57 15.51 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.199 1.933 . . . . 0.0 110.525 174.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -71.46 0.8 7.5 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.048 0.928 . . . . 0.0 113.05 -175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.1 -17.77 54.52 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.115 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 74.03 -0.42 3.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.548 1.539 . . . . 0.0 110.471 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -85.95 118.0 69.71 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.616 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.64 -26.58 9.8 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.86 1.706 . . . . 0.0 112.383 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -157.92 -179.94 8.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.9 t -166.91 169.82 12.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.9 m -155.91 171.31 20.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.07 -24.36 61.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.364 0.602 . . . . 0.0 111.667 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -85.89 -59.11 2.4 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -81.48 80.08 7.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.9 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.13 -2.78 9.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.627 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.38 4.44 72.6 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.609 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.28 -31.69 33.54 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.902 -0.175 . . . . 0.0 111.316 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -114.11 105.5 13.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -124.81 127.01 6.2 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.099 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.0 t70 76.94 -36.21 0.25 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 126.851 2.06 . . . . 0.0 113.074 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 18' ' ' GLY . 47.1 mmtm -97.39 -40.83 8.51 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.46 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 62.3 m -139.4 168.69 19.26 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.047 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 m -135.97 148.92 48.68 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -106.58 143.62 34.43 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.018 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.22 102.41 18.1 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.8 Cg_exo -73.67 126.27 10.68 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.615 2.21 . . . . 0.0 112.691 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.404 HD11 ' O ' ' A' ' 26' ' ' LEU . 1.2 pp -156.88 97.27 2.11 Favored Pre-proline 0 N--CA 1.425 -1.701 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.692 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -81.85 -62.09 0.03 OUTLIER 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.097 -3.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.17 -43.6 14.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.979 0.418 . . . . 0.0 110.481 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -83.5 154.77 23.7 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -137.46 156.07 23.33 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.608 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.414 ' O ' HD12 ' A' ' 31' ' ' LEU . 4.1 pp -85.79 139.96 30.87 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.2 t -91.98 119.72 31.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -112.03 130.79 22.9 Favored Pre-proline 0 C--O 1.25 1.084 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.791 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 18.7 Cg_endo -58.31 126.55 21.8 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.686 2.257 . . . . 0.0 112.226 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -91.36 -56.91 2.96 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.216 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 C--N 1.311 -1.082 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.027 178.022 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.63 129.63 14.86 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.048 2.499 . . . . 0.0 112.754 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.6 mtm105 -109.27 171.04 7.67 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.5 m -92.66 -22.52 19.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t70 69.82 28.87 4.21 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.535 1.534 . . . . 0.0 108.811 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -97.56 109.55 50.98 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.852 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -73.14 -24.47 16.99 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.826 1.684 . . . . 0.0 112.142 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -157.49 -179.87 8.59 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.2 t -160.27 169.34 23.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 m -155.7 169.55 24.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 28' ' ' ILE . 2.2 pt? -71.32 -30.15 65.88 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.06 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.44 -16.97 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.079 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -125.29 78.97 1.76 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.5 pt -99.71 -1.25 10.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.435 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.04 -15.81 69.96 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.69 -44.61 81.29 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -126.87 89.91 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.583 0.706 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -139.99 136.72 7.94 Favored Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t70 74.87 -25.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.242 1.417 . . . . 0.0 113.498 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 18' ' ' GLY . 54.5 mttp -113.55 -39.44 4.07 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -174.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 p -148.86 169.66 20.02 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -122.53 144.4 49.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.8 139.83 52.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.782 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.12 107.9 60.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.576 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 57.5 Cg_endo -75.81 134.78 16.87 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.646 2.231 . . . . 0.0 112.246 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -150.09 90.95 4.33 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.797 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -86.0 -40.41 0.64 Allowed 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.619 -0.992 . . . . 0.0 111.829 -7.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.46 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 48.7 mm -98.48 -53.91 7.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.76 138.87 46.75 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.449 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -136.26 156.72 23.14 Favored Glycine 0 N--CA 1.41 -3.062 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.596 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.5 143.0 27.91 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.6 t -98.23 146.01 26.05 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.89 129.04 7.12 Favored Pre-proline 0 N--CA 1.425 -1.683 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.0 116.84 4.71 Favored 'Trans proline' 0 C--O 1.254 1.313 0 C-N-CA 121.8 1.667 . . . . 0.0 109.361 172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.61 -50.3 8.92 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.734 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.295 -1.771 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.804 -179.65 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.82 154.94 48.89 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.922 2.415 . . . . 0.0 111.364 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -103.95 170.21 8.05 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.649 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.2 m -85.1 -40.06 17.21 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 17.68 9.13 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.73 1.212 . . . . 0.0 113.893 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.4 m -148.07 137.96 12.52 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.17 -60.03 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.561 2.174 . . . . 0.0 112.043 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -139.38 175.35 9.63 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 p -129.72 -165.47 1.53 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 m -148.5 163.92 35.76 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.95 -23.87 67.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.704 0.764 . . . . 0.0 110.848 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -80.78 -54.31 5.72 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.054 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -105.36 90.19 3.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.656 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 pt -97.21 -4.23 9.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.41 -5.19 41.83 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.199 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.47 -40.45 70.26 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.42 85.71 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.352 0.596 . . . . 0.0 109.919 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.97 126.45 4.06 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 67.41 -6.58 0.62 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.684 1.194 . . . . 0.0 112.416 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' GLY . 54.0 mttp -101.81 -55.94 2.39 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.815 0.846 . . . . 0.0 109.229 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -147.66 -179.92 7.22 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 130.75 53.76 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.2 p -121.13 129.78 53.44 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.925 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.97 118.68 62.41 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.455 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.7 Cg_exo -76.81 120.61 5.55 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.256 1.97 . . . . 0.0 111.823 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 2.0 pt? -150.63 101.12 3.1 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.786 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -83.67 -57.0 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.652 -0.978 . . . . 0.0 111.897 -3.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.05 -44.17 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -83.69 151.88 25.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -126.34 144.65 15.24 Favored Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 119.07 -1.538 . . . . 0.0 114.055 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.4 127.22 33.05 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.04 116.47 30.33 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.58 132.58 23.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.79 113.36 3.18 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.847 1.698 . . . . 0.0 110.094 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.86 -8.14 56.26 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.452 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 C--N 1.285 -2.23 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.576 -177.749 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.3 128.68 14.01 Favored 'Trans proline' 0 CA--C 1.511 -0.673 0 C-N-CA 122.642 2.228 . . . . 0.0 110.299 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -109.96 146.82 34.59 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.001 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -98.69 -5.81 30.86 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.517 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 70.94 14.14 6.93 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 125.233 1.413 . . . . 0.0 109.535 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 m -108.4 115.99 57.15 Favored Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.182 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.93 -22.13 17.7 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.826 1.684 . . . . 0.0 109.905 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -169.94 -179.94 3.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.8 t -152.47 164.04 38.35 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 m -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.19 -26.51 64.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.071 0.462 . . . . 0.0 111.137 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -105.54 1.14 27.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -140.1 78.92 1.68 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.33 -4.34 9.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.111 0.482 . . . . 0.0 110.378 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.66 -12.23 73.76 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.203 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.39 -46.66 79.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 m -85.94 94.4 9.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -79.66 69.13 3.08 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.435 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 70.84 -21.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.328 1.851 . . . . 0.0 112.772 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.2 mttt -65.76 -34.13 77.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.215 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 71.1 m -138.5 -179.94 6.1 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.328 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 m -124.67 146.88 48.88 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -116.83 133.11 56.41 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.506 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.6 p -97.91 113.62 63.98 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.017 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 96.1 Cg_endo -88.42 148.09 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.787 2.325 . . . . 0.0 112.188 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.3 pt? -142.85 88.01 8.65 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.181 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -91.22 -18.68 13.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.09 -1.212 . . . . 0.0 111.597 -9.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.9 mt -108.47 -46.59 7.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.214 0.53 . . . . 0.0 111.357 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -99.54 146.7 26.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 25' ' ' PRO . . . -160.12 -168.8 22.58 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.597 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.0 156.21 23.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.64 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 6.5 t -101.26 141.02 34.75 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.9 134.58 15.98 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -67.87 140.28 50.14 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.748 1.632 . . . . 0.0 109.551 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.72 -35.08 33.98 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.418 -2.03 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.132 178.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.67 133.59 46.13 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 122.45 2.1 . . . . 0.0 111.702 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -81.87 95.65 7.39 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.482 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.7 m -74.54 -45.37 46.07 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 16.5 t70 59.67 20.03 8.69 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.274 1.43 . . . . 0.0 110.762 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -82.86 112.65 39.5 Favored Pre-proline 0 N--CA 1.424 -1.748 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 5' ' ' ASP . 23.1 Cg_exo -64.07 -49.41 3.85 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 121.971 1.781 . . . . 0.0 108.745 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -146.04 165.8 27.99 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.58 154.02 31.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.3 m -144.7 175.37 10.22 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.49 -23.27 62.64 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.38 0.61 . . . . 0.0 110.302 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -85.37 -56.9 3.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.03 79.74 6.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.023 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.8 pt -92.63 -13.92 8.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.796 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.15 -5.3 33.32 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.574 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.34 -24.33 50.78 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.524 -0.398 . . . . 0.0 110.13 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -115.61 87.35 2.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -91.69 94.68 1.96 Allowed Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.73 -0.748 . . . . 0.0 114.316 -172.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 74.11 -31.2 0.21 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.398 1.879 . . . . 0.0 114.051 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' GLY . 56.1 mmtt -90.54 -26.09 19.91 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.518 -174.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 32.8 m -137.54 165.06 27.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -136.45 141.62 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.1 p -103.33 135.73 44.4 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.357 0.599 . . . . 0.0 111.155 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.616 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 58.6 t -98.39 105.72 31.2 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.499 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.9 Cg_exo -78.21 135.79 13.9 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.73 2.286 . . . . 0.0 112.458 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -146.24 93.23 5.09 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-O 120.948 0.404 . . . . 0.0 112.074 177.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.5 Cg_exo -87.36 -27.64 5.06 Favored 'Cis proline' 0 C--N 1.354 0.865 0 C-N-CA 124.562 -1.016 . . . . 0.0 111.651 -7.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.499 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 48.1 mm -100.77 -57.32 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -100.6 158.33 16.02 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.22 -163.02 11.85 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.238 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 pp -101.3 154.39 18.82 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.76 0.329 . . . . 0.0 110.537 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -102.54 125.14 49.16 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.5 135.48 23.64 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.8 126.1 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.328 2.018 . . . . 0.0 111.128 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.76 -40.01 14.44 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.299 -1.598 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.476 178.922 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.452 ' H1 ' HD12 ' A' ' 1' ' ' LEU . 8.4 mp . . . . . 0 CA--C 1.512 -0.484 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.73 150.5 35.18 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.134 1.89 . . . . 0.0 110.658 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -77.59 -23.6 49.87 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.5 m -114.35 -11.55 12.52 Favored 'General case' 0 C--N 1.254 -3.57 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.003 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 61.16 20.98 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.093 0.957 . . . . 0.0 112.269 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 t -120.59 121.28 29.21 Favored Pre-proline 0 N--CA 1.423 -1.816 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.71 -39.48 8.76 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.682 1.588 . . . . 0.0 110.884 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -170.62 164.07 8.24 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.7 -173.28 4.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -155.77 172.68 17.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.46 -27.4 68.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.932 0.787 . . . . 0.0 112.353 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 91.6 m-85 -81.54 -21.36 38.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 9.4 mpt_? -130.74 82.15 2.04 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.64 -5.21 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.759 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -8.06 47.55 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.872 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.74 -34.03 77.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.834 0.35 . . . . 0.0 110.287 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.3 m -127.04 102.21 6.88 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.162 0.506 . . . . 0.0 110.855 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -136.45 146.61 18.58 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 74.84 -27.27 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 113.443 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 18' ' ' GLY . 49.8 mttm -119.68 -43.83 2.57 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -172.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 63.6 m -135.88 165.56 25.34 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -125.53 141.26 52.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m -90.37 123.32 34.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.844 0.354 . . . . 0.0 110.922 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.91 100.16 19.26 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 9.8 Cg_exo -73.37 123.88 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.785 2.323 . . . . 0.0 111.678 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -135.43 89.68 22.1 Favored Pre-proline 0 N--CA 1.417 -2.124 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.6 Cg_exo -88.03 -27.64 4.7 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.498 -1.043 . . . . 0.0 111.998 -6.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.0 mt -110.4 -48.43 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 O-C-N 122.191 -0.318 . . . . 0.0 111.258 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -75.27 144.51 42.48 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 25' ' ' PRO . . . -124.18 148.25 16.73 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 119.468 -1.349 . . . . 0.0 113.931 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.95 140.0 34.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.0 t -94.99 114.92 26.79 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.35 130.17 23.11 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.164 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.604 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 19.9 Cg_endo -61.04 118.1 4.94 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.81 2.34 . . . . 0.0 110.503 177.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -103.11 -43.84 5.37 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.42 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t . . . . . 0 C--N 1.304 -1.406 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.783 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.88 132.5 28.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.495 2.13 . . . . 0.0 110.571 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -92.11 76.95 5.35 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.5 m -126.07 -18.27 5.07 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.852 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 65.09 26.8 12.52 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.744 0.783 . . . . 0.0 109.593 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 m -114.81 109.42 47.57 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.211 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.72 -29.95 18.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.546 1.498 . . . . 0.0 111.138 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -163.06 -179.98 7.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 38.9 t -154.82 173.07 16.97 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 p -150.08 168.47 23.82 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.18 -25.22 60.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.38 0.61 . . . . 0.0 109.978 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -78.63 -46.57 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -118.45 95.48 4.89 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.941 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.631 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 32.6 pt -93.32 -3.92 10.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 0.7 22.27 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.648 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.21 -30.53 66.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -94.08 122.87 37.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -88.8 53.76 4.03 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.63 -174.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 70.43 -18.47 0.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.642 1.577 . . . . 0.0 113.604 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 18' ' ' GLY . 56.7 mtpt -84.77 -17.86 36.9 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.993 0.902 . . . . 0.0 111.092 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 60.5 m -136.51 153.29 51.06 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.668 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 m -125.28 142.57 51.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 29.5 p -108.53 156.32 19.64 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.63 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.628 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 7.5 p -120.5 118.48 30.95 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -80.96 124.08 4.85 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 121.902 1.735 . . . . 0.0 111.428 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -139.8 92.12 10.15 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.863 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.5 Cg_exo -87.57 -35.9 1.14 Allowed 'Cis proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.73 -0.946 . . . . 0.0 112.973 -5.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mm -100.13 -52.6 8.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.118 0.485 . . . . 0.0 110.295 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -101.44 150.2 23.28 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -154.03 -174.22 23.93 Favored Glycine 0 N--CA 1.415 -2.745 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.855 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.26 153.47 18.01 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.133 -0.534 . . . . 0.0 109.585 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 27.1 t -109.66 131.09 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.61 134.94 25.2 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 21.6 Cg_endo -63.15 124.63 14.25 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.225 1.95 . . . . 0.0 110.224 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -73.25 -54.95 7.14 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 C--N 1.292 -1.902 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.89 175.827 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.474 HD23 ' H1 ' ' A' ' 1' ' ' LEU . 2.2 pt? . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.98 135.82 49.6 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.17 1.913 . . . . 0.0 112.147 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -119.7 23.58 11.06 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 m -81.02 -57.57 3.47 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.007 -170.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 70.18 0.09 3.01 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.255 1.422 . . . . 0.0 113.008 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 m -68.3 121.46 80.49 Favored Pre-proline 0 N--CA 1.427 -1.615 0 C-N-CA 123.725 0.81 . . . . 0.0 108.871 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -72.67 -26.73 15.95 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.214 1.943 . . . . 0.0 112.569 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.78 -179.69 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 t -175.33 158.15 2.29 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 m -148.51 169.9 19.25 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 12' ' ' PHE . 3.3 pp -66.47 -24.45 66.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.633 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.401 ' N ' HD13 ' A' ' 11' ' ' LEU . 75.4 m-85 -78.81 -64.72 1.11 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.96 87.35 5.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.537 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 pt -92.71 -3.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.409 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.7 -0.44 87.79 Favored Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.476 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.29 -34.66 78.86 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.196 0.522 . . . . 0.0 110.115 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 57.4 m -97.64 116.5 29.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.21 128.45 5.8 Favored Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.177 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 79.07 -38.01 0.2 Allowed 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 127.023 2.129 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -119.87 -22.35 6.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -132.6 164.38 26.81 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.953 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -136.74 137.16 39.6 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 27.2 p -95.59 142.83 27.46 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.05 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.43 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 61.6 t -105.11 101.41 30.19 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 14.7 Cg_exo -69.25 128.01 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.501 2.134 . . . . 0.0 110.773 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.1 pp -134.42 88.49 29.66 Favored Pre-proline 0 N--CA 1.423 -1.813 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -87.88 -21.97 12.07 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.626 -8.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.5 -57.42 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.717 0.294 . . . . 0.0 110.772 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.62 145.84 24.12 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -148.79 -175.19 21.07 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 118.427 -1.844 . . . . 0.0 114.553 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.4 151.44 21.52 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.09 -1.055 . . . . 0.0 109.222 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.2 119.84 39.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.58 139.1 29.3 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.1 118.61 5.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.292 1.995 . . . . 0.0 109.897 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -104.35 -46.91 4.27 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.076 0.465 . . . . 0.0 109.971 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.277 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.244 0.778 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.24 137.32 30.97 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.655 2.903 . . . . 0.0 114.218 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -121.36 107.21 12.23 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.933 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 20' ' ' LYS . 61.9 m -78.77 -36.8 42.41 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 53.7 34.01 17.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.57 1.148 . . . . 0.0 111.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.4 m -83.85 121.26 75.93 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.651 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.05 -33.15 32.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 111.34 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -143.79 166.11 25.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.785 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 46.1 t -156.24 167.24 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.0 m -147.06 168.59 21.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.4 -26.23 64.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.514 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -81.82 -53.17 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.647 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -96.22 85.29 3.95 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.481 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.401 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 26.0 pt -99.68 -6.34 9.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.435 0.635 . . . . 0.0 109.504 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.43 -15.69 59.58 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.56 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.31 -36.87 84.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.776 0.798 . . . . 0.0 109.828 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -111.39 13.2 21.54 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.715 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -40.77 96.27 0.01 OUTLIER Glycine 0 N--CA 1.466 0.681 0 C-N-CA 125.364 1.459 . . . . 0.0 115.618 -173.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t70 71.09 -19.98 0.23 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.497 2.319 . . . . 0.0 113.177 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 18' ' ' GLY . 30.8 mmtp -79.26 -50.96 10.1 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.712 0.805 . . . . 0.0 111.23 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.5 m -128.76 -179.12 4.9 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -123.72 137.68 54.66 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.1 p -118.57 147.55 43.58 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.166 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 43.5 t -112.67 99.29 47.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 21.8 Cg_exo -70.86 122.99 9.34 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.567 2.178 . . . . 0.0 110.574 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -132.0 92.65 29.04 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-O 120.97 0.414 . . . . 0.0 111.961 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 94.7 Cg_endo -92.28 -7.76 38.08 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.057 -1.226 . . . . 0.0 111.737 -6.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 73.1 mt -121.09 -49.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.998 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.69 148.34 26.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -155.42 -175.84 26.92 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.685 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.58 165.15 11.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.5 t -114.65 136.0 53.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 130.3 22.95 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.932 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.64 131.28 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.577 1.518 . . . . 0.0 109.842 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -100.11 -37.89 8.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.42 -1.947 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.475 177.876 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 26.2 tp . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.15 131.26 44.13 Favored 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.356 2.037 . . . . 0.0 110.347 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -105.58 150.59 25.26 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.966 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m -77.97 -39.05 43.71 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.1 t70 73.89 6.0 4.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.857 1.663 . . . . 0.0 111.887 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -148.31 133.48 9.24 Favored Pre-proline 0 C--N 1.289 -2.031 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.29 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.46 -45.51 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.256 1.971 . . . . 0.0 111.411 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -117.96 171.49 8.04 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.502 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 43.3 t -166.81 175.6 7.66 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.2 m -147.11 165.11 30.95 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.86 -28.11 67.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.144 0.497 . . . . 0.0 110.774 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.85 -31.49 40.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.386 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -126.24 88.13 2.79 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.544 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 23.2 pt -99.43 -0.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.601 0.715 . . . . 0.0 110.799 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -8.09 87.17 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.33 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.45 -51.88 63.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.1 m -64.77 127.16 30.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.865 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -75.03 40.88 1.23 Allowed Glycine 0 CA--C 1.535 1.344 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.1 t70 71.07 -25.76 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.546 1.938 . . . . 0.0 114.145 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 18' ' ' GLY . 48.0 mttp -88.02 1.46 54.15 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.328 1.061 . . . . 0.0 110.201 -176.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.69 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 58.6 m -144.1 155.43 43.95 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -130.39 147.92 52.15 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.1 p -103.04 144.85 30.74 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.61 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 42.5 t -105.13 100.23 23.87 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.43 118.78 5.01 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.479 2.119 . . . . 0.0 111.787 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -139.42 97.57 8.38 Favored Pre-proline 0 N--CA 1.416 -2.134 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -84.91 -26.49 7.5 Favored 'Cis proline' 0 C--N 1.35 0.637 0 C-N-CA 124.551 -1.02 . . . . 0.0 111.618 -6.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -111.34 -54.95 4.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -93.2 151.47 19.8 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -158.32 176.17 35.33 Favored Glycine 0 C--N 1.28 -2.567 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.78 155.78 18.01 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.298 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -98.58 119.54 37.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.39 127.5 26.77 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.69 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.8 Cg_endo -61.23 134.18 50.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.482 2.122 . . . . 0.0 112.708 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.79 -13.0 32.23 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.768 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.307 -1.256 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.994 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.464 ' H2 ' HD23 ' A' ' 1' ' ' LEU . 2.1 pt? . . . . . 0 CA--C 1.507 -0.698 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.54 123.13 10.7 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.565 2.177 . . . . 0.0 113.464 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -116.45 -9.98 11.36 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.406 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 m -102.29 -34.32 9.26 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.439 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 61.66 30.81 18.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.435 1.094 . . . . 0.0 112.099 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.3 m -132.98 116.68 14.63 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.19 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.88 -35.1 27.97 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.71 2.274 . . . . 0.0 113.224 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.69 160.15 28.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.1 m -130.63 -177.76 4.49 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -142.94 170.35 15.86 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt -51.9 -43.44 63.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.488 0.661 . . . . 0.0 111.167 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -84.51 -37.8 20.84 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.081 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.9 88.02 2.64 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.195 0.521 . . . . 0.0 110.642 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.7 pt -109.29 -0.39 9.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.74 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.04 2.73 68.33 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.183 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.4 -27.52 69.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.333 0.587 . . . . 0.0 109.876 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -121.35 90.6 3.35 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -85.93 86.73 1.55 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.624 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t70 73.69 -20.88 0.28 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.631 1.972 . . . . 0.0 113.4 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.3 mttt -60.29 -39.91 88.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.721 0.772 . . . . 0.0 109.31 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.613 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.9 m -153.6 179.03 9.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -122.72 133.77 54.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.7 m -82.3 129.34 34.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 96.5 44.29 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 10.4 Cg_exo -74.86 129.48 12.51 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.26 2.64 . . . . 0.0 112.828 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.3 pt? -153.75 105.71 2.51 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.301 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.37 -29.29 5.5 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.603 -0.999 . . . . 0.0 111.619 -7.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt -110.94 -54.59 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -87.96 144.28 26.63 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.966 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -132.22 167.81 22.81 Favored Glycine 0 N--CA 1.402 -3.596 0 C-N-CA 119.546 -1.311 . . . . 0.0 114.666 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 mt -92.38 160.78 14.94 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 42.3 t -117.57 118.01 30.98 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.85 134.31 26.17 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.998 -176.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 42.6 Cg_endo -74.17 136.56 22.42 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.086 1.858 . . . . 0.0 112.744 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.95 -44.59 39.3 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.431 -1.417 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.028 179.272 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.429 ' H1 ' HD13 ' A' ' 1' ' ' LEU . 8.5 mp . . . . . 0 C--O 1.238 0.486 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.86 173.12 15.0 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.901 2.401 . . . . 0.0 112.032 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -93.43 111.75 23.49 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 34' ' ' PRO . 59.4 m -66.88 -35.5 80.17 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.575 -177.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 64.03 21.36 12.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.663 1.22 . . . . 0.0 109.24 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -105.24 113.09 64.87 Favored Pre-proline 0 N--CA 1.429 -1.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.978 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.39 -37.3 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.768 1.645 . . . . 0.0 111.718 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.18 -179.81 7.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.2 t -160.94 162.16 31.89 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.0 m -154.64 169.91 22.77 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 28' ' ' ILE . 2.3 pt? -72.86 -22.7 60.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.549 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -88.71 -14.02 38.24 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.694 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -136.22 79.61 1.78 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.1 pt -102.81 -4.24 9.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.19 0.519 . . . . 0.0 110.92 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.55 -0.95 64.29 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.247 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.39 -27.68 67.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.958 0.503 . . . . 0.0 110.427 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.49 128.66 55.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.46 103.14 0.39 Allowed Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.069 -177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.9 t70 76.94 -31.29 0.18 Allowed 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.67 1.988 . . . . 0.0 114.27 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -101.88 -42.06 6.27 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.487 0.661 . . . . 0.0 111.488 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.3 m -116.29 161.9 18.31 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.963 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -139.22 143.87 38.23 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 p -113.72 158.44 20.91 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.625 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.2 p -119.83 106.21 41.93 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.869 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.12 115.45 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.287 1.992 . . . . 0.0 110.357 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -133.36 98.34 15.41 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.252 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -89.09 -20.44 13.53 Favored 'Cis proline' 0 C--N 1.353 0.787 0 C-N-CA 124.724 -0.948 . . . . 0.0 111.785 -7.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.421 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 45.7 mm -108.72 -58.26 3.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.269 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.17 156.94 16.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -162.87 -176.69 35.19 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -106.4 155.84 19.14 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -103.32 130.47 50.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.42 136.87 29.57 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.472 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 28.7 Cg_endo -65.38 115.57 3.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.391 2.061 . . . . 0.0 109.912 175.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.98 -20.06 11.18 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.223 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 C--O 1.254 1.313 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.76 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 CA--C 1.514 -0.423 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.14 177.35 3.16 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.715 2.277 . . . . 0.0 110.757 172.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -79.36 92.08 5.14 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.023 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 83.5 m -127.49 -0.54 6.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.05 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.74 -0.59 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.633 1.173 . . . . 0.0 112.943 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.7 m -118.69 133.72 23.58 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.608 -0.682 . . . . 0.0 110.862 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.91 -36.69 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.799 2.332 . . . . 0.0 112.361 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -147.18 160.56 42.31 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.8 p -139.88 -168.31 2.48 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.0 p -141.97 166.25 25.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.88 -21.76 64.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.447 0.642 . . . . 0.0 110.996 175.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -76.49 -59.77 2.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.35 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.45 92.04 4.03 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.341 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.5 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 37.9 pt -91.6 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.25 -7.39 57.13 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.636 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.73 -25.67 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.55 0.69 . . . . 0.0 109.524 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 52.9 m -98.1 100.18 11.48 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -71.97 72.93 0.87 Allowed Glycine 0 C--N 1.312 -0.765 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 -170.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 72.31 -33.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.653 2.381 . . . . 0.0 113.909 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 18' ' ' GLY . 68.1 mttm -83.19 -22.69 33.12 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-O 122.207 1.004 . . . . 0.0 110.2 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 1.6 p -124.21 149.33 46.51 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.716 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.9 m -112.14 154.33 25.64 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.398 1.079 . . . . 0.0 108.629 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 61.0 m -88.28 129.14 35.45 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.24 95.64 8.5 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.95 124.3 4.39 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.899 1.733 . . . . 0.0 112.048 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.5 89.82 21.56 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.039 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -87.82 -29.94 3.15 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 124.309 -1.121 . . . . 0.0 111.191 -7.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 52.6 mt -110.1 -49.4 6.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.919 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -71.73 132.08 44.02 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.54 16.57 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.993 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -117.53 150.2 39.35 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.0 m -78.11 113.48 16.09 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.516 0.51 . . . . 0.0 110.394 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.69 134.96 20.23 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.15 112.99 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.694 1.596 . . . . 0.0 110.666 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.3 -38.64 11.39 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.426 -1.644 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.895 175.754 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.434 ' H3 ' HD21 ' A' ' 1' ' ' LEU . 3.7 mm? . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.22 143.74 17.86 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 122.074 1.849 . . . . 0.0 110.499 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -130.24 -177.48 4.33 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.5 m -110.89 -50.47 2.94 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.002 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 67.26 29.22 7.73 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.559 1.171 . . . . 0.0 109.566 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 m -91.58 116.04 65.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.129 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.36 -47.85 3.95 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.697 2.264 . . . . 0.0 113.099 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -145.21 -179.75 6.84 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 16.3 t -156.17 162.75 40.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.0 p -145.09 170.29 16.49 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.72 -20.04 64.38 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.629 0.728 . . . . 0.0 110.534 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.22 -59.08 2.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.865 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.84 90.73 4.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.444 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.519 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 38.0 pt -100.38 -0.14 10.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 109.643 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.86 64.92 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.243 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.85 -33.59 75.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 m -128.72 83.84 2.19 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -110.31 99.55 1.19 Allowed Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.939 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 72.63 -22.92 0.21 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.147 1.779 . . . . 0.0 112.685 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 18' ' ' GLY . 97.8 mttt -79.77 -29.96 40.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.548 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 p -163.0 177.75 8.92 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.044 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -134.49 148.71 50.61 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.6 p -124.7 139.86 53.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -113.84 102.7 55.06 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.47 142.34 65.01 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.897 2.398 . . . . 0.0 110.88 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -149.33 92.22 4.31 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-O 120.706 0.289 . . . . 0.0 111.75 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.0 Cg_exo -87.62 -28.48 4.2 Favored 'Cis proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.592 -1.003 . . . . 0.0 111.95 -6.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.1 mt -101.99 -47.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -109.05 154.02 22.82 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.36 177.51 33.33 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.772 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.6 163.97 12.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -108.3 140.22 41.88 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.05 138.85 24.25 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.63 132.06 45.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.89 1.727 . . . . 0.0 109.421 173.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.71 -43.64 12.42 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -173.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.405 -2.675 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.317 178.161 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.29 30.32 9.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.925 . . . . 0.0 111.743 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.2 m -54.48 122.94 41.31 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 124.311 1.044 . . . . 0.0 109.066 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.73 -25.12 61.39 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 123.046 2.498 . . . . 0.0 113.808 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -151.84 169.03 23.25 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 32.7 t -167.74 165.55 14.13 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.8 m -151.88 166.41 31.55 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.687 0.676 . . . . 0.0 109.724 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -70.03 -20.42 63.26 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.73 -34.84 34.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.453 0.644 . . . . 0.0 110.035 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -130.71 90.31 2.89 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.549 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 31.9 pt -91.23 -5.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.541 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.47 0.21 35.06 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.427 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.8 -24.4 63.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -129.98 85.06 2.26 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.54 133.1 11.36 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.579 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 74.01 -27.07 0.19 Allowed 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.574 1.95 . . . . 0.0 114.478 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -117.35 -39.41 3.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.3 m -127.02 175.26 8.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -139.82 141.62 36.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.2 p -108.32 148.18 30.43 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.379 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.569 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 3.7 p -110.42 108.05 58.42 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 123.76 5.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.045 1.83 . . . . 0.0 111.518 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.2 pt? -154.93 100.19 2.35 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.172 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.0 Cg_exo -81.38 -60.53 0.04 OUTLIER 'Cis proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.792 -0.92 . . . . 0.0 113.368 -2.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.37 -46.21 14.51 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 CA-C-O 121.174 0.511 . . . . 0.0 109.958 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.24 161.75 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -159.85 -179.72 34.84 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.916 -1.135 . . . . 0.0 111.5 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.0 161.25 13.73 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 t -105.28 130.27 53.45 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -122.4 125.5 26.49 Favored Pre-proline 0 N--CA 1.422 -1.853 0 CA-C-O 121.177 0.513 . . . . 0.0 110.338 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -87.5 125.99 2.18 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 122.012 1.808 . . . . 0.0 109.777 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 C--N 1.31 -1.109 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.738 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.434 -1.252 0 CA-C-O 120.364 0.126 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 59.44 15.57 4.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.702 1.201 . . . . 0.0 113.383 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.49 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 10.6 t -141.92 132.5 12.87 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.99 -55.8 1.18 Allowed 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.942 2.428 . . . . 0.0 114.848 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -138.21 -179.8 6.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.18 0.514 . . . . 0.0 112.228 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 40.4 t -159.35 167.93 27.63 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 65.7 p -160.19 176.82 11.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.68 -38.32 77.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -70.42 -55.49 8.91 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.622 ' HB3' HD23 ' A' ' 16' ' ' LEU . 32.5 mmt180 -109.54 89.18 2.93 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.291 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.549 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 5.8 pt -98.83 -9.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.467 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.48 73.54 Favored Glycine 0 C--N 1.316 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.979 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 13' ' ' ARG . 4.2 mm? -80.24 -32.66 38.38 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.654 -0.321 . . . . 0.0 111.611 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 6' ' ' SER . 69.3 m -133.36 109.49 9.39 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.321 0.581 . . . . 0.0 110.019 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.93 159.81 28.01 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.3 t70 77.01 -35.1 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.802 1.641 . . . . 0.0 112.633 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -113.37 -50.53 2.85 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.953 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.7 m -132.71 145.17 50.82 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -99.84 139.77 35.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.12 127.79 53.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 120.945 0.402 . . . . 0.0 111.917 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.53 106.54 56.59 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.198 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 22.3 Cg_exo -68.47 128.25 16.93 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.828 2.352 . . . . 0.0 111.983 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -131.91 89.56 38.33 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.12 0.486 . . . . 0.0 112.091 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -92.9 -13.77 20.53 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.527 -1.03 . . . . 0.0 110.674 -8.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 44.1 mm -106.85 -57.5 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.316 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 88.1 m-85 -96.86 146.76 24.63 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.78 162.4 27.04 Favored Glycine 0 N--CA 1.416 -2.693 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.418 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.19 156.67 16.22 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.43 121.69 35.08 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.15 126.66 26.93 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.424 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -64.96 116.49 3.86 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.262 1.975 . . . . 0.0 110.439 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--N 1.319 -0.755 0 C-N-CA 124.354 1.061 . . . . 0.0 112.791 -176.796 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.13 28.97 18.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.034 0.921 . . . . 0.0 110.493 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 p -102.8 129.12 26.4 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.04 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.35 -24.21 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.905 1.736 . . . . 0.0 111.128 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -165.79 172.48 11.67 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.1 t -153.01 156.64 39.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 p -150.11 169.12 22.01 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -70.45 -24.04 62.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.428 0.558 . . . . 0.0 110.247 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -82.11 -47.5 12.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.399 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -108.25 91.64 3.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt -100.01 -5.52 9.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 O-C-N 123.691 0.619 . . . . 0.0 109.458 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.8 -13.41 56.42 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.866 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.13 -26.57 64.01 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -141.71 90.31 2.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.471 0.653 . . . . 0.0 110.426 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.22 126.47 4.2 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 176.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 t70 72.71 -23.18 0.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.244 1.418 . . . . 0.0 112.595 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 18' ' ' GLY . 41.4 mmtm -90.54 -38.48 13.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 3.9 p -170.48 171.48 6.47 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 m -120.86 139.98 52.41 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.68 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 30.0 p -100.53 144.75 29.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.544 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 40.3 t -106.22 95.22 10.87 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 4.2 Cg_exo -76.48 118.31 4.85 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.945 2.43 . . . . 0.0 111.325 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -144.8 100.02 4.68 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.58 -33.54 2.69 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.052 -4.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 61.9 mt -102.42 -56.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.594 -174.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -101.15 162.29 13.0 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.631 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -164.46 177.23 40.18 Favored Glycine 0 N--CA 1.418 -2.552 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.481 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.96 156.38 16.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 124.044 0.496 . . . . 0.0 110.564 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 80.7 m -101.44 121.77 42.55 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.191 0.519 . . . . 0.0 110.722 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.19 130.22 23.23 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.27 149.4 85.76 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 122.367 2.045 . . . . 0.0 111.661 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--N 1.298 -1.632 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.133 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 120.384 0.135 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.65 34.65 22.26 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.489 0.715 . . . . 0.0 112.587 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 p -83.91 118.24 70.81 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.17 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -72.24 -30.42 13.05 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.378 1.385 . . . . 0.0 108.806 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -169.11 173.35 6.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.4 t -165.48 162.62 19.4 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.3 m -149.12 167.45 25.87 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.521 0.6 . . . . 0.0 110.362 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 11' ' ' LEU . 1.9 pt? -68.21 -26.7 65.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.851 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -83.0 -35.96 25.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.318 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -122.36 88.64 2.97 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt -101.12 -1.16 9.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.27 53.96 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.626 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.43 -40.57 74.98 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -133.76 138.87 46.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.299 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.18 14.26 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 75.3 -33.12 0.23 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.63 1.972 . . . . 0.0 113.48 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -113.78 -44.95 3.13 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -172.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -129.35 154.16 47.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.267 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -126.84 147.47 50.03 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.556 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 26.6 p -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.113 -1.035 . . . . 0.0 113.107 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.7 p -115.36 112.81 43.54 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-N 114.392 -1.277 . . . . 0.0 107.942 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -85.47 132.84 4.39 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.359 2.039 . . . . 0.0 112.538 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -151.97 99.87 2.9 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.2 Cg_exo -78.6 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 124.407 -1.08 . . . . 0.0 112.116 -4.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.84 -51.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.48 139.56 30.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.009 0.433 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -153.12 -177.49 26.73 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.4 mt -112.12 165.49 12.09 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 117.716 0.758 . . . . 0.0 110.743 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 m -89.19 135.8 33.37 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.304 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.35 128.95 24.69 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.71 123.97 11.01 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.086 1.857 . . . . 0.0 111.715 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 CA--C 1.484 -1.579 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.812 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.25 1.101 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 59.42 21.92 10.34 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.725 1.21 . . . . 0.0 111.127 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -80.16 126.84 78.48 Favored Pre-proline 0 N--CA 1.426 -1.649 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.32 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -74.03 -27.31 12.11 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.125 1.884 . . . . 0.0 111.846 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 45.7 p90 -164.62 179.6 6.53 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 18.5 t -174.24 162.11 3.61 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.3 p -156.88 -179.77 8.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -75.48 -20.19 58.93 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.647 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 58.1 m-85 -86.24 -34.78 20.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 5.5 mpt_? -121.37 87.42 2.75 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 36.4 pt -97.02 -7.6 9.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.875 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.66 -19.15 62.44 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.163 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.94 -37.84 87.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.252 0.549 . . . . 0.0 110.094 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.09 -23.16 35.89 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.914 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.33 56.56 6.15 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.434 -1.257 . . . . 0.0 115.793 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 71.9 -23.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.183 1.393 . . . . 0.0 113.672 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -81.65 -28.74 33.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 111.27 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 60.7 m -133.65 169.21 17.35 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.369 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -131.22 124.43 30.58 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 25.6 p -94.14 138.04 32.64 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.635 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -98.99 107.31 43.2 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.1 Cg_exo -79.09 127.91 7.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.713 2.276 . . . . 0.0 111.322 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.8 pt? -134.16 90.21 26.37 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.874 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.6 Cg_endo -90.78 -21.68 9.32 Favored 'Cis proline' 0 C--N 1.357 1.015 0 C-N-CA 124.399 -1.084 . . . . 0.0 111.704 -7.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 49.1 mm -108.85 -57.28 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.183 0.516 . . . . 0.0 110.296 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 58.9 t80 -88.45 146.15 25.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.46 -169.03 15.46 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.67 -1.729 . . . . 0.0 113.722 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 23.2 t -99.05 120.25 39.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -111.17 132.7 21.6 Favored Pre-proline 0 C--O 1.257 1.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.0 Cg_endo -54.51 119.62 6.7 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.172 2.582 . . . . 0.0 112.074 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.501 ' H ' ' HA ' ' A' ' 21' ' ' CYS . 17.0 t70 . . . . . 0 C--N 1.301 -1.531 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.641 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.2 m . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 60.88 18.62 8.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.102 0.961 . . . . 0.0 113.319 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -54.33 125.49 51.31 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.307 0.643 . . . . 0.0 109.307 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.44 -44.4 14.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.751 2.301 . . . . 0.0 113.36 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.82 145.74 51.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 t -158.29 163.46 37.35 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.0 m -151.37 178.6 9.11 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -77.22 -22.66 51.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 109.707 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -81.14 -45.21 16.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.908 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -112.52 89.06 2.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.877 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.5 pt -95.99 -5.97 9.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.698 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.19 6.92 32.88 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.53 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.97 -14.17 56.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.251 0.548 . . . . 0.0 110.081 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -134.43 107.59 7.67 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.48 100.03 1.1 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.864 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 t70 74.25 -29.47 0.2 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.293 2.237 . . . . 0.0 113.518 171.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -77.75 -50.11 13.04 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.811 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.3 m -130.75 171.06 13.54 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -133.81 144.03 48.74 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -98.33 144.83 27.31 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.494 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.572 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.3 p -108.31 100.48 37.59 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.262 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 10.0 Cg_exo -72.77 128.86 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.618 2.212 . . . . 0.0 111.339 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -135.99 89.5 20.48 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-O 120.897 0.38 . . . . 0.0 112.02 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.2 Cg_endo -89.45 -19.39 15.19 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.479 -1.05 . . . . 0.0 111.405 -7.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 70.6 mt -107.77 -59.68 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.98 146.18 24.08 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.32 178.24 32.92 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.922 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.37 165.03 12.98 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 124.15 0.559 . . . . 0.0 110.49 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 19.3 t -103.23 112.46 25.34 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.07 137.69 27.78 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.302 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.96 113.76 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.126 1.217 . . . . 0.0 109.321 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 C--N 1.301 -1.513 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.113 -176.164 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 74.03 -0.42 3.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.548 1.539 . . . . 0.0 110.471 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -85.95 118.0 69.71 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.616 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.64 -26.58 9.8 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.86 1.706 . . . . 0.0 112.383 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -157.92 -179.94 8.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.9 t -166.91 169.82 12.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.9 m -155.91 171.31 20.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.07 -24.36 61.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.364 0.602 . . . . 0.0 111.667 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -85.89 -59.11 2.4 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -81.48 80.08 7.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.9 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.13 -2.78 9.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.627 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.38 4.44 72.6 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.609 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.28 -31.69 33.54 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.902 -0.175 . . . . 0.0 111.316 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -114.11 105.5 13.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.81 127.01 6.2 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.099 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.0 t70 76.94 -36.21 0.25 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 126.851 2.06 . . . . 0.0 113.074 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -97.39 -40.83 8.51 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.46 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.763 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 62.3 m -139.4 168.69 19.26 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.047 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 m -135.97 148.92 48.68 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -106.58 143.62 34.43 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.018 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.22 102.41 18.1 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.8 Cg_exo -73.67 126.27 10.68 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.615 2.21 . . . . 0.0 112.691 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -156.88 97.27 2.11 Favored Pre-proline 0 N--CA 1.425 -1.701 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.692 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -81.85 -62.09 0.03 OUTLIER 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.097 -3.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.17 -43.6 14.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.979 0.418 . . . . 0.0 110.481 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -83.5 154.77 23.7 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -137.46 156.07 23.33 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.608 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 31' ' ' LEU . 4.1 pp -85.79 139.96 30.87 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.2 t -91.98 119.72 31.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -112.03 130.79 22.9 Favored Pre-proline 0 C--O 1.25 1.084 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.763 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 18.7 Cg_endo -58.31 126.55 21.8 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.686 2.257 . . . . 0.0 112.226 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--N 1.306 -1.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.216 -178.856 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t70 69.82 28.87 4.21 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.535 1.534 . . . . 0.0 108.811 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -97.56 109.55 50.98 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.852 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -73.14 -24.47 16.99 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.826 1.684 . . . . 0.0 112.142 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -157.49 -179.87 8.59 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.2 t -160.27 169.34 23.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 m -155.7 169.55 24.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.2 pt? -71.32 -30.15 65.88 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.06 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.44 -16.97 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.079 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -125.29 78.97 1.76 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.5 pt -99.71 -1.25 10.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.435 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.04 -15.81 69.96 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.69 -44.61 81.29 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -126.87 89.91 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.583 0.706 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.99 136.72 7.94 Favored Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t70 74.87 -25.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.242 1.417 . . . . 0.0 113.498 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -113.55 -39.44 4.07 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 p -148.86 169.66 20.02 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -122.53 144.4 49.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.8 139.83 52.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.782 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.12 107.9 60.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.576 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 57.5 Cg_endo -75.81 134.78 16.87 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.646 2.231 . . . . 0.0 112.246 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -150.09 90.95 4.33 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.797 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -86.0 -40.41 0.64 Allowed 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.619 -0.992 . . . . 0.0 111.829 -7.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.464 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 48.7 mm -98.48 -53.91 7.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.76 138.87 46.75 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -136.26 156.72 23.14 Favored Glycine 0 N--CA 1.41 -3.062 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.596 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.5 143.0 27.91 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.6 t -98.23 146.01 26.05 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.89 129.04 7.12 Favored Pre-proline 0 N--CA 1.425 -1.683 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.0 116.84 4.71 Favored 'Trans proline' 0 C--O 1.254 1.313 0 C-N-CA 121.8 1.667 . . . . 0.0 109.361 172.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.734 -177.259 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 17.68 9.13 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.73 1.212 . . . . 0.0 113.893 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.4 m -148.07 137.96 12.52 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.17 -60.03 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.561 2.174 . . . . 0.0 112.043 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -139.38 175.35 9.63 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 p -129.72 -165.47 1.53 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 m -148.5 163.92 35.76 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.95 -23.87 67.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.704 0.764 . . . . 0.0 110.848 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -80.78 -54.31 5.72 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.054 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -105.36 90.19 3.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.656 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 pt -97.21 -4.23 9.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.41 -5.19 41.83 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.199 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.47 -40.45 70.26 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.42 85.71 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.352 0.596 . . . . 0.0 109.919 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.97 126.45 4.06 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 67.41 -6.58 0.62 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.684 1.194 . . . . 0.0 112.416 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 18' ' ' GLY . 54.0 mttp -101.81 -55.94 2.39 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.815 0.846 . . . . 0.0 109.229 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -147.66 -179.92 7.22 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 130.75 53.76 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 31.2 p -121.13 129.78 53.44 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.925 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.97 118.68 62.41 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.7 Cg_exo -76.81 120.61 5.55 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.256 1.97 . . . . 0.0 111.823 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 2.0 pt? -150.63 101.12 3.1 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.786 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 3.0 Cg_endo -83.67 -57.0 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.652 -0.978 . . . . 0.0 111.897 -3.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.05 -44.17 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -83.69 151.88 25.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -126.34 144.65 15.24 Favored Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 119.07 -1.538 . . . . 0.0 114.055 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 88.9 mt -82.4 127.22 33.05 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.04 116.47 30.33 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.58 132.58 23.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.79 113.36 3.18 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.847 1.698 . . . . 0.0 110.094 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.452 -177.716 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 70.94 14.14 6.93 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 125.233 1.413 . . . . 0.0 109.535 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 m -108.4 115.99 57.15 Favored Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.182 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.93 -22.13 17.7 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.826 1.684 . . . . 0.0 109.905 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -169.94 -179.94 3.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.8 t -152.47 164.04 38.35 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 m -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.19 -26.51 64.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.071 0.462 . . . . 0.0 111.137 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -105.54 1.14 27.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -140.1 78.92 1.68 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.33 -4.34 9.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.111 0.482 . . . . 0.0 110.378 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.66 -12.23 73.76 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.203 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.39 -46.66 79.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 m -85.94 94.4 9.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -79.66 69.13 3.08 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.435 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 70.84 -21.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.328 1.851 . . . . 0.0 112.772 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.2 mttt -65.76 -34.13 77.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.215 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.557 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 71.1 m -138.5 -179.94 6.1 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.328 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 m -124.67 146.88 48.88 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -116.83 133.11 56.41 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.506 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.409 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.6 p -97.91 113.62 63.98 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.017 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.458 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 96.1 Cg_endo -88.42 148.09 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.787 2.325 . . . . 0.0 112.188 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.3 pt? -142.85 88.01 8.65 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.181 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -91.22 -18.68 13.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.09 -1.212 . . . . 0.0 111.597 -9.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.9 mt -108.47 -46.59 7.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.214 0.53 . . . . 0.0 111.357 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -99.54 146.7 26.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 25' ' ' PRO . . . -160.12 -168.8 22.58 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.597 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.0 156.21 23.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.64 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 6.5 t -101.26 141.02 34.75 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.9 134.58 15.98 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -67.87 140.28 50.14 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.748 1.632 . . . . 0.0 109.551 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--N 1.304 -1.373 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -176.2 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 16.5 t70 59.67 20.03 8.69 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.274 1.43 . . . . 0.0 110.762 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -82.86 112.65 39.5 Favored Pre-proline 0 N--CA 1.424 -1.748 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 5' ' ' ASP . 23.1 Cg_exo -64.07 -49.41 3.85 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 121.971 1.781 . . . . 0.0 108.745 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.419 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 77.0 m-85 -146.04 165.8 27.99 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.58 154.02 31.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.3 m -144.7 175.37 10.22 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.2 pt? -70.49 -23.27 62.64 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.38 0.61 . . . . 0.0 110.302 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -85.37 -56.9 3.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.03 79.74 6.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.023 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.8 pt -92.63 -13.92 8.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.796 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.15 -5.3 33.32 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.574 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 8' ' ' PHE . 3.4 mm? -77.34 -24.33 50.78 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.524 -0.398 . . . . 0.0 110.13 177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -115.61 87.35 2.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' LYS . . . -91.69 94.68 1.96 Allowed Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.73 -0.748 . . . . 0.0 114.316 -172.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 74.11 -31.2 0.21 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.398 1.879 . . . . 0.0 114.051 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 56.1 mmtt -90.54 -26.09 19.91 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.518 -174.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.442 ' HA ' ' H ' ' A' ' 35' ' ' ASP . 32.8 m -137.54 165.06 27.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -136.45 141.62 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.1 p -103.33 135.73 44.4 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.357 0.599 . . . . 0.0 111.155 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 58.6 t -98.39 105.72 31.2 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.9 Cg_exo -78.21 135.79 13.9 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.73 2.286 . . . . 0.0 112.458 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -146.24 93.23 5.09 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-O 120.948 0.404 . . . . 0.0 112.074 177.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.5 Cg_exo -87.36 -27.64 5.06 Favored 'Cis proline' 0 C--N 1.354 0.865 0 C-N-CA 124.562 -1.016 . . . . 0.0 111.651 -7.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 48.1 mm -100.77 -57.32 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -100.6 158.33 16.02 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.22 -163.02 11.85 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.238 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 pp -101.3 154.39 18.82 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.76 0.329 . . . . 0.0 110.537 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -102.54 125.14 49.16 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.5 135.48 23.64 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.8 126.1 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.328 2.018 . . . . 0.0 111.128 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' H ' ' HA ' ' A' ' 21' ' ' CYS . 31.0 t70 . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.5 m . . . . . 0 CA--C 1.509 -0.598 0 CA-C-O 120.818 0.342 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 61.16 20.98 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.093 0.957 . . . . 0.0 112.269 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 t -120.59 121.28 29.21 Favored Pre-proline 0 N--CA 1.423 -1.816 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.71 -39.48 8.76 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.682 1.588 . . . . 0.0 110.884 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -170.62 164.07 8.24 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.7 -173.28 4.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -155.77 172.68 17.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.46 -27.4 68.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.932 0.787 . . . . 0.0 112.353 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.429 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 91.6 m-85 -81.54 -21.36 38.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 9.4 mpt_? -130.74 82.15 2.04 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.64 -5.21 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.759 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -8.06 47.55 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.872 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.74 -34.03 77.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.834 0.35 . . . . 0.0 110.287 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.3 m -127.04 102.21 6.88 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.162 0.506 . . . . 0.0 110.855 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.45 146.61 18.58 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 74.84 -27.27 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 113.443 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -119.68 -43.83 2.57 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 63.6 m -135.88 165.56 25.34 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -125.53 141.26 52.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m -90.37 123.32 34.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.844 0.354 . . . . 0.0 110.922 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.91 100.16 19.26 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.513 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 9.8 Cg_exo -73.37 123.88 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.785 2.323 . . . . 0.0 111.678 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -135.43 89.68 22.1 Favored Pre-proline 0 N--CA 1.417 -2.124 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.6 Cg_exo -88.03 -27.64 4.7 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.498 -1.043 . . . . 0.0 111.998 -6.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.0 mt -110.4 -48.43 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 O-C-N 122.191 -0.318 . . . . 0.0 111.258 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -75.27 144.51 42.48 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 25' ' ' PRO . . . -124.18 148.25 16.73 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 119.468 -1.349 . . . . 0.0 113.931 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.95 140.0 34.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.0 t -94.99 114.92 26.79 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.35 130.17 23.11 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.164 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.588 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 19.9 Cg_endo -61.04 118.1 4.94 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.81 2.34 . . . . 0.0 110.503 177.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--N 1.304 -1.393 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.42 -175.831 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.433 -1.278 0 CA-C-O 120.345 0.117 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 65.09 26.8 12.52 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.744 0.783 . . . . 0.0 109.593 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 m -114.81 109.42 47.57 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.211 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.72 -29.95 18.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.546 1.498 . . . . 0.0 111.138 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -163.06 -179.98 7.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 38.9 t -154.82 173.07 16.97 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.416 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 47.9 p -150.08 168.47 23.82 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.1 pt? -73.18 -25.22 60.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.38 0.61 . . . . 0.0 109.978 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -78.63 -46.57 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -118.45 95.48 4.89 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.941 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.629 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 32.6 pt -93.32 -3.92 10.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 0.7 22.27 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.648 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.21 -30.53 66.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -94.08 122.87 37.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.8 53.76 4.03 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.63 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 70.43 -18.47 0.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.642 1.577 . . . . 0.0 113.604 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -84.77 -17.86 36.9 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.993 0.902 . . . . 0.0 111.092 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.5 m -136.51 153.29 51.06 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.668 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 m -125.28 142.57 51.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 29.5 p -108.53 156.32 19.64 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.63 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.64 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 7.5 p -120.5 118.48 30.95 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -80.96 124.08 4.85 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 121.902 1.735 . . . . 0.0 111.428 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -139.8 92.12 10.15 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.863 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.5 Cg_exo -87.57 -35.9 1.14 Allowed 'Cis proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.73 -0.946 . . . . 0.0 112.973 -5.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mm -100.13 -52.6 8.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.118 0.485 . . . . 0.0 110.295 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 99.3 m-85 -101.44 150.2 23.28 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -154.03 -174.22 23.93 Favored Glycine 0 N--CA 1.415 -2.745 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.855 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.26 153.47 18.01 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.133 -0.534 . . . . 0.0 109.585 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 27.1 t -109.66 131.09 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.61 134.94 25.2 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.15 124.63 14.25 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.225 1.95 . . . . 0.0 110.224 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 . . . . . 0 C--N 1.304 -1.382 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.641 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.434 -1.23 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 70.18 0.09 3.01 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.255 1.422 . . . . 0.0 113.008 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 m -68.3 121.46 80.49 Favored Pre-proline 0 N--CA 1.427 -1.615 0 C-N-CA 123.725 0.81 . . . . 0.0 108.871 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -72.67 -26.73 15.95 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.214 1.943 . . . . 0.0 112.569 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.78 -179.69 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 t -175.33 158.15 2.29 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 m -148.51 169.9 19.25 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 12' ' ' PHE . 3.3 pp -66.47 -24.45 66.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.633 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' N ' HD12 ' A' ' 11' ' ' LEU . 75.4 m-85 -78.81 -64.72 1.11 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.96 87.35 5.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.537 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 pt -92.71 -3.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.409 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.7 -0.44 87.79 Favored Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.476 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.29 -34.66 78.86 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.196 0.522 . . . . 0.0 110.115 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 57.4 m -97.64 116.5 29.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.21 128.45 5.8 Favored Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.177 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 79.07 -38.01 0.2 Allowed 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 127.023 2.129 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -119.87 -22.35 6.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -132.6 164.38 26.81 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.953 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -136.74 137.16 39.6 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 27.2 p -95.59 142.83 27.46 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.05 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 61.6 t -105.11 101.41 30.19 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 14.7 Cg_exo -69.25 128.01 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.501 2.134 . . . . 0.0 110.773 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.1 pp -134.42 88.49 29.66 Favored Pre-proline 0 N--CA 1.423 -1.813 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -87.88 -21.97 12.07 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.626 -8.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.5 -57.42 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.717 0.294 . . . . 0.0 110.772 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.62 145.84 24.12 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -148.79 -175.19 21.07 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 118.427 -1.844 . . . . 0.0 114.553 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.4 151.44 21.52 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.09 -1.055 . . . . 0.0 109.222 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.2 119.84 39.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.58 139.1 29.3 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.1 118.61 5.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.292 1.995 . . . . 0.0 109.897 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 121.076 0.465 . . . . 0.0 109.971 -174.321 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 20' ' ' LYS . 61.9 m . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 53.7 34.01 17.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.57 1.148 . . . . 0.0 111.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.4 m -83.85 121.26 75.93 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.651 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.05 -33.15 32.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 111.34 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -143.79 166.11 25.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.785 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 46.1 t -156.24 167.24 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 13' ' ' ARG . 20.0 m -147.06 168.59 21.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.4 -26.23 64.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.514 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -81.82 -53.17 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.647 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 10' ' ' SER . 8.4 mpt_? -96.22 85.29 3.95 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.481 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.401 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 26.0 pt -99.68 -6.34 9.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.435 0.635 . . . . 0.0 109.504 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.43 -15.69 59.58 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.56 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.31 -36.87 84.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.776 0.798 . . . . 0.0 109.828 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -111.39 13.2 21.54 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.715 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -40.77 96.27 0.01 OUTLIER Glycine 0 N--CA 1.466 0.681 0 C-N-CA 125.364 1.459 . . . . 0.0 115.618 -173.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t70 71.09 -19.98 0.23 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.497 2.319 . . . . 0.0 113.177 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.8 mmtp -79.26 -50.96 10.1 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.712 0.805 . . . . 0.0 111.23 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.5 m -128.76 -179.12 4.9 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -123.72 137.68 54.66 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 29.1 p -118.57 147.55 43.58 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.166 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.52 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 43.5 t -112.67 99.29 47.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 21.8 Cg_exo -70.86 122.99 9.34 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.567 2.178 . . . . 0.0 110.574 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -132.0 92.65 29.04 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-O 120.97 0.414 . . . . 0.0 111.961 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 94.7 Cg_endo -92.28 -7.76 38.08 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.057 -1.226 . . . . 0.0 111.737 -6.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 73.1 mt -121.09 -49.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.998 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.69 148.34 26.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -155.42 -175.84 26.92 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.685 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.58 165.15 11.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.5 t -114.65 136.0 53.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 130.3 22.95 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.932 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.64 131.28 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.577 1.518 . . . . 0.0 109.842 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--N 1.298 -1.662 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.372 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.497 -1.085 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.1 t70 73.89 6.0 4.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.857 1.663 . . . . 0.0 111.887 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -148.31 133.48 9.24 Favored Pre-proline 0 C--N 1.289 -2.031 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.29 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.46 -45.51 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.256 1.971 . . . . 0.0 111.411 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -117.96 171.49 8.04 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.502 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.551 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 43.3 t -166.81 175.6 7.66 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.2 m -147.11 165.11 30.95 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.86 -28.11 67.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.144 0.497 . . . . 0.0 110.774 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.85 -31.49 40.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.386 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -126.24 88.13 2.79 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.551 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 23.2 pt -99.43 -0.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.601 0.715 . . . . 0.0 110.799 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -8.09 87.17 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.33 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.45 -51.88 63.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.1 m -64.77 127.16 30.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.865 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.03 40.88 1.23 Allowed Glycine 0 CA--C 1.535 1.344 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.1 t70 71.07 -25.76 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.546 1.938 . . . . 0.0 114.145 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -88.02 1.46 54.15 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.328 1.061 . . . . 0.0 110.201 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 58.6 m -144.1 155.43 43.95 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -130.39 147.92 52.15 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.1 p -103.04 144.85 30.74 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.61 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 42.5 t -105.13 100.23 23.87 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.43 118.78 5.01 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.479 2.119 . . . . 0.0 111.787 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -139.42 97.57 8.38 Favored Pre-proline 0 N--CA 1.416 -2.134 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.255 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -84.91 -26.49 7.5 Favored 'Cis proline' 0 C--N 1.35 0.637 0 C-N-CA 124.551 -1.02 . . . . 0.0 111.618 -6.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -111.34 -54.95 4.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -93.2 151.47 19.8 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -158.32 176.17 35.33 Favored Glycine 0 C--N 1.28 -2.567 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.78 155.78 18.01 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.298 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -98.58 119.54 37.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.39 127.5 26.77 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.8 Cg_endo -61.23 134.18 50.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.482 2.122 . . . . 0.0 112.708 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--N 1.306 -1.302 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.768 176.878 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.442 -0.862 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 61.66 30.81 18.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.435 1.094 . . . . 0.0 112.099 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.3 m -132.98 116.68 14.63 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.19 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.88 -35.1 27.97 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.71 2.274 . . . . 0.0 113.224 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.69 160.15 28.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 58.1 m -130.63 -177.76 4.49 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -142.94 170.35 15.86 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt -51.9 -43.44 63.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.488 0.661 . . . . 0.0 111.167 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -84.51 -37.8 20.84 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.081 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.9 88.02 2.64 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.195 0.521 . . . . 0.0 110.642 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.7 pt -109.29 -0.39 9.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.74 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.04 2.73 68.33 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.183 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.4 -27.52 69.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.333 0.587 . . . . 0.0 109.876 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -121.35 90.6 3.35 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.93 86.73 1.55 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.624 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t70 73.69 -20.88 0.28 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.631 1.972 . . . . 0.0 113.4 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.29 -39.91 88.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.721 0.772 . . . . 0.0 109.31 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.628 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.9 m -153.6 179.03 9.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -122.72 133.77 54.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 9' ' ' CYS . 66.7 m -82.3 129.34 34.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 96.5 44.29 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 10.4 Cg_exo -74.86 129.48 12.51 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.26 2.64 . . . . 0.0 112.828 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.3 pt? -153.75 105.71 2.51 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.301 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.37 -29.29 5.5 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.603 -0.999 . . . . 0.0 111.619 -7.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt -110.94 -54.59 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -87.96 144.28 26.63 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.966 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -132.22 167.81 22.81 Favored Glycine 0 N--CA 1.402 -3.596 0 C-N-CA 119.546 -1.311 . . . . 0.0 114.666 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 mt -92.38 160.78 14.94 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 42.3 t -117.57 118.01 30.98 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.85 134.31 26.17 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.998 -176.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 42.6 Cg_endo -74.17 136.56 22.42 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.086 1.858 . . . . 0.0 112.744 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.696 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' A' ' 34' ' ' PRO . 59.4 m . . . . . 0 C--O 1.238 0.453 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 64.03 21.36 12.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.663 1.22 . . . . 0.0 109.24 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -105.24 113.09 64.87 Favored Pre-proline 0 N--CA 1.429 -1.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.978 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.39 -37.3 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.768 1.645 . . . . 0.0 111.718 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.18 -179.81 7.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.2 t -160.94 162.16 31.89 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.0 m -154.64 169.91 22.77 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -72.86 -22.7 60.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.549 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -88.71 -14.02 38.24 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.694 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -136.22 79.61 1.78 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.1 pt -102.81 -4.24 9.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.19 0.519 . . . . 0.0 110.92 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.55 -0.95 64.29 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.247 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.39 -27.68 67.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.958 0.503 . . . . 0.0 110.427 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.49 128.66 55.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.46 103.14 0.39 Allowed Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.069 -177.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.9 t70 76.94 -31.29 0.18 Allowed 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.67 1.988 . . . . 0.0 114.27 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -101.88 -42.06 6.27 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.487 0.661 . . . . 0.0 111.488 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.3 m -116.29 161.9 18.31 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.963 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -139.22 143.87 38.23 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 p -113.72 158.44 20.91 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.646 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.2 p -119.83 106.21 41.93 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.869 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.12 115.45 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.287 1.992 . . . . 0.0 110.357 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -133.36 98.34 15.41 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.252 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -89.09 -20.44 13.53 Favored 'Cis proline' 0 C--N 1.353 0.787 0 C-N-CA 124.724 -0.948 . . . . 0.0 111.785 -7.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 45.7 mm -108.72 -58.26 3.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.269 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.17 156.94 16.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -162.87 -176.69 35.19 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -106.4 155.84 19.14 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -103.32 130.47 50.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.42 136.87 29.57 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 28.7 Cg_endo -65.38 115.57 3.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.391 2.061 . . . . 0.0 109.912 175.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 C--N 1.304 -1.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.223 -174.657 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.74 -0.59 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.633 1.173 . . . . 0.0 112.943 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.7 m -118.69 133.72 23.58 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.608 -0.682 . . . . 0.0 110.862 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.91 -36.69 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.799 2.332 . . . . 0.0 112.361 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -147.18 160.56 42.31 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 30.8 p -139.88 -168.31 2.48 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.0 p -141.97 166.25 25.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.88 -21.76 64.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.447 0.642 . . . . 0.0 110.996 175.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -76.49 -59.77 2.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.35 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.45 92.04 4.03 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.341 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 37.9 pt -91.6 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.25 -7.39 57.13 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.636 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 3.9 mm? -67.73 -25.67 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.55 0.69 . . . . 0.0 109.524 174.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 52.9 m -98.1 100.18 11.48 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.97 72.93 0.87 Allowed Glycine 0 C--N 1.312 -0.765 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 72.31 -33.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.653 2.381 . . . . 0.0 113.909 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -83.19 -22.69 33.12 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-O 122.207 1.004 . . . . 0.0 110.2 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 1.6 p -124.21 149.33 46.51 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.716 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.9 m -112.14 154.33 25.64 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.398 1.079 . . . . 0.0 108.629 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 61.0 m -88.28 129.14 35.45 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.24 95.64 8.5 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.95 124.3 4.39 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.899 1.733 . . . . 0.0 112.048 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.7 pt? -135.5 89.82 21.56 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.039 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 3.4 Cg_exo -87.82 -29.94 3.15 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 124.309 -1.121 . . . . 0.0 111.191 -7.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 52.6 mt -110.1 -49.4 6.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.919 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -71.73 132.08 44.02 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.54 16.57 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.993 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -117.53 150.2 39.35 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.0 m -78.11 113.48 16.09 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.516 0.51 . . . . 0.0 110.394 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.69 134.96 20.23 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.15 112.99 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.694 1.596 . . . . 0.0 110.666 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.053 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.443 -0.806 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 67.26 29.22 7.73 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.559 1.171 . . . . 0.0 109.566 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 m -91.58 116.04 65.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.129 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.36 -47.85 3.95 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.697 2.264 . . . . 0.0 113.099 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -145.21 -179.75 6.84 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 16.3 t -156.17 162.75 40.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.0 p -145.09 170.29 16.49 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 28' ' ' ILE . 4.0 pp -68.72 -20.04 64.38 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.629 0.728 . . . . 0.0 110.534 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.22 -59.08 2.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.865 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.84 90.73 4.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.444 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 38.0 pt -100.38 -0.14 10.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 109.643 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.86 64.92 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.243 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.85 -33.59 75.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 m -128.72 83.84 2.19 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -110.31 99.55 1.19 Allowed Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.939 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 72.63 -22.92 0.21 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.147 1.779 . . . . 0.0 112.685 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 18' ' ' GLY . 97.8 mttt -79.77 -29.96 40.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.548 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 p -163.0 177.75 8.92 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.044 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -134.49 148.71 50.61 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.6 p -124.7 139.86 53.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -113.84 102.7 55.06 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.47 142.34 65.01 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.897 2.398 . . . . 0.0 110.88 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -149.33 92.22 4.31 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-O 120.706 0.289 . . . . 0.0 111.75 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.0 Cg_exo -87.62 -28.48 4.2 Favored 'Cis proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.592 -1.003 . . . . 0.0 111.95 -6.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.44 ' HA ' HD23 ' A' ' 11' ' ' LEU . 58.1 mt -101.99 -47.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -109.05 154.02 22.82 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.36 177.51 33.33 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.772 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.6 163.97 12.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -108.3 140.22 41.88 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.05 138.85 24.25 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.63 132.06 45.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.89 1.727 . . . . 0.0 109.421 173.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 C--N 1.297 -1.684 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -173.894 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.4 155.33 66.59 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.5 2.134 . . . . 0.0 110.712 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -119.34 145.55 46.07 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.557 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.3 m -92.98 -65.13 1.02 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.29 30.32 9.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.925 . . . . 0.0 111.743 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.2 m -54.48 122.94 41.31 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 124.311 1.044 . . . . 0.0 109.066 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.73 -25.12 61.39 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 123.046 2.498 . . . . 0.0 113.808 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -151.84 169.03 23.25 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 32.7 t -167.74 165.55 14.13 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.8 m -151.88 166.41 31.55 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.687 0.676 . . . . 0.0 109.724 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -70.03 -20.42 63.26 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.73 -34.84 34.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.453 0.644 . . . . 0.0 110.035 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -130.71 90.31 2.89 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.549 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 31.9 pt -91.23 -5.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.541 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.47 0.21 35.06 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.427 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.8 -24.4 63.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -129.98 85.06 2.26 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.54 133.1 11.36 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.579 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 74.01 -27.07 0.19 Allowed 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.574 1.95 . . . . 0.0 114.478 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -117.35 -39.41 3.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.3 m -127.02 175.26 8.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -139.82 141.62 36.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.2 p -108.32 148.18 30.43 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.379 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.569 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 3.7 p -110.42 108.05 58.42 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 123.76 5.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.045 1.83 . . . . 0.0 111.518 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.2 pt? -154.93 100.19 2.35 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.172 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.0 Cg_exo -81.38 -60.53 0.04 OUTLIER 'Cis proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.792 -0.92 . . . . 0.0 113.368 -2.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.37 -46.21 14.51 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 CA-C-O 121.174 0.511 . . . . 0.0 109.958 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.24 161.75 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -159.85 -179.72 34.84 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.916 -1.135 . . . . 0.0 111.5 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.0 161.25 13.73 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 t -105.28 130.27 53.45 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -122.4 125.5 26.49 Favored Pre-proline 0 N--CA 1.422 -1.853 0 CA-C-O 121.177 0.513 . . . . 0.0 110.338 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -87.5 125.99 2.18 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 122.012 1.808 . . . . 0.0 109.777 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.53 -34.03 35.88 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.422 -1.857 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.43 178.274 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 C--O 1.222 -0.351 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.29 141.57 82.52 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 122.965 2.444 . . . . 0.0 113.004 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -105.07 152.23 23.01 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -84.13 -40.54 18.11 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.807 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 59.44 15.57 4.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.702 1.201 . . . . 0.0 113.383 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.49 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 10.6 t -141.92 132.5 12.87 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.99 -55.8 1.18 Allowed 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.942 2.428 . . . . 0.0 114.848 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -138.21 -179.8 6.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.18 0.514 . . . . 0.0 112.228 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 40.4 t -159.35 167.93 27.63 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 65.7 p -160.19 176.82 11.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.68 -38.32 77.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -70.42 -55.49 8.91 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.622 ' HB3' HD23 ' A' ' 16' ' ' LEU . 32.5 mmt180 -109.54 89.18 2.93 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.291 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.549 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 5.8 pt -98.83 -9.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.467 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.48 73.54 Favored Glycine 0 C--N 1.316 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.979 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 13' ' ' ARG . 4.2 mm? -80.24 -32.66 38.38 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.654 -0.321 . . . . 0.0 111.611 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 6' ' ' SER . 69.3 m -133.36 109.49 9.39 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.321 0.581 . . . . 0.0 110.019 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.93 159.81 28.01 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.3 t70 77.01 -35.1 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.802 1.641 . . . . 0.0 112.633 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -113.37 -50.53 2.85 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.953 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.7 m -132.71 145.17 50.82 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -99.84 139.77 35.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.12 127.79 53.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 120.945 0.402 . . . . 0.0 111.917 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.53 106.54 56.59 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.198 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 22.3 Cg_exo -68.47 128.25 16.93 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.828 2.352 . . . . 0.0 111.983 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -131.91 89.56 38.33 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.12 0.486 . . . . 0.0 112.091 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -92.9 -13.77 20.53 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.527 -1.03 . . . . 0.0 110.674 -8.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 44.1 mm -106.85 -57.5 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.316 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 88.1 m-85 -96.86 146.76 24.63 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.78 162.4 27.04 Favored Glycine 0 N--CA 1.416 -2.693 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.418 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.19 156.67 16.22 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.43 121.69 35.08 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.15 126.66 26.93 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.424 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -64.96 116.49 3.86 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.262 1.975 . . . . 0.0 110.439 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.12 -35.76 67.44 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 124.354 1.061 . . . . 0.0 112.791 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 C--N 1.304 -1.372 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.865 177.737 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--O 1.238 0.471 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -64.2 136.31 51.1 Favored 'Trans proline' 0 CA--C 1.507 -0.844 0 C-N-CA 122.38 2.053 . . . . 0.0 110.892 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -108.92 167.51 10.03 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.0 m -88.4 -52.71 5.04 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.1 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.13 28.97 18.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.034 0.921 . . . . 0.0 110.493 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 p -102.8 129.12 26.4 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.04 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.35 -24.21 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.905 1.736 . . . . 0.0 111.128 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -165.79 172.48 11.67 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.1 t -153.01 156.64 39.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 p -150.11 169.12 22.01 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -70.45 -24.04 62.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.428 0.558 . . . . 0.0 110.247 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -82.11 -47.5 12.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.399 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -108.25 91.64 3.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt -100.01 -5.52 9.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 O-C-N 123.691 0.619 . . . . 0.0 109.458 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.8 -13.41 56.42 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.866 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.13 -26.57 64.01 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -141.71 90.31 2.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.471 0.653 . . . . 0.0 110.426 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.22 126.47 4.2 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 176.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 t70 72.71 -23.18 0.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.244 1.418 . . . . 0.0 112.595 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 18' ' ' GLY . 41.4 mmtm -90.54 -38.48 13.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 3.9 p -170.48 171.48 6.47 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 m -120.86 139.98 52.41 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.68 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 30.0 p -100.53 144.75 29.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.544 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 40.3 t -106.22 95.22 10.87 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 4.2 Cg_exo -76.48 118.31 4.85 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.945 2.43 . . . . 0.0 111.325 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -144.8 100.02 4.68 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.58 -33.54 2.69 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.052 -4.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 61.9 mt -102.42 -56.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.594 -174.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -101.15 162.29 13.0 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.631 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -164.46 177.23 40.18 Favored Glycine 0 N--CA 1.418 -2.552 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.481 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.96 156.38 16.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 124.044 0.496 . . . . 0.0 110.564 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 80.7 m -101.44 121.77 42.55 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.191 0.519 . . . . 0.0 110.722 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.19 130.22 23.23 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.27 149.4 85.76 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 122.367 2.045 . . . . 0.0 111.661 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -99.13 -1.16 40.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.133 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.432 -1.359 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.445 175.733 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.4 155.84 55.1 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 122.641 2.227 . . . . 0.0 112.645 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -116.99 178.19 4.44 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m -98.25 -47.09 5.59 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.799 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.65 34.65 22.26 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.489 0.715 . . . . 0.0 112.587 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 p -83.91 118.24 70.81 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.17 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -72.24 -30.42 13.05 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.378 1.385 . . . . 0.0 108.806 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -169.11 173.35 6.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.4 t -165.48 162.62 19.4 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.3 m -149.12 167.45 25.87 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.521 0.6 . . . . 0.0 110.362 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 11' ' ' LEU . 1.9 pt? -68.21 -26.7 65.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.851 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -83.0 -35.96 25.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.318 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -122.36 88.64 2.97 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt -101.12 -1.16 9.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.27 53.96 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.626 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.43 -40.57 74.98 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -133.76 138.87 46.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.299 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.18 14.26 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 75.3 -33.12 0.23 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.63 1.972 . . . . 0.0 113.48 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -113.78 -44.95 3.13 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -172.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -129.35 154.16 47.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.267 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -126.84 147.47 50.03 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.556 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 26.6 p -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.113 -1.035 . . . . 0.0 113.107 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.7 p -115.36 112.81 43.54 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-N 114.392 -1.277 . . . . 0.0 107.942 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -85.47 132.84 4.39 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.359 2.039 . . . . 0.0 112.538 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -151.97 99.87 2.9 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.2 Cg_exo -78.6 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 124.407 -1.08 . . . . 0.0 112.116 -4.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.84 -51.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.48 139.56 30.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.009 0.433 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -153.12 -177.49 26.73 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.4 mt -112.12 165.49 12.09 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 117.716 0.758 . . . . 0.0 110.743 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 m -89.19 135.8 33.37 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.304 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.35 128.95 24.69 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.71 123.97 11.01 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.086 1.857 . . . . 0.0 111.715 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -83.61 -36.0 24.23 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.417 -2.076 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.63 -179.649 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -52.09 135.34 51.89 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 123.122 2.548 . . . . 0.0 112.465 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -123.88 -171.34 2.3 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 m -85.67 -58.47 2.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 59.42 21.92 10.34 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.725 1.21 . . . . 0.0 111.127 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -80.16 126.84 78.48 Favored Pre-proline 0 N--CA 1.426 -1.649 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.32 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -74.03 -27.31 12.11 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.125 1.884 . . . . 0.0 111.846 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 45.7 p90 -164.62 179.6 6.53 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 18.5 t -174.24 162.11 3.61 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.3 p -156.88 -179.77 8.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -75.48 -20.19 58.93 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.647 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 58.1 m-85 -86.24 -34.78 20.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 5.5 mpt_? -121.37 87.42 2.75 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 36.4 pt -97.02 -7.6 9.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.875 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.66 -19.15 62.44 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.163 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.94 -37.84 87.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.252 0.549 . . . . 0.0 110.094 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.09 -23.16 35.89 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.914 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.33 56.56 6.15 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.434 -1.257 . . . . 0.0 115.793 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 71.9 -23.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.183 1.393 . . . . 0.0 113.672 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -81.65 -28.74 33.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 111.27 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 60.7 m -133.65 169.21 17.35 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.369 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -131.22 124.43 30.58 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 25.6 p -94.14 138.04 32.64 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.635 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -98.99 107.31 43.2 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.1 Cg_exo -79.09 127.91 7.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.713 2.276 . . . . 0.0 111.322 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.8 pt? -134.16 90.21 26.37 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.874 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.6 Cg_endo -90.78 -21.68 9.32 Favored 'Cis proline' 0 C--N 1.357 1.015 0 C-N-CA 124.399 -1.084 . . . . 0.0 111.704 -7.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 49.1 mm -108.85 -57.28 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.183 0.516 . . . . 0.0 110.296 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 58.9 t80 -88.45 146.15 25.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.46 -169.03 15.46 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.67 -1.729 . . . . 0.0 113.722 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 23.2 t -99.05 120.25 39.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -111.17 132.7 21.6 Favored Pre-proline 0 C--O 1.257 1.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.0 Cg_endo -54.51 119.62 6.7 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.172 2.582 . . . . 0.0 112.074 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.501 ' H ' ' HA ' ' A' ' 21' ' ' CYS . 17.0 t70 -88.91 -34.84 16.8 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.641 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.432 -1.373 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.622 175.408 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.8 139.37 79.83 Favored 'Trans proline' 0 C--O 1.25 1.089 0 C-N-CA 123.678 2.919 . . . . 0.0 111.767 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.412 ' NH1' ' HG3' ' A' ' 34' ' ' PRO . 26.9 mmt180 -129.62 126.84 39.35 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.132 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.2 m -128.38 -50.44 1.29 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 60.88 18.62 8.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.102 0.961 . . . . 0.0 113.319 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -54.33 125.49 51.31 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.307 0.643 . . . . 0.0 109.307 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.44 -44.4 14.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.751 2.301 . . . . 0.0 113.36 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.82 145.74 51.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 t -158.29 163.46 37.35 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.0 m -151.37 178.6 9.11 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -77.22 -22.66 51.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 109.707 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -81.14 -45.21 16.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.908 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -112.52 89.06 2.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.877 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.5 pt -95.99 -5.97 9.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.698 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.19 6.92 32.88 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.53 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.97 -14.17 56.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.251 0.548 . . . . 0.0 110.081 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -134.43 107.59 7.67 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.48 100.03 1.1 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.864 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 t70 74.25 -29.47 0.2 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.293 2.237 . . . . 0.0 113.518 171.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -77.75 -50.11 13.04 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.811 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.3 m -130.75 171.06 13.54 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -133.81 144.03 48.74 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -98.33 144.83 27.31 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.494 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.572 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.3 p -108.31 100.48 37.59 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.262 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 10.0 Cg_exo -72.77 128.86 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.618 2.212 . . . . 0.0 111.339 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -135.99 89.5 20.48 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-O 120.897 0.38 . . . . 0.0 112.02 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.2 Cg_endo -89.45 -19.39 15.19 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.479 -1.05 . . . . 0.0 111.405 -7.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 70.6 mt -107.77 -59.68 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.98 146.18 24.08 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.32 178.24 32.92 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.922 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.37 165.03 12.98 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 124.15 0.559 . . . . 0.0 110.49 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 19.3 t -103.23 112.46 25.34 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.07 137.69 27.78 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.302 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HG3' ' NH1' ' A' ' 3' ' ' ARG . 30.5 Cg_endo -67.96 113.76 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.126 1.217 . . . . 0.0 109.321 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -86.35 -6.69 58.88 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.113 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--N 1.276 -2.599 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.706 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.55 169.57 15.51 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.199 1.933 . . . . 0.0 110.525 174.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -71.46 0.8 7.5 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.048 0.928 . . . . 0.0 113.05 -175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.1 -17.77 54.52 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.115 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 74.03 -0.42 3.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.548 1.539 . . . . 0.0 110.471 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -85.95 118.0 69.71 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.616 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.64 -26.58 9.8 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.86 1.706 . . . . 0.0 112.383 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -157.92 -179.94 8.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.9 t -166.91 169.82 12.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.9 m -155.91 171.31 20.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.07 -24.36 61.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.364 0.602 . . . . 0.0 111.667 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -85.89 -59.11 2.4 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -81.48 80.08 7.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.9 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.13 -2.78 9.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.627 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.38 4.44 72.6 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.609 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.28 -31.69 33.54 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.902 -0.175 . . . . 0.0 111.316 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -114.11 105.5 13.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.81 127.01 6.2 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.099 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.0 t70 76.94 -36.21 0.25 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 126.851 2.06 . . . . 0.0 113.074 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' A' ' 36' ' ' VAL . 47.1 mmtm -97.39 -40.83 8.51 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.46 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.763 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 62.3 m -139.4 168.69 19.26 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.047 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 m -135.97 148.92 48.68 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -106.58 143.62 34.43 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.018 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.22 102.41 18.1 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.8 Cg_exo -73.67 126.27 10.68 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.615 2.21 . . . . 0.0 112.691 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -156.88 97.27 2.11 Favored Pre-proline 0 N--CA 1.425 -1.701 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.692 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -81.85 -62.09 0.03 OUTLIER 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.097 -3.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.17 -43.6 14.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.979 0.418 . . . . 0.0 110.481 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -83.5 154.77 23.7 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -137.46 156.07 23.33 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.608 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 31' ' ' LEU . 4.1 pp -85.79 139.96 30.87 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.2 t -91.98 119.72 31.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -112.03 130.79 22.9 Favored Pre-proline 0 C--O 1.25 1.084 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.763 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 18.7 Cg_endo -58.31 126.55 21.8 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.686 2.257 . . . . 0.0 112.226 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -91.36 -56.91 2.96 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.216 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 20' ' ' LYS . 16.6 m . . . . . 0 C--N 1.311 -1.082 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.027 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.63 129.63 14.86 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.048 2.499 . . . . 0.0 112.754 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.6 mtm105 -109.27 171.04 7.67 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.5 m -92.66 -22.52 19.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t70 69.82 28.87 4.21 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.535 1.534 . . . . 0.0 108.811 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -97.56 109.55 50.98 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.852 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -73.14 -24.47 16.99 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.826 1.684 . . . . 0.0 112.142 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -157.49 -179.87 8.59 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.2 t -160.27 169.34 23.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 m -155.7 169.55 24.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.2 pt? -71.32 -30.15 65.88 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.06 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.44 -16.97 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.079 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -125.29 78.97 1.76 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.5 pt -99.71 -1.25 10.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.435 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.04 -15.81 69.96 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.69 -44.61 81.29 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -126.87 89.91 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.583 0.706 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.99 136.72 7.94 Favored Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t70 74.87 -25.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.242 1.417 . . . . 0.0 113.498 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -113.55 -39.44 4.07 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 p -148.86 169.66 20.02 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -122.53 144.4 49.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.8 139.83 52.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.782 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.12 107.9 60.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.576 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 57.5 Cg_endo -75.81 134.78 16.87 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.646 2.231 . . . . 0.0 112.246 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -150.09 90.95 4.33 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.797 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -86.0 -40.41 0.64 Allowed 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.619 -0.992 . . . . 0.0 111.829 -7.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.464 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 48.7 mm -98.48 -53.91 7.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.76 138.87 46.75 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -136.26 156.72 23.14 Favored Glycine 0 N--CA 1.41 -3.062 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.596 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.5 143.0 27.91 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.6 t -98.23 146.01 26.05 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.89 129.04 7.12 Favored Pre-proline 0 N--CA 1.425 -1.683 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.0 116.84 4.71 Favored 'Trans proline' 0 C--O 1.254 1.313 0 C-N-CA 121.8 1.667 . . . . 0.0 109.361 172.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.61 -50.3 8.92 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.734 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.295 -1.771 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.804 -179.65 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.82 154.94 48.89 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.922 2.415 . . . . 0.0 111.364 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 43.9 mtp180 -103.95 170.21 8.05 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.649 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.2 m -85.1 -40.06 17.21 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 17.68 9.13 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.73 1.212 . . . . 0.0 113.893 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.4 m -148.07 137.96 12.52 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.17 -60.03 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.561 2.174 . . . . 0.0 112.043 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -139.38 175.35 9.63 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 p -129.72 -165.47 1.53 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 m -148.5 163.92 35.76 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.95 -23.87 67.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.704 0.764 . . . . 0.0 110.848 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -80.78 -54.31 5.72 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.054 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -105.36 90.19 3.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.656 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 pt -97.21 -4.23 9.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.41 -5.19 41.83 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.199 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.47 -40.45 70.26 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.42 85.71 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.352 0.596 . . . . 0.0 109.919 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.97 126.45 4.06 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 67.41 -6.58 0.62 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.684 1.194 . . . . 0.0 112.416 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 18' ' ' GLY . 54.0 mttp -101.81 -55.94 2.39 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.815 0.846 . . . . 0.0 109.229 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -147.66 -179.92 7.22 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 130.75 53.76 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 31.2 p -121.13 129.78 53.44 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.925 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.97 118.68 62.41 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.7 Cg_exo -76.81 120.61 5.55 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.256 1.97 . . . . 0.0 111.823 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 2.0 pt? -150.63 101.12 3.1 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.786 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 3.0 Cg_endo -83.67 -57.0 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.652 -0.978 . . . . 0.0 111.897 -3.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.05 -44.17 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -83.69 151.88 25.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -126.34 144.65 15.24 Favored Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 119.07 -1.538 . . . . 0.0 114.055 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 88.9 mt -82.4 127.22 33.05 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.04 116.47 30.33 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.58 132.58 23.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.79 113.36 3.18 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.847 1.698 . . . . 0.0 110.094 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.86 -8.14 56.26 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.452 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 C--N 1.285 -2.23 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.576 -177.749 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.3 128.68 14.01 Favored 'Trans proline' 0 CA--C 1.511 -0.673 0 C-N-CA 122.642 2.228 . . . . 0.0 110.299 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -109.96 146.82 34.59 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.001 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -98.69 -5.81 30.86 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.517 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 70.94 14.14 6.93 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 125.233 1.413 . . . . 0.0 109.535 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 m -108.4 115.99 57.15 Favored Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.182 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.93 -22.13 17.7 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.826 1.684 . . . . 0.0 109.905 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -169.94 -179.94 3.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.8 t -152.47 164.04 38.35 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 m -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.19 -26.51 64.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.071 0.462 . . . . 0.0 111.137 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -105.54 1.14 27.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -140.1 78.92 1.68 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.33 -4.34 9.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.111 0.482 . . . . 0.0 110.378 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.66 -12.23 73.76 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.203 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.39 -46.66 79.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 m -85.94 94.4 9.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -79.66 69.13 3.08 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.435 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 70.84 -21.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.328 1.851 . . . . 0.0 112.772 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.2 mttt -65.76 -34.13 77.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.215 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.557 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 71.1 m -138.5 -179.94 6.1 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.328 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 m -124.67 146.88 48.88 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -116.83 133.11 56.41 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.506 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.409 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.6 p -97.91 113.62 63.98 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.017 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 96.1 Cg_endo -88.42 148.09 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.787 2.325 . . . . 0.0 112.188 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.3 pt? -142.85 88.01 8.65 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.181 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -91.22 -18.68 13.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.09 -1.212 . . . . 0.0 111.597 -9.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.9 mt -108.47 -46.59 7.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.214 0.53 . . . . 0.0 111.357 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -99.54 146.7 26.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 25' ' ' PRO . . . -160.12 -168.8 22.58 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.597 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.0 156.21 23.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.64 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 6.5 t -101.26 141.02 34.75 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.9 134.58 15.98 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -67.87 140.28 50.14 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.748 1.632 . . . . 0.0 109.551 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.72 -35.08 33.98 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.418 -2.03 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.132 178.964 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.67 133.59 46.13 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 122.45 2.1 . . . . 0.0 111.702 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -81.87 95.65 7.39 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.482 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.7 m -74.54 -45.37 46.07 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 16.5 t70 59.67 20.03 8.69 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.274 1.43 . . . . 0.0 110.762 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -82.86 112.65 39.5 Favored Pre-proline 0 N--CA 1.424 -1.748 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 5' ' ' ASP . 23.1 Cg_exo -64.07 -49.41 3.85 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 121.971 1.781 . . . . 0.0 108.745 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.419 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 77.0 m-85 -146.04 165.8 27.99 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.58 154.02 31.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.3 m -144.7 175.37 10.22 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.2 pt? -70.49 -23.27 62.64 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.38 0.61 . . . . 0.0 110.302 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -85.37 -56.9 3.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.03 79.74 6.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.023 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.8 pt -92.63 -13.92 8.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.796 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.15 -5.3 33.32 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.574 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 8' ' ' PHE . 3.4 mm? -77.34 -24.33 50.78 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.524 -0.398 . . . . 0.0 110.13 177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -115.61 87.35 2.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' LYS . . . -91.69 94.68 1.96 Allowed Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.73 -0.748 . . . . 0.0 114.316 -172.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 74.11 -31.2 0.21 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.398 1.879 . . . . 0.0 114.051 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 56.1 mmtt -90.54 -26.09 19.91 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.518 -174.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.442 ' HA ' ' H ' ' A' ' 35' ' ' ASP . 32.8 m -137.54 165.06 27.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -136.45 141.62 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.1 p -103.33 135.73 44.4 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.357 0.599 . . . . 0.0 111.155 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 58.6 t -98.39 105.72 31.2 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.9 Cg_exo -78.21 135.79 13.9 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.73 2.286 . . . . 0.0 112.458 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -146.24 93.23 5.09 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-O 120.948 0.404 . . . . 0.0 112.074 177.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.5 Cg_exo -87.36 -27.64 5.06 Favored 'Cis proline' 0 C--N 1.354 0.865 0 C-N-CA 124.562 -1.016 . . . . 0.0 111.651 -7.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 48.1 mm -100.77 -57.32 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -100.6 158.33 16.02 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.22 -163.02 11.85 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.238 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 pp -101.3 154.39 18.82 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.76 0.329 . . . . 0.0 110.537 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -102.54 125.14 49.16 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.5 135.48 23.64 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.8 126.1 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.328 2.018 . . . . 0.0 111.128 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' H ' ' HA ' ' A' ' 21' ' ' CYS . 31.0 t70 -87.76 -40.01 14.44 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -175.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.299 -1.598 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.476 178.922 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.512 -0.484 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.73 150.5 35.18 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.134 1.89 . . . . 0.0 110.658 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -77.59 -23.6 49.87 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.5 m -114.35 -11.55 12.52 Favored 'General case' 0 C--N 1.254 -3.57 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.003 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 61.16 20.98 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.093 0.957 . . . . 0.0 112.269 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 t -120.59 121.28 29.21 Favored Pre-proline 0 N--CA 1.423 -1.816 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.71 -39.48 8.76 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.682 1.588 . . . . 0.0 110.884 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -170.62 164.07 8.24 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.7 -173.28 4.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -155.77 172.68 17.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.46 -27.4 68.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.932 0.787 . . . . 0.0 112.353 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.429 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 91.6 m-85 -81.54 -21.36 38.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 9.4 mpt_? -130.74 82.15 2.04 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.64 -5.21 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.759 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -8.06 47.55 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.872 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.74 -34.03 77.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.834 0.35 . . . . 0.0 110.287 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.3 m -127.04 102.21 6.88 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.162 0.506 . . . . 0.0 110.855 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.45 146.61 18.58 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 74.84 -27.27 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 113.443 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -119.68 -43.83 2.57 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 63.6 m -135.88 165.56 25.34 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -125.53 141.26 52.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m -90.37 123.32 34.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.844 0.354 . . . . 0.0 110.922 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.91 100.16 19.26 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.513 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 9.8 Cg_exo -73.37 123.88 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.785 2.323 . . . . 0.0 111.678 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -135.43 89.68 22.1 Favored Pre-proline 0 N--CA 1.417 -2.124 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.6 Cg_exo -88.03 -27.64 4.7 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.498 -1.043 . . . . 0.0 111.998 -6.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.0 mt -110.4 -48.43 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 O-C-N 122.191 -0.318 . . . . 0.0 111.258 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -75.27 144.51 42.48 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 25' ' ' PRO . . . -124.18 148.25 16.73 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 119.468 -1.349 . . . . 0.0 113.931 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.95 140.0 34.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.0 t -94.99 114.92 26.79 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.35 130.17 23.11 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.164 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.588 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 19.9 Cg_endo -61.04 118.1 4.94 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.81 2.34 . . . . 0.0 110.503 177.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -103.11 -43.84 5.37 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.42 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t . . . . . 0 C--N 1.304 -1.406 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.783 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.88 132.5 28.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.495 2.13 . . . . 0.0 110.571 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -92.11 76.95 5.35 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.5 m -126.07 -18.27 5.07 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.852 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 65.09 26.8 12.52 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.744 0.783 . . . . 0.0 109.593 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 m -114.81 109.42 47.57 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.211 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.72 -29.95 18.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.546 1.498 . . . . 0.0 111.138 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -163.06 -179.98 7.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 38.9 t -154.82 173.07 16.97 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.416 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 47.9 p -150.08 168.47 23.82 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.1 pt? -73.18 -25.22 60.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.38 0.61 . . . . 0.0 109.978 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -78.63 -46.57 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -118.45 95.48 4.89 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.941 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.629 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 32.6 pt -93.32 -3.92 10.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 0.7 22.27 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.648 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.21 -30.53 66.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -94.08 122.87 37.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.8 53.76 4.03 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.63 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 70.43 -18.47 0.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.642 1.577 . . . . 0.0 113.604 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -84.77 -17.86 36.9 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.993 0.902 . . . . 0.0 111.092 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.5 m -136.51 153.29 51.06 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.668 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 m -125.28 142.57 51.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 29.5 p -108.53 156.32 19.64 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.63 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.64 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 7.5 p -120.5 118.48 30.95 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -80.96 124.08 4.85 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 121.902 1.735 . . . . 0.0 111.428 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -139.8 92.12 10.15 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.863 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.5 Cg_exo -87.57 -35.9 1.14 Allowed 'Cis proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.73 -0.946 . . . . 0.0 112.973 -5.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mm -100.13 -52.6 8.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.118 0.485 . . . . 0.0 110.295 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 99.3 m-85 -101.44 150.2 23.28 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -154.03 -174.22 23.93 Favored Glycine 0 N--CA 1.415 -2.745 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.855 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.26 153.47 18.01 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.133 -0.534 . . . . 0.0 109.585 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 27.1 t -109.66 131.09 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.61 134.94 25.2 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.15 124.63 14.25 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.225 1.95 . . . . 0.0 110.224 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -73.25 -54.95 7.14 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 C--N 1.292 -1.902 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.89 175.827 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.98 135.82 49.6 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.17 1.913 . . . . 0.0 112.147 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -119.7 23.58 11.06 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 m -81.02 -57.57 3.47 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.007 -170.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 70.18 0.09 3.01 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.255 1.422 . . . . 0.0 113.008 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 m -68.3 121.46 80.49 Favored Pre-proline 0 N--CA 1.427 -1.615 0 C-N-CA 123.725 0.81 . . . . 0.0 108.871 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -72.67 -26.73 15.95 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.214 1.943 . . . . 0.0 112.569 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.78 -179.69 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 t -175.33 158.15 2.29 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 m -148.51 169.9 19.25 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 12' ' ' PHE . 3.3 pp -66.47 -24.45 66.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.633 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' N ' HD12 ' A' ' 11' ' ' LEU . 75.4 m-85 -78.81 -64.72 1.11 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.96 87.35 5.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.537 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 pt -92.71 -3.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.409 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.7 -0.44 87.79 Favored Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.476 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.29 -34.66 78.86 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.196 0.522 . . . . 0.0 110.115 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 57.4 m -97.64 116.5 29.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.21 128.45 5.8 Favored Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.177 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 79.07 -38.01 0.2 Allowed 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 127.023 2.129 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -119.87 -22.35 6.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -132.6 164.38 26.81 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.953 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -136.74 137.16 39.6 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 27.2 p -95.59 142.83 27.46 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.05 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 61.6 t -105.11 101.41 30.19 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 14.7 Cg_exo -69.25 128.01 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.501 2.134 . . . . 0.0 110.773 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.1 pp -134.42 88.49 29.66 Favored Pre-proline 0 N--CA 1.423 -1.813 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -87.88 -21.97 12.07 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.626 -8.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.5 -57.42 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.717 0.294 . . . . 0.0 110.772 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.62 145.84 24.12 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -148.79 -175.19 21.07 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 118.427 -1.844 . . . . 0.0 114.553 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.4 151.44 21.52 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.09 -1.055 . . . . 0.0 109.222 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.2 119.84 39.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.58 139.1 29.3 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.1 118.61 5.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.292 1.995 . . . . 0.0 109.897 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -104.35 -46.91 4.27 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.076 0.465 . . . . 0.0 109.971 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.277 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 36' ' ' VAL . 96.1 mt . . . . . 0 C--O 1.244 0.778 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.24 137.32 30.97 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.655 2.903 . . . . 0.0 114.218 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -121.36 107.21 12.23 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.933 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 20' ' ' LYS . 61.9 m -78.77 -36.8 42.41 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 53.7 34.01 17.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.57 1.148 . . . . 0.0 111.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.4 m -83.85 121.26 75.93 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.651 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.05 -33.15 32.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 111.34 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -143.79 166.11 25.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.785 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 46.1 t -156.24 167.24 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 13' ' ' ARG . 20.0 m -147.06 168.59 21.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.4 -26.23 64.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.514 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -81.82 -53.17 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.647 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 10' ' ' SER . 8.4 mpt_? -96.22 85.29 3.95 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.481 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.401 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 26.0 pt -99.68 -6.34 9.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.435 0.635 . . . . 0.0 109.504 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.43 -15.69 59.58 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.56 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.31 -36.87 84.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.776 0.798 . . . . 0.0 109.828 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -111.39 13.2 21.54 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.715 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -40.77 96.27 0.01 OUTLIER Glycine 0 N--CA 1.466 0.681 0 C-N-CA 125.364 1.459 . . . . 0.0 115.618 -173.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t70 71.09 -19.98 0.23 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.497 2.319 . . . . 0.0 113.177 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.8 mmtp -79.26 -50.96 10.1 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.712 0.805 . . . . 0.0 111.23 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.5 m -128.76 -179.12 4.9 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -123.72 137.68 54.66 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 29.1 p -118.57 147.55 43.58 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.166 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.52 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 43.5 t -112.67 99.29 47.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 21.8 Cg_exo -70.86 122.99 9.34 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.567 2.178 . . . . 0.0 110.574 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -132.0 92.65 29.04 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-O 120.97 0.414 . . . . 0.0 111.961 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 94.7 Cg_endo -92.28 -7.76 38.08 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.057 -1.226 . . . . 0.0 111.737 -6.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 73.1 mt -121.09 -49.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.998 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.69 148.34 26.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -155.42 -175.84 26.92 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.685 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.58 165.15 11.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.5 t -114.65 136.0 53.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 130.3 22.95 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.932 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.64 131.28 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.577 1.518 . . . . 0.0 109.842 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -100.11 -37.89 8.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.402 ' O ' HD22 ' A' ' 1' ' ' LEU . 3.9 p . . . . . 0 N--CA 1.42 -1.947 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.475 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 26.2 tp . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.15 131.26 44.13 Favored 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.356 2.037 . . . . 0.0 110.347 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -105.58 150.59 25.26 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.966 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m -77.97 -39.05 43.71 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.1 t70 73.89 6.0 4.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.857 1.663 . . . . 0.0 111.887 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -148.31 133.48 9.24 Favored Pre-proline 0 C--N 1.289 -2.031 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.29 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.46 -45.51 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.256 1.971 . . . . 0.0 111.411 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -117.96 171.49 8.04 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.502 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.551 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 43.3 t -166.81 175.6 7.66 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.2 m -147.11 165.11 30.95 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.86 -28.11 67.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.144 0.497 . . . . 0.0 110.774 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.85 -31.49 40.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.386 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -126.24 88.13 2.79 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.551 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 23.2 pt -99.43 -0.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.601 0.715 . . . . 0.0 110.799 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -8.09 87.17 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.33 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.45 -51.88 63.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.1 m -64.77 127.16 30.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.865 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.03 40.88 1.23 Allowed Glycine 0 CA--C 1.535 1.344 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.1 t70 71.07 -25.76 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.546 1.938 . . . . 0.0 114.145 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -88.02 1.46 54.15 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.328 1.061 . . . . 0.0 110.201 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 58.6 m -144.1 155.43 43.95 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -130.39 147.92 52.15 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.1 p -103.04 144.85 30.74 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.61 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 42.5 t -105.13 100.23 23.87 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.43 118.78 5.01 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.479 2.119 . . . . 0.0 111.787 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -139.42 97.57 8.38 Favored Pre-proline 0 N--CA 1.416 -2.134 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.255 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -84.91 -26.49 7.5 Favored 'Cis proline' 0 C--N 1.35 0.637 0 C-N-CA 124.551 -1.02 . . . . 0.0 111.618 -6.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -111.34 -54.95 4.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -93.2 151.47 19.8 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -158.32 176.17 35.33 Favored Glycine 0 C--N 1.28 -2.567 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.78 155.78 18.01 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.298 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -98.58 119.54 37.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.39 127.5 26.77 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.8 Cg_endo -61.23 134.18 50.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.482 2.122 . . . . 0.0 112.708 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.79 -13.0 32.23 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.768 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.307 -1.256 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.994 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.507 -0.698 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.54 123.13 10.7 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.565 2.177 . . . . 0.0 113.464 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -116.45 -9.98 11.36 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.406 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 m -102.29 -34.32 9.26 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.439 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 61.66 30.81 18.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.435 1.094 . . . . 0.0 112.099 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.3 m -132.98 116.68 14.63 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.19 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.88 -35.1 27.97 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.71 2.274 . . . . 0.0 113.224 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.69 160.15 28.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 58.1 m -130.63 -177.76 4.49 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -142.94 170.35 15.86 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt -51.9 -43.44 63.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.488 0.661 . . . . 0.0 111.167 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -84.51 -37.8 20.84 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.081 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.9 88.02 2.64 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.195 0.521 . . . . 0.0 110.642 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.7 pt -109.29 -0.39 9.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.74 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.04 2.73 68.33 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.183 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.4 -27.52 69.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.333 0.587 . . . . 0.0 109.876 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -121.35 90.6 3.35 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.93 86.73 1.55 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.624 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t70 73.69 -20.88 0.28 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.631 1.972 . . . . 0.0 113.4 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.29 -39.91 88.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.721 0.772 . . . . 0.0 109.31 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.628 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.9 m -153.6 179.03 9.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -122.72 133.77 54.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 9' ' ' CYS . 66.7 m -82.3 129.34 34.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 96.5 44.29 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 10.4 Cg_exo -74.86 129.48 12.51 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.26 2.64 . . . . 0.0 112.828 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.3 pt? -153.75 105.71 2.51 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.301 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.37 -29.29 5.5 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.603 -0.999 . . . . 0.0 111.619 -7.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt -110.94 -54.59 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -87.96 144.28 26.63 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.966 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -132.22 167.81 22.81 Favored Glycine 0 N--CA 1.402 -3.596 0 C-N-CA 119.546 -1.311 . . . . 0.0 114.666 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 mt -92.38 160.78 14.94 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 42.3 t -117.57 118.01 30.98 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.85 134.31 26.17 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.998 -176.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 42.6 Cg_endo -74.17 136.56 22.42 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.086 1.858 . . . . 0.0 112.744 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.95 -44.59 39.3 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.431 -1.417 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.028 179.272 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.238 0.486 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.86 173.12 15.0 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.901 2.401 . . . . 0.0 112.032 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -93.43 111.75 23.49 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' A' ' 34' ' ' PRO . 59.4 m -66.88 -35.5 80.17 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.575 -177.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 64.03 21.36 12.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.663 1.22 . . . . 0.0 109.24 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -105.24 113.09 64.87 Favored Pre-proline 0 N--CA 1.429 -1.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.978 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.39 -37.3 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.768 1.645 . . . . 0.0 111.718 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.18 -179.81 7.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.2 t -160.94 162.16 31.89 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.0 m -154.64 169.91 22.77 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -72.86 -22.7 60.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.549 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -88.71 -14.02 38.24 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.694 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -136.22 79.61 1.78 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.1 pt -102.81 -4.24 9.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.19 0.519 . . . . 0.0 110.92 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.55 -0.95 64.29 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.247 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.39 -27.68 67.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.958 0.503 . . . . 0.0 110.427 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.49 128.66 55.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.46 103.14 0.39 Allowed Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.069 -177.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.9 t70 76.94 -31.29 0.18 Allowed 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.67 1.988 . . . . 0.0 114.27 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -101.88 -42.06 6.27 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.487 0.661 . . . . 0.0 111.488 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.3 m -116.29 161.9 18.31 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.963 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -139.22 143.87 38.23 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 p -113.72 158.44 20.91 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.646 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.2 p -119.83 106.21 41.93 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.869 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.12 115.45 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.287 1.992 . . . . 0.0 110.357 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -133.36 98.34 15.41 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.252 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -89.09 -20.44 13.53 Favored 'Cis proline' 0 C--N 1.353 0.787 0 C-N-CA 124.724 -0.948 . . . . 0.0 111.785 -7.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 45.7 mm -108.72 -58.26 3.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.269 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.17 156.94 16.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -162.87 -176.69 35.19 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -106.4 155.84 19.14 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -103.32 130.47 50.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.42 136.87 29.57 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 28.7 Cg_endo -65.38 115.57 3.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.391 2.061 . . . . 0.0 109.912 175.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.98 -20.06 11.18 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.223 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 C--O 1.254 1.313 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.76 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 CA--C 1.514 -0.423 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.14 177.35 3.16 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.715 2.277 . . . . 0.0 110.757 172.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -79.36 92.08 5.14 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.023 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 83.5 m -127.49 -0.54 6.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.05 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.74 -0.59 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.633 1.173 . . . . 0.0 112.943 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.7 m -118.69 133.72 23.58 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.608 -0.682 . . . . 0.0 110.862 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.91 -36.69 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.799 2.332 . . . . 0.0 112.361 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -147.18 160.56 42.31 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 30.8 p -139.88 -168.31 2.48 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.0 p -141.97 166.25 25.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.88 -21.76 64.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.447 0.642 . . . . 0.0 110.996 175.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -76.49 -59.77 2.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.35 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.45 92.04 4.03 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.341 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 37.9 pt -91.6 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.25 -7.39 57.13 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.636 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 3.9 mm? -67.73 -25.67 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.55 0.69 . . . . 0.0 109.524 174.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 52.9 m -98.1 100.18 11.48 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.97 72.93 0.87 Allowed Glycine 0 C--N 1.312 -0.765 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 72.31 -33.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.653 2.381 . . . . 0.0 113.909 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -83.19 -22.69 33.12 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-O 122.207 1.004 . . . . 0.0 110.2 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 1.6 p -124.21 149.33 46.51 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.716 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.9 m -112.14 154.33 25.64 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.398 1.079 . . . . 0.0 108.629 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 61.0 m -88.28 129.14 35.45 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.24 95.64 8.5 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.95 124.3 4.39 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.899 1.733 . . . . 0.0 112.048 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.7 pt? -135.5 89.82 21.56 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.039 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 3.4 Cg_exo -87.82 -29.94 3.15 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 124.309 -1.121 . . . . 0.0 111.191 -7.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 52.6 mt -110.1 -49.4 6.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.919 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -71.73 132.08 44.02 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.54 16.57 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.993 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -117.53 150.2 39.35 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.0 m -78.11 113.48 16.09 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.516 0.51 . . . . 0.0 110.394 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.69 134.96 20.23 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.15 112.99 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.694 1.596 . . . . 0.0 110.666 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.3 -38.64 11.39 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.426 -1.644 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.895 175.754 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.22 143.74 17.86 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 122.074 1.849 . . . . 0.0 110.499 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -130.24 -177.48 4.33 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.5 m -110.89 -50.47 2.94 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.002 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 67.26 29.22 7.73 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.559 1.171 . . . . 0.0 109.566 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 m -91.58 116.04 65.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.129 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.36 -47.85 3.95 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.697 2.264 . . . . 0.0 113.099 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -145.21 -179.75 6.84 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 16.3 t -156.17 162.75 40.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.0 p -145.09 170.29 16.49 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 28' ' ' ILE . 4.0 pp -68.72 -20.04 64.38 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.629 0.728 . . . . 0.0 110.534 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.22 -59.08 2.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.865 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.84 90.73 4.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.444 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 38.0 pt -100.38 -0.14 10.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 109.643 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.86 64.92 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.243 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.85 -33.59 75.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 m -128.72 83.84 2.19 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -110.31 99.55 1.19 Allowed Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.939 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 72.63 -22.92 0.21 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.147 1.779 . . . . 0.0 112.685 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 18' ' ' GLY . 97.8 mttt -79.77 -29.96 40.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.548 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 p -163.0 177.75 8.92 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.044 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -134.49 148.71 50.61 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.6 p -124.7 139.86 53.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -113.84 102.7 55.06 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.47 142.34 65.01 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.897 2.398 . . . . 0.0 110.88 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -149.33 92.22 4.31 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-O 120.706 0.289 . . . . 0.0 111.75 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.0 Cg_exo -87.62 -28.48 4.2 Favored 'Cis proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.592 -1.003 . . . . 0.0 111.95 -6.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.44 ' HA ' HD23 ' A' ' 11' ' ' LEU . 58.1 mt -101.99 -47.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -109.05 154.02 22.82 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.36 177.51 33.33 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.772 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.6 163.97 12.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -108.3 140.22 41.88 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.05 138.85 24.25 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.63 132.06 45.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.89 1.727 . . . . 0.0 109.421 173.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.71 -43.64 12.42 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -173.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.405 -2.675 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.317 178.161 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.29 30.32 9.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.925 . . . . 0.0 111.743 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.2 m -54.48 122.94 41.31 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 124.311 1.044 . . . . 0.0 109.066 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.73 -25.12 61.39 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 123.046 2.498 . . . . 0.0 113.808 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -151.84 169.03 23.25 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 32.7 t -167.74 165.55 14.13 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.8 m -151.88 166.41 31.55 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.687 0.676 . . . . 0.0 109.724 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -70.03 -20.42 63.26 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.73 -34.84 34.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.453 0.644 . . . . 0.0 110.035 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -130.71 90.31 2.89 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.549 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 31.9 pt -91.23 -5.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.541 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.47 0.21 35.06 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.427 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.8 -24.4 63.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -129.98 85.06 2.26 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.54 133.1 11.36 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.579 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 74.01 -27.07 0.19 Allowed 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.574 1.95 . . . . 0.0 114.478 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -117.35 -39.41 3.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.3 m -127.02 175.26 8.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -139.82 141.62 36.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.2 p -108.32 148.18 30.43 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.379 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.569 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 3.7 p -110.42 108.05 58.42 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 123.76 5.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.045 1.83 . . . . 0.0 111.518 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.2 pt? -154.93 100.19 2.35 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.172 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.0 Cg_exo -81.38 -60.53 0.04 OUTLIER 'Cis proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.792 -0.92 . . . . 0.0 113.368 -2.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.37 -46.21 14.51 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 CA-C-O 121.174 0.511 . . . . 0.0 109.958 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.24 161.75 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -159.85 -179.72 34.84 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.916 -1.135 . . . . 0.0 111.5 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.0 161.25 13.73 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 t -105.28 130.27 53.45 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -122.4 125.5 26.49 Favored Pre-proline 0 N--CA 1.422 -1.853 0 CA-C-O 121.177 0.513 . . . . 0.0 110.338 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -87.5 125.99 2.18 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 122.012 1.808 . . . . 0.0 109.777 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 C--N 1.31 -1.109 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.738 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.434 -1.252 0 CA-C-O 120.364 0.126 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 59.44 15.57 4.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.702 1.201 . . . . 0.0 113.383 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.49 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 10.6 t -141.92 132.5 12.87 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.99 -55.8 1.18 Allowed 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.942 2.428 . . . . 0.0 114.848 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -138.21 -179.8 6.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.18 0.514 . . . . 0.0 112.228 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 40.4 t -159.35 167.93 27.63 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 65.7 p -160.19 176.82 11.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.68 -38.32 77.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -70.42 -55.49 8.91 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.622 ' HB3' HD23 ' A' ' 16' ' ' LEU . 32.5 mmt180 -109.54 89.18 2.93 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.291 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.549 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 5.8 pt -98.83 -9.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.467 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.48 73.54 Favored Glycine 0 C--N 1.316 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.979 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 13' ' ' ARG . 4.2 mm? -80.24 -32.66 38.38 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.654 -0.321 . . . . 0.0 111.611 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 6' ' ' SER . 69.3 m -133.36 109.49 9.39 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.321 0.581 . . . . 0.0 110.019 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.93 159.81 28.01 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.3 t70 77.01 -35.1 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.802 1.641 . . . . 0.0 112.633 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -113.37 -50.53 2.85 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.953 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.7 m -132.71 145.17 50.82 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -99.84 139.77 35.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.12 127.79 53.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 120.945 0.402 . . . . 0.0 111.917 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.53 106.54 56.59 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.198 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 22.3 Cg_exo -68.47 128.25 16.93 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.828 2.352 . . . . 0.0 111.983 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -131.91 89.56 38.33 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.12 0.486 . . . . 0.0 112.091 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -92.9 -13.77 20.53 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.527 -1.03 . . . . 0.0 110.674 -8.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 44.1 mm -106.85 -57.5 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.316 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 88.1 m-85 -96.86 146.76 24.63 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.78 162.4 27.04 Favored Glycine 0 N--CA 1.416 -2.693 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.418 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.19 156.67 16.22 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.43 121.69 35.08 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.15 126.66 26.93 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.424 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -64.96 116.49 3.86 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.262 1.975 . . . . 0.0 110.439 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--N 1.319 -0.755 0 C-N-CA 124.354 1.061 . . . . 0.0 112.791 -176.796 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.13 28.97 18.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.034 0.921 . . . . 0.0 110.493 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 p -102.8 129.12 26.4 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.04 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.35 -24.21 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.905 1.736 . . . . 0.0 111.128 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -165.79 172.48 11.67 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.1 t -153.01 156.64 39.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 p -150.11 169.12 22.01 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -70.45 -24.04 62.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.428 0.558 . . . . 0.0 110.247 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -82.11 -47.5 12.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.399 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -108.25 91.64 3.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt -100.01 -5.52 9.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 O-C-N 123.691 0.619 . . . . 0.0 109.458 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.8 -13.41 56.42 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.866 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.13 -26.57 64.01 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -141.71 90.31 2.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.471 0.653 . . . . 0.0 110.426 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.22 126.47 4.2 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 176.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 t70 72.71 -23.18 0.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.244 1.418 . . . . 0.0 112.595 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 18' ' ' GLY . 41.4 mmtm -90.54 -38.48 13.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 3.9 p -170.48 171.48 6.47 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 m -120.86 139.98 52.41 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.68 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 30.0 p -100.53 144.75 29.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.544 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 40.3 t -106.22 95.22 10.87 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 4.2 Cg_exo -76.48 118.31 4.85 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.945 2.43 . . . . 0.0 111.325 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -144.8 100.02 4.68 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.58 -33.54 2.69 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.052 -4.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 61.9 mt -102.42 -56.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.594 -174.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -101.15 162.29 13.0 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.631 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -164.46 177.23 40.18 Favored Glycine 0 N--CA 1.418 -2.552 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.481 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.96 156.38 16.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 124.044 0.496 . . . . 0.0 110.564 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 80.7 m -101.44 121.77 42.55 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.191 0.519 . . . . 0.0 110.722 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.19 130.22 23.23 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.27 149.4 85.76 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 122.367 2.045 . . . . 0.0 111.661 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--N 1.298 -1.632 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.133 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 120.384 0.135 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.65 34.65 22.26 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.489 0.715 . . . . 0.0 112.587 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 p -83.91 118.24 70.81 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.17 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -72.24 -30.42 13.05 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.378 1.385 . . . . 0.0 108.806 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -169.11 173.35 6.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.4 t -165.48 162.62 19.4 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.3 m -149.12 167.45 25.87 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.521 0.6 . . . . 0.0 110.362 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 11' ' ' LEU . 1.9 pt? -68.21 -26.7 65.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.851 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -83.0 -35.96 25.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.318 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -122.36 88.64 2.97 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt -101.12 -1.16 9.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.27 53.96 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.626 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.43 -40.57 74.98 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -133.76 138.87 46.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.299 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.18 14.26 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 75.3 -33.12 0.23 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.63 1.972 . . . . 0.0 113.48 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -113.78 -44.95 3.13 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -172.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -129.35 154.16 47.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.267 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -126.84 147.47 50.03 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.556 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 26.6 p -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.113 -1.035 . . . . 0.0 113.107 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.7 p -115.36 112.81 43.54 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-N 114.392 -1.277 . . . . 0.0 107.942 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -85.47 132.84 4.39 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.359 2.039 . . . . 0.0 112.538 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -151.97 99.87 2.9 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.2 Cg_exo -78.6 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 124.407 -1.08 . . . . 0.0 112.116 -4.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.84 -51.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.48 139.56 30.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.009 0.433 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -153.12 -177.49 26.73 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.4 mt -112.12 165.49 12.09 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 117.716 0.758 . . . . 0.0 110.743 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 m -89.19 135.8 33.37 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.304 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.35 128.95 24.69 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.71 123.97 11.01 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.086 1.857 . . . . 0.0 111.715 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 CA--C 1.484 -1.579 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.812 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.25 1.101 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 59.42 21.92 10.34 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.725 1.21 . . . . 0.0 111.127 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -80.16 126.84 78.48 Favored Pre-proline 0 N--CA 1.426 -1.649 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.32 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -74.03 -27.31 12.11 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.125 1.884 . . . . 0.0 111.846 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 45.7 p90 -164.62 179.6 6.53 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 18.5 t -174.24 162.11 3.61 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.3 p -156.88 -179.77 8.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -75.48 -20.19 58.93 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.647 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 58.1 m-85 -86.24 -34.78 20.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 5.5 mpt_? -121.37 87.42 2.75 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 36.4 pt -97.02 -7.6 9.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.875 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.66 -19.15 62.44 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.163 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.94 -37.84 87.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.252 0.549 . . . . 0.0 110.094 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.09 -23.16 35.89 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.914 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.33 56.56 6.15 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.434 -1.257 . . . . 0.0 115.793 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 71.9 -23.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.183 1.393 . . . . 0.0 113.672 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -81.65 -28.74 33.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 111.27 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 60.7 m -133.65 169.21 17.35 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.369 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -131.22 124.43 30.58 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 25.6 p -94.14 138.04 32.64 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.635 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -98.99 107.31 43.2 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.1 Cg_exo -79.09 127.91 7.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.713 2.276 . . . . 0.0 111.322 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.8 pt? -134.16 90.21 26.37 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.874 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.6 Cg_endo -90.78 -21.68 9.32 Favored 'Cis proline' 0 C--N 1.357 1.015 0 C-N-CA 124.399 -1.084 . . . . 0.0 111.704 -7.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 49.1 mm -108.85 -57.28 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.183 0.516 . . . . 0.0 110.296 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 58.9 t80 -88.45 146.15 25.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.46 -169.03 15.46 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.67 -1.729 . . . . 0.0 113.722 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 23.2 t -99.05 120.25 39.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -111.17 132.7 21.6 Favored Pre-proline 0 C--O 1.257 1.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.0 Cg_endo -54.51 119.62 6.7 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.172 2.582 . . . . 0.0 112.074 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.501 ' H ' ' HA ' ' A' ' 21' ' ' CYS . 17.0 t70 . . . . . 0 C--N 1.301 -1.531 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.641 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.2 m . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 60.88 18.62 8.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.102 0.961 . . . . 0.0 113.319 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -54.33 125.49 51.31 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.307 0.643 . . . . 0.0 109.307 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.44 -44.4 14.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.751 2.301 . . . . 0.0 113.36 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.82 145.74 51.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 t -158.29 163.46 37.35 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.0 m -151.37 178.6 9.11 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -77.22 -22.66 51.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 109.707 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -81.14 -45.21 16.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.908 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -112.52 89.06 2.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.877 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.5 pt -95.99 -5.97 9.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.698 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.19 6.92 32.88 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.53 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.97 -14.17 56.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.251 0.548 . . . . 0.0 110.081 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -134.43 107.59 7.67 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.48 100.03 1.1 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.864 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 t70 74.25 -29.47 0.2 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.293 2.237 . . . . 0.0 113.518 171.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -77.75 -50.11 13.04 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.811 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.3 m -130.75 171.06 13.54 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -133.81 144.03 48.74 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -98.33 144.83 27.31 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.494 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.572 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.3 p -108.31 100.48 37.59 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.262 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 10.0 Cg_exo -72.77 128.86 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.618 2.212 . . . . 0.0 111.339 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -135.99 89.5 20.48 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-O 120.897 0.38 . . . . 0.0 112.02 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.2 Cg_endo -89.45 -19.39 15.19 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.479 -1.05 . . . . 0.0 111.405 -7.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 70.6 mt -107.77 -59.68 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.98 146.18 24.08 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.32 178.24 32.92 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.922 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.37 165.03 12.98 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 124.15 0.559 . . . . 0.0 110.49 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 19.3 t -103.23 112.46 25.34 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.07 137.69 27.78 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.302 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.96 113.76 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.126 1.217 . . . . 0.0 109.321 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 C--N 1.301 -1.513 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.113 -176.164 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 74.03 -0.42 3.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.548 1.539 . . . . 0.0 110.471 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -85.95 118.0 69.71 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.616 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.64 -26.58 9.8 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.86 1.706 . . . . 0.0 112.383 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -157.92 -179.94 8.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.9 t -166.91 169.82 12.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.9 m -155.91 171.31 20.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.07 -24.36 61.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.364 0.602 . . . . 0.0 111.667 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -85.89 -59.11 2.4 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -81.48 80.08 7.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.9 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.13 -2.78 9.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.627 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.38 4.44 72.6 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.609 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.28 -31.69 33.54 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.902 -0.175 . . . . 0.0 111.316 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -114.11 105.5 13.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.81 127.01 6.2 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.099 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.0 t70 76.94 -36.21 0.25 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 126.851 2.06 . . . . 0.0 113.074 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -97.39 -40.83 8.51 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.46 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.763 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 62.3 m -139.4 168.69 19.26 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.047 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 m -135.97 148.92 48.68 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -106.58 143.62 34.43 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.018 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.22 102.41 18.1 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.8 Cg_exo -73.67 126.27 10.68 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.615 2.21 . . . . 0.0 112.691 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -156.88 97.27 2.11 Favored Pre-proline 0 N--CA 1.425 -1.701 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.692 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -81.85 -62.09 0.03 OUTLIER 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.097 -3.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.17 -43.6 14.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.979 0.418 . . . . 0.0 110.481 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -83.5 154.77 23.7 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -137.46 156.07 23.33 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.608 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 31' ' ' LEU . 4.1 pp -85.79 139.96 30.87 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.2 t -91.98 119.72 31.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -112.03 130.79 22.9 Favored Pre-proline 0 C--O 1.25 1.084 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.763 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 18.7 Cg_endo -58.31 126.55 21.8 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.686 2.257 . . . . 0.0 112.226 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--N 1.306 -1.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.216 -178.856 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t70 69.82 28.87 4.21 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.535 1.534 . . . . 0.0 108.811 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -97.56 109.55 50.98 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.852 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -73.14 -24.47 16.99 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.826 1.684 . . . . 0.0 112.142 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -157.49 -179.87 8.59 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.2 t -160.27 169.34 23.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 m -155.7 169.55 24.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.2 pt? -71.32 -30.15 65.88 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.06 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.44 -16.97 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.079 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -125.29 78.97 1.76 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.5 pt -99.71 -1.25 10.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.435 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.04 -15.81 69.96 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.69 -44.61 81.29 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -126.87 89.91 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.583 0.706 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.99 136.72 7.94 Favored Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t70 74.87 -25.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.242 1.417 . . . . 0.0 113.498 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -113.55 -39.44 4.07 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 p -148.86 169.66 20.02 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -122.53 144.4 49.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.8 139.83 52.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.782 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.12 107.9 60.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.576 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 57.5 Cg_endo -75.81 134.78 16.87 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.646 2.231 . . . . 0.0 112.246 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -150.09 90.95 4.33 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.797 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -86.0 -40.41 0.64 Allowed 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.619 -0.992 . . . . 0.0 111.829 -7.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.464 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 48.7 mm -98.48 -53.91 7.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.76 138.87 46.75 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -136.26 156.72 23.14 Favored Glycine 0 N--CA 1.41 -3.062 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.596 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.5 143.0 27.91 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.6 t -98.23 146.01 26.05 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.89 129.04 7.12 Favored Pre-proline 0 N--CA 1.425 -1.683 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.0 116.84 4.71 Favored 'Trans proline' 0 C--O 1.254 1.313 0 C-N-CA 121.8 1.667 . . . . 0.0 109.361 172.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.734 -177.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 17.68 9.13 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.73 1.212 . . . . 0.0 113.893 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.4 m -148.07 137.96 12.52 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.17 -60.03 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.561 2.174 . . . . 0.0 112.043 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -139.38 175.35 9.63 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 p -129.72 -165.47 1.53 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 m -148.5 163.92 35.76 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.95 -23.87 67.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.704 0.764 . . . . 0.0 110.848 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -80.78 -54.31 5.72 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.054 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -105.36 90.19 3.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.656 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 pt -97.21 -4.23 9.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.41 -5.19 41.83 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.199 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.47 -40.45 70.26 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.42 85.71 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.352 0.596 . . . . 0.0 109.919 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.97 126.45 4.06 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 67.41 -6.58 0.62 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.684 1.194 . . . . 0.0 112.416 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 18' ' ' GLY . 54.0 mttp -101.81 -55.94 2.39 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.815 0.846 . . . . 0.0 109.229 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -147.66 -179.92 7.22 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 130.75 53.76 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 31.2 p -121.13 129.78 53.44 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.925 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.97 118.68 62.41 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.7 Cg_exo -76.81 120.61 5.55 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.256 1.97 . . . . 0.0 111.823 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 2.0 pt? -150.63 101.12 3.1 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.786 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 3.0 Cg_endo -83.67 -57.0 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.652 -0.978 . . . . 0.0 111.897 -3.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.05 -44.17 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -83.69 151.88 25.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -126.34 144.65 15.24 Favored Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 119.07 -1.538 . . . . 0.0 114.055 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 88.9 mt -82.4 127.22 33.05 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.04 116.47 30.33 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.58 132.58 23.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.79 113.36 3.18 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.847 1.698 . . . . 0.0 110.094 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.452 -177.716 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 70.94 14.14 6.93 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 125.233 1.413 . . . . 0.0 109.535 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 m -108.4 115.99 57.15 Favored Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.182 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.93 -22.13 17.7 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.826 1.684 . . . . 0.0 109.905 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -169.94 -179.94 3.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.8 t -152.47 164.04 38.35 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 m -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.19 -26.51 64.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.071 0.462 . . . . 0.0 111.137 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -105.54 1.14 27.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -140.1 78.92 1.68 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.33 -4.34 9.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.111 0.482 . . . . 0.0 110.378 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.66 -12.23 73.76 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.203 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.39 -46.66 79.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 m -85.94 94.4 9.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -79.66 69.13 3.08 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.435 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 70.84 -21.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.328 1.851 . . . . 0.0 112.772 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.2 mttt -65.76 -34.13 77.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.215 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.557 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 71.1 m -138.5 -179.94 6.1 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.328 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 m -124.67 146.88 48.88 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -116.83 133.11 56.41 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.506 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.409 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.6 p -97.91 113.62 63.98 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.017 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.458 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 96.1 Cg_endo -88.42 148.09 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.787 2.325 . . . . 0.0 112.188 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.3 pt? -142.85 88.01 8.65 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.181 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -91.22 -18.68 13.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.09 -1.212 . . . . 0.0 111.597 -9.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.9 mt -108.47 -46.59 7.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.214 0.53 . . . . 0.0 111.357 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -99.54 146.7 26.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 25' ' ' PRO . . . -160.12 -168.8 22.58 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.597 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.0 156.21 23.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.64 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 6.5 t -101.26 141.02 34.75 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.9 134.58 15.98 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -67.87 140.28 50.14 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.748 1.632 . . . . 0.0 109.551 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--N 1.304 -1.373 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -176.2 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 16.5 t70 59.67 20.03 8.69 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.274 1.43 . . . . 0.0 110.762 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -82.86 112.65 39.5 Favored Pre-proline 0 N--CA 1.424 -1.748 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 5' ' ' ASP . 23.1 Cg_exo -64.07 -49.41 3.85 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 121.971 1.781 . . . . 0.0 108.745 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.419 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 77.0 m-85 -146.04 165.8 27.99 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.58 154.02 31.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.3 m -144.7 175.37 10.22 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.2 pt? -70.49 -23.27 62.64 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.38 0.61 . . . . 0.0 110.302 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -85.37 -56.9 3.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.03 79.74 6.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.023 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.8 pt -92.63 -13.92 8.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.796 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.15 -5.3 33.32 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.574 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 8' ' ' PHE . 3.4 mm? -77.34 -24.33 50.78 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.524 -0.398 . . . . 0.0 110.13 177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -115.61 87.35 2.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' LYS . . . -91.69 94.68 1.96 Allowed Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.73 -0.748 . . . . 0.0 114.316 -172.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 74.11 -31.2 0.21 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.398 1.879 . . . . 0.0 114.051 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 56.1 mmtt -90.54 -26.09 19.91 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.518 -174.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.442 ' HA ' ' H ' ' A' ' 35' ' ' ASP . 32.8 m -137.54 165.06 27.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -136.45 141.62 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.1 p -103.33 135.73 44.4 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.357 0.599 . . . . 0.0 111.155 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 58.6 t -98.39 105.72 31.2 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.9 Cg_exo -78.21 135.79 13.9 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.73 2.286 . . . . 0.0 112.458 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -146.24 93.23 5.09 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-O 120.948 0.404 . . . . 0.0 112.074 177.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.5 Cg_exo -87.36 -27.64 5.06 Favored 'Cis proline' 0 C--N 1.354 0.865 0 C-N-CA 124.562 -1.016 . . . . 0.0 111.651 -7.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 48.1 mm -100.77 -57.32 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -100.6 158.33 16.02 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.22 -163.02 11.85 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.238 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 pp -101.3 154.39 18.82 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.76 0.329 . . . . 0.0 110.537 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -102.54 125.14 49.16 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.5 135.48 23.64 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.8 126.1 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.328 2.018 . . . . 0.0 111.128 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' H ' ' HA ' ' A' ' 21' ' ' CYS . 31.0 t70 . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.5 m . . . . . 0 CA--C 1.509 -0.598 0 CA-C-O 120.818 0.342 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 61.16 20.98 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.093 0.957 . . . . 0.0 112.269 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 t -120.59 121.28 29.21 Favored Pre-proline 0 N--CA 1.423 -1.816 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.71 -39.48 8.76 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.682 1.588 . . . . 0.0 110.884 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -170.62 164.07 8.24 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.7 -173.28 4.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -155.77 172.68 17.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.46 -27.4 68.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.932 0.787 . . . . 0.0 112.353 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.429 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 91.6 m-85 -81.54 -21.36 38.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 9.4 mpt_? -130.74 82.15 2.04 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.64 -5.21 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.759 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -8.06 47.55 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.872 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.74 -34.03 77.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.834 0.35 . . . . 0.0 110.287 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.3 m -127.04 102.21 6.88 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.162 0.506 . . . . 0.0 110.855 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.45 146.61 18.58 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 74.84 -27.27 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 113.443 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -119.68 -43.83 2.57 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 63.6 m -135.88 165.56 25.34 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -125.53 141.26 52.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m -90.37 123.32 34.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.844 0.354 . . . . 0.0 110.922 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.91 100.16 19.26 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.513 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 9.8 Cg_exo -73.37 123.88 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.785 2.323 . . . . 0.0 111.678 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -135.43 89.68 22.1 Favored Pre-proline 0 N--CA 1.417 -2.124 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.6 Cg_exo -88.03 -27.64 4.7 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.498 -1.043 . . . . 0.0 111.998 -6.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.0 mt -110.4 -48.43 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 O-C-N 122.191 -0.318 . . . . 0.0 111.258 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -75.27 144.51 42.48 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 25' ' ' PRO . . . -124.18 148.25 16.73 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 119.468 -1.349 . . . . 0.0 113.931 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.95 140.0 34.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.0 t -94.99 114.92 26.79 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.35 130.17 23.11 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.164 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.588 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 19.9 Cg_endo -61.04 118.1 4.94 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.81 2.34 . . . . 0.0 110.503 177.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--N 1.304 -1.393 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.42 -175.831 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.433 -1.278 0 CA-C-O 120.345 0.117 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 65.09 26.8 12.52 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.744 0.783 . . . . 0.0 109.593 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 m -114.81 109.42 47.57 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.211 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.72 -29.95 18.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.546 1.498 . . . . 0.0 111.138 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -163.06 -179.98 7.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 38.9 t -154.82 173.07 16.97 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.416 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 47.9 p -150.08 168.47 23.82 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.1 pt? -73.18 -25.22 60.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.38 0.61 . . . . 0.0 109.978 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -78.63 -46.57 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -118.45 95.48 4.89 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.941 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.629 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 32.6 pt -93.32 -3.92 10.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 0.7 22.27 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.648 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.21 -30.53 66.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -94.08 122.87 37.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.8 53.76 4.03 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.63 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 70.43 -18.47 0.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.642 1.577 . . . . 0.0 113.604 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -84.77 -17.86 36.9 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.993 0.902 . . . . 0.0 111.092 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.5 m -136.51 153.29 51.06 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.668 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 m -125.28 142.57 51.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 29.5 p -108.53 156.32 19.64 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.63 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.64 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 7.5 p -120.5 118.48 30.95 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -80.96 124.08 4.85 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 121.902 1.735 . . . . 0.0 111.428 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -139.8 92.12 10.15 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.863 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.5 Cg_exo -87.57 -35.9 1.14 Allowed 'Cis proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.73 -0.946 . . . . 0.0 112.973 -5.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mm -100.13 -52.6 8.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.118 0.485 . . . . 0.0 110.295 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 99.3 m-85 -101.44 150.2 23.28 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -154.03 -174.22 23.93 Favored Glycine 0 N--CA 1.415 -2.745 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.855 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.26 153.47 18.01 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.133 -0.534 . . . . 0.0 109.585 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 27.1 t -109.66 131.09 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.61 134.94 25.2 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.15 124.63 14.25 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.225 1.95 . . . . 0.0 110.224 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 . . . . . 0 C--N 1.304 -1.382 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.641 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.434 -1.23 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 70.18 0.09 3.01 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.255 1.422 . . . . 0.0 113.008 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 m -68.3 121.46 80.49 Favored Pre-proline 0 N--CA 1.427 -1.615 0 C-N-CA 123.725 0.81 . . . . 0.0 108.871 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -72.67 -26.73 15.95 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.214 1.943 . . . . 0.0 112.569 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.78 -179.69 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 t -175.33 158.15 2.29 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 m -148.51 169.9 19.25 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 12' ' ' PHE . 3.3 pp -66.47 -24.45 66.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.633 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' N ' HD12 ' A' ' 11' ' ' LEU . 75.4 m-85 -78.81 -64.72 1.11 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.96 87.35 5.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.537 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 pt -92.71 -3.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.409 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.7 -0.44 87.79 Favored Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.476 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.29 -34.66 78.86 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.196 0.522 . . . . 0.0 110.115 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 57.4 m -97.64 116.5 29.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.21 128.45 5.8 Favored Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.177 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 79.07 -38.01 0.2 Allowed 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 127.023 2.129 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -119.87 -22.35 6.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -132.6 164.38 26.81 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.953 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -136.74 137.16 39.6 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 27.2 p -95.59 142.83 27.46 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.05 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 61.6 t -105.11 101.41 30.19 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 14.7 Cg_exo -69.25 128.01 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.501 2.134 . . . . 0.0 110.773 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.1 pp -134.42 88.49 29.66 Favored Pre-proline 0 N--CA 1.423 -1.813 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -87.88 -21.97 12.07 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.626 -8.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.5 -57.42 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.717 0.294 . . . . 0.0 110.772 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.62 145.84 24.12 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -148.79 -175.19 21.07 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 118.427 -1.844 . . . . 0.0 114.553 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.4 151.44 21.52 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.09 -1.055 . . . . 0.0 109.222 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.2 119.84 39.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.58 139.1 29.3 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.1 118.61 5.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.292 1.995 . . . . 0.0 109.897 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 121.076 0.465 . . . . 0.0 109.971 -174.321 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 20' ' ' LYS . 61.9 m . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 53.7 34.01 17.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.57 1.148 . . . . 0.0 111.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.4 m -83.85 121.26 75.93 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.651 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.05 -33.15 32.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 111.34 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -143.79 166.11 25.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.785 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 46.1 t -156.24 167.24 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 13' ' ' ARG . 20.0 m -147.06 168.59 21.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.4 -26.23 64.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.514 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -81.82 -53.17 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.647 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 10' ' ' SER . 8.4 mpt_? -96.22 85.29 3.95 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.481 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.401 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 26.0 pt -99.68 -6.34 9.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.435 0.635 . . . . 0.0 109.504 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.43 -15.69 59.58 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.56 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.31 -36.87 84.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.776 0.798 . . . . 0.0 109.828 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -111.39 13.2 21.54 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.715 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -40.77 96.27 0.01 OUTLIER Glycine 0 N--CA 1.466 0.681 0 C-N-CA 125.364 1.459 . . . . 0.0 115.618 -173.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t70 71.09 -19.98 0.23 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.497 2.319 . . . . 0.0 113.177 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.8 mmtp -79.26 -50.96 10.1 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.712 0.805 . . . . 0.0 111.23 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.5 m -128.76 -179.12 4.9 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -123.72 137.68 54.66 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 29.1 p -118.57 147.55 43.58 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.166 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.52 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 43.5 t -112.67 99.29 47.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 21.8 Cg_exo -70.86 122.99 9.34 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.567 2.178 . . . . 0.0 110.574 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -132.0 92.65 29.04 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-O 120.97 0.414 . . . . 0.0 111.961 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 94.7 Cg_endo -92.28 -7.76 38.08 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.057 -1.226 . . . . 0.0 111.737 -6.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 73.1 mt -121.09 -49.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.998 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.69 148.34 26.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -155.42 -175.84 26.92 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.685 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.58 165.15 11.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.5 t -114.65 136.0 53.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 130.3 22.95 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.932 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.64 131.28 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.577 1.518 . . . . 0.0 109.842 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--N 1.298 -1.662 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.372 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.497 -1.085 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.1 t70 73.89 6.0 4.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.857 1.663 . . . . 0.0 111.887 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -148.31 133.48 9.24 Favored Pre-proline 0 C--N 1.289 -2.031 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.29 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.46 -45.51 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.256 1.971 . . . . 0.0 111.411 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -117.96 171.49 8.04 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.502 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.551 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 43.3 t -166.81 175.6 7.66 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.2 m -147.11 165.11 30.95 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.86 -28.11 67.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.144 0.497 . . . . 0.0 110.774 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.85 -31.49 40.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.386 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -126.24 88.13 2.79 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.551 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 23.2 pt -99.43 -0.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.601 0.715 . . . . 0.0 110.799 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -8.09 87.17 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.33 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.45 -51.88 63.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.1 m -64.77 127.16 30.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.865 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.03 40.88 1.23 Allowed Glycine 0 CA--C 1.535 1.344 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.1 t70 71.07 -25.76 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.546 1.938 . . . . 0.0 114.145 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -88.02 1.46 54.15 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.328 1.061 . . . . 0.0 110.201 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 58.6 m -144.1 155.43 43.95 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -130.39 147.92 52.15 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.1 p -103.04 144.85 30.74 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.61 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 42.5 t -105.13 100.23 23.87 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.43 118.78 5.01 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.479 2.119 . . . . 0.0 111.787 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -139.42 97.57 8.38 Favored Pre-proline 0 N--CA 1.416 -2.134 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -84.91 -26.49 7.5 Favored 'Cis proline' 0 C--N 1.35 0.637 0 C-N-CA 124.551 -1.02 . . . . 0.0 111.618 -6.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -111.34 -54.95 4.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -93.2 151.47 19.8 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -158.32 176.17 35.33 Favored Glycine 0 C--N 1.28 -2.567 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.78 155.78 18.01 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.298 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -98.58 119.54 37.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.39 127.5 26.77 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.8 Cg_endo -61.23 134.18 50.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.482 2.122 . . . . 0.0 112.708 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--N 1.306 -1.302 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.768 176.878 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.442 -0.862 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 61.66 30.81 18.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.435 1.094 . . . . 0.0 112.099 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.3 m -132.98 116.68 14.63 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.19 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.88 -35.1 27.97 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.71 2.274 . . . . 0.0 113.224 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.69 160.15 28.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 58.1 m -130.63 -177.76 4.49 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -142.94 170.35 15.86 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt -51.9 -43.44 63.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.488 0.661 . . . . 0.0 111.167 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -84.51 -37.8 20.84 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.081 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.9 88.02 2.64 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.195 0.521 . . . . 0.0 110.642 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.7 pt -109.29 -0.39 9.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.74 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.04 2.73 68.33 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.183 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.4 -27.52 69.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.333 0.587 . . . . 0.0 109.876 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -121.35 90.6 3.35 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.93 86.73 1.55 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.624 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t70 73.69 -20.88 0.28 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.631 1.972 . . . . 0.0 113.4 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.29 -39.91 88.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.721 0.772 . . . . 0.0 109.31 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.628 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.9 m -153.6 179.03 9.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -122.72 133.77 54.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 9' ' ' CYS . 66.7 m -82.3 129.34 34.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 96.5 44.29 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 10.4 Cg_exo -74.86 129.48 12.51 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.26 2.64 . . . . 0.0 112.828 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.3 pt? -153.75 105.71 2.51 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.301 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.37 -29.29 5.5 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.603 -0.999 . . . . 0.0 111.619 -7.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt -110.94 -54.59 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -87.96 144.28 26.63 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.966 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -132.22 167.81 22.81 Favored Glycine 0 N--CA 1.402 -3.596 0 C-N-CA 119.546 -1.311 . . . . 0.0 114.666 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 mt -92.38 160.78 14.94 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 42.3 t -117.57 118.01 30.98 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.85 134.31 26.17 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.998 -176.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 42.6 Cg_endo -74.17 136.56 22.42 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.086 1.858 . . . . 0.0 112.744 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.696 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' A' ' 34' ' ' PRO . 59.4 m . . . . . 0 C--O 1.238 0.453 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 64.03 21.36 12.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.663 1.22 . . . . 0.0 109.24 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -105.24 113.09 64.87 Favored Pre-proline 0 N--CA 1.429 -1.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.978 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.39 -37.3 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.768 1.645 . . . . 0.0 111.718 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.18 -179.81 7.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.2 t -160.94 162.16 31.89 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.0 m -154.64 169.91 22.77 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -72.86 -22.7 60.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.549 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -88.71 -14.02 38.24 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.694 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -136.22 79.61 1.78 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.1 pt -102.81 -4.24 9.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.19 0.519 . . . . 0.0 110.92 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.55 -0.95 64.29 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.247 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.39 -27.68 67.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.958 0.503 . . . . 0.0 110.427 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.49 128.66 55.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.46 103.14 0.39 Allowed Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.069 -177.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.9 t70 76.94 -31.29 0.18 Allowed 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.67 1.988 . . . . 0.0 114.27 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -101.88 -42.06 6.27 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.487 0.661 . . . . 0.0 111.488 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.3 m -116.29 161.9 18.31 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.963 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -139.22 143.87 38.23 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 p -113.72 158.44 20.91 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.646 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.2 p -119.83 106.21 41.93 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.869 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.12 115.45 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.287 1.992 . . . . 0.0 110.357 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -133.36 98.34 15.41 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.252 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -89.09 -20.44 13.53 Favored 'Cis proline' 0 C--N 1.353 0.787 0 C-N-CA 124.724 -0.948 . . . . 0.0 111.785 -7.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 45.7 mm -108.72 -58.26 3.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.269 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.17 156.94 16.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -162.87 -176.69 35.19 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -106.4 155.84 19.14 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -103.32 130.47 50.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.42 136.87 29.57 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 28.7 Cg_endo -65.38 115.57 3.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.391 2.061 . . . . 0.0 109.912 175.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 C--N 1.304 -1.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.223 -174.657 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.74 -0.59 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.633 1.173 . . . . 0.0 112.943 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.7 m -118.69 133.72 23.58 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.608 -0.682 . . . . 0.0 110.862 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.91 -36.69 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.799 2.332 . . . . 0.0 112.361 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -147.18 160.56 42.31 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 30.8 p -139.88 -168.31 2.48 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.0 p -141.97 166.25 25.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.88 -21.76 64.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.447 0.642 . . . . 0.0 110.996 175.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -76.49 -59.77 2.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.35 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.45 92.04 4.03 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.341 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 37.9 pt -91.6 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.25 -7.39 57.13 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.636 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 3.9 mm? -67.73 -25.67 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.55 0.69 . . . . 0.0 109.524 174.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 52.9 m -98.1 100.18 11.48 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.97 72.93 0.87 Allowed Glycine 0 C--N 1.312 -0.765 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 72.31 -33.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.653 2.381 . . . . 0.0 113.909 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -83.19 -22.69 33.12 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-O 122.207 1.004 . . . . 0.0 110.2 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 1.6 p -124.21 149.33 46.51 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.716 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.9 m -112.14 154.33 25.64 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.398 1.079 . . . . 0.0 108.629 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 61.0 m -88.28 129.14 35.45 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.24 95.64 8.5 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.95 124.3 4.39 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.899 1.733 . . . . 0.0 112.048 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.7 pt? -135.5 89.82 21.56 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.039 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 3.4 Cg_exo -87.82 -29.94 3.15 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 124.309 -1.121 . . . . 0.0 111.191 -7.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 52.6 mt -110.1 -49.4 6.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.919 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -71.73 132.08 44.02 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.54 16.57 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.993 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -117.53 150.2 39.35 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.0 m -78.11 113.48 16.09 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.516 0.51 . . . . 0.0 110.394 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.69 134.96 20.23 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.15 112.99 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.694 1.596 . . . . 0.0 110.666 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.053 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.443 -0.806 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 67.26 29.22 7.73 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.559 1.171 . . . . 0.0 109.566 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 m -91.58 116.04 65.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.129 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.36 -47.85 3.95 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.697 2.264 . . . . 0.0 113.099 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -145.21 -179.75 6.84 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 16.3 t -156.17 162.75 40.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.0 p -145.09 170.29 16.49 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 28' ' ' ILE . 4.0 pp -68.72 -20.04 64.38 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.629 0.728 . . . . 0.0 110.534 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.22 -59.08 2.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.865 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.84 90.73 4.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.444 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 38.0 pt -100.38 -0.14 10.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 109.643 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.86 64.92 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.243 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.85 -33.59 75.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 m -128.72 83.84 2.19 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -110.31 99.55 1.19 Allowed Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.939 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 72.63 -22.92 0.21 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.147 1.779 . . . . 0.0 112.685 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 18' ' ' GLY . 97.8 mttt -79.77 -29.96 40.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.548 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 p -163.0 177.75 8.92 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.044 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -134.49 148.71 50.61 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.6 p -124.7 139.86 53.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -113.84 102.7 55.06 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.47 142.34 65.01 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.897 2.398 . . . . 0.0 110.88 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -149.33 92.22 4.31 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-O 120.706 0.289 . . . . 0.0 111.75 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.0 Cg_exo -87.62 -28.48 4.2 Favored 'Cis proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.592 -1.003 . . . . 0.0 111.95 -6.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.44 ' HA ' HD23 ' A' ' 11' ' ' LEU . 58.1 mt -101.99 -47.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -109.05 154.02 22.82 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.36 177.51 33.33 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.772 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.6 163.97 12.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -108.3 140.22 41.88 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.05 138.85 24.25 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.63 132.06 45.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.89 1.727 . . . . 0.0 109.421 173.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 C--N 1.297 -1.684 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -173.894 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.4 155.33 66.59 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.5 2.134 . . . . 0.0 110.712 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -119.34 145.55 46.07 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.557 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.3 m -92.98 -65.13 1.02 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.29 30.32 9.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.925 . . . . 0.0 111.743 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.2 m -54.48 122.94 41.31 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 124.311 1.044 . . . . 0.0 109.066 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.73 -25.12 61.39 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 123.046 2.498 . . . . 0.0 113.808 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -151.84 169.03 23.25 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 32.7 t -167.74 165.55 14.13 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.8 m -151.88 166.41 31.55 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.687 0.676 . . . . 0.0 109.724 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -70.03 -20.42 63.26 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.73 -34.84 34.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.453 0.644 . . . . 0.0 110.035 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -130.71 90.31 2.89 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.549 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 31.9 pt -91.23 -5.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.541 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.47 0.21 35.06 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.427 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.8 -24.4 63.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -129.98 85.06 2.26 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.54 133.1 11.36 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.579 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 74.01 -27.07 0.19 Allowed 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.574 1.95 . . . . 0.0 114.478 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -117.35 -39.41 3.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.3 m -127.02 175.26 8.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -139.82 141.62 36.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.2 p -108.32 148.18 30.43 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.379 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.569 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 3.7 p -110.42 108.05 58.42 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.17 123.76 5.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.045 1.83 . . . . 0.0 111.518 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.2 pt? -154.93 100.19 2.35 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.172 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.0 Cg_exo -81.38 -60.53 0.04 OUTLIER 'Cis proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.792 -0.92 . . . . 0.0 113.368 -2.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.37 -46.21 14.51 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 CA-C-O 121.174 0.511 . . . . 0.0 109.958 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.24 161.75 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -159.85 -179.72 34.84 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.916 -1.135 . . . . 0.0 111.5 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.0 161.25 13.73 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 t -105.28 130.27 53.45 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -122.4 125.5 26.49 Favored Pre-proline 0 N--CA 1.422 -1.853 0 CA-C-O 121.177 0.513 . . . . 0.0 110.338 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -87.5 125.99 2.18 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 122.012 1.808 . . . . 0.0 109.777 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.53 -34.03 35.88 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.422 -1.857 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.43 178.274 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 C--O 1.222 -0.351 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.29 141.57 82.52 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 122.965 2.444 . . . . 0.0 113.004 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -105.07 152.23 23.01 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -84.13 -40.54 18.11 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.807 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 59.44 15.57 4.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.702 1.201 . . . . 0.0 113.383 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.49 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 10.6 t -141.92 132.5 12.87 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.99 -55.8 1.18 Allowed 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.942 2.428 . . . . 0.0 114.848 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -138.21 -179.8 6.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.18 0.514 . . . . 0.0 112.228 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 40.4 t -159.35 167.93 27.63 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 65.7 p -160.19 176.82 11.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.68 -38.32 77.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -70.42 -55.49 8.91 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.622 ' HB3' HD23 ' A' ' 16' ' ' LEU . 32.5 mmt180 -109.54 89.18 2.93 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.291 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.549 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 5.8 pt -98.83 -9.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.467 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.48 73.54 Favored Glycine 0 C--N 1.316 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.979 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 13' ' ' ARG . 4.2 mm? -80.24 -32.66 38.38 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.654 -0.321 . . . . 0.0 111.611 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 6' ' ' SER . 69.3 m -133.36 109.49 9.39 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.321 0.581 . . . . 0.0 110.019 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.93 159.81 28.01 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.3 t70 77.01 -35.1 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.802 1.641 . . . . 0.0 112.633 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -113.37 -50.53 2.85 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.953 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.7 m -132.71 145.17 50.82 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -99.84 139.77 35.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.12 127.79 53.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 120.945 0.402 . . . . 0.0 111.917 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.53 106.54 56.59 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.198 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 22.3 Cg_exo -68.47 128.25 16.93 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.828 2.352 . . . . 0.0 111.983 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -131.91 89.56 38.33 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.12 0.486 . . . . 0.0 112.091 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -92.9 -13.77 20.53 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.527 -1.03 . . . . 0.0 110.674 -8.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 44.1 mm -106.85 -57.5 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.316 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 88.1 m-85 -96.86 146.76 24.63 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.78 162.4 27.04 Favored Glycine 0 N--CA 1.416 -2.693 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.418 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.19 156.67 16.22 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.43 121.69 35.08 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.15 126.66 26.93 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.424 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -64.96 116.49 3.86 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.262 1.975 . . . . 0.0 110.439 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.12 -35.76 67.44 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 124.354 1.061 . . . . 0.0 112.791 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 C--N 1.304 -1.372 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.865 177.737 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--O 1.238 0.471 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -64.2 136.31 51.1 Favored 'Trans proline' 0 CA--C 1.507 -0.844 0 C-N-CA 122.38 2.053 . . . . 0.0 110.892 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -108.92 167.51 10.03 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.0 m -88.4 -52.71 5.04 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.1 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.13 28.97 18.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.034 0.921 . . . . 0.0 110.493 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 p -102.8 129.12 26.4 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.04 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.35 -24.21 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.905 1.736 . . . . 0.0 111.128 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -165.79 172.48 11.67 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.1 t -153.01 156.64 39.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 p -150.11 169.12 22.01 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -70.45 -24.04 62.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.428 0.558 . . . . 0.0 110.247 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -82.11 -47.5 12.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.399 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -108.25 91.64 3.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.8 pt -100.01 -5.52 9.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 O-C-N 123.691 0.619 . . . . 0.0 109.458 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.8 -13.41 56.42 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.866 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.13 -26.57 64.01 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -141.71 90.31 2.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.471 0.653 . . . . 0.0 110.426 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.22 126.47 4.2 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 176.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 t70 72.71 -23.18 0.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.244 1.418 . . . . 0.0 112.595 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 18' ' ' GLY . 41.4 mmtm -90.54 -38.48 13.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 3.9 p -170.48 171.48 6.47 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.5 m -120.86 139.98 52.41 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.68 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 30.0 p -100.53 144.75 29.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.544 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 40.3 t -106.22 95.22 10.87 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 4.2 Cg_exo -76.48 118.31 4.85 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.945 2.43 . . . . 0.0 111.325 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -144.8 100.02 4.68 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.58 -33.54 2.69 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.052 -4.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 61.9 mt -102.42 -56.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.594 -174.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -101.15 162.29 13.0 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.631 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -164.46 177.23 40.18 Favored Glycine 0 N--CA 1.418 -2.552 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.481 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.96 156.38 16.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 124.044 0.496 . . . . 0.0 110.564 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 80.7 m -101.44 121.77 42.55 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.191 0.519 . . . . 0.0 110.722 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.19 130.22 23.23 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.27 149.4 85.76 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 122.367 2.045 . . . . 0.0 111.661 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -99.13 -1.16 40.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.133 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.432 -1.359 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.445 175.733 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.4 155.84 55.1 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 122.641 2.227 . . . . 0.0 112.645 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -116.99 178.19 4.44 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.4 m -98.25 -47.09 5.59 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.799 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.65 34.65 22.26 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 123.489 0.715 . . . . 0.0 112.587 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 p -83.91 118.24 70.81 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.17 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -72.24 -30.42 13.05 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.378 1.385 . . . . 0.0 108.806 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -169.11 173.35 6.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.4 t -165.48 162.62 19.4 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.3 m -149.12 167.45 25.87 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.521 0.6 . . . . 0.0 110.362 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 11' ' ' LEU . 1.9 pt? -68.21 -26.7 65.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.851 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -83.0 -35.96 25.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.318 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -122.36 88.64 2.97 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt -101.12 -1.16 9.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.96 -12.27 53.96 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.626 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.43 -40.57 74.98 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.71 0.804 . . . . 0.0 111.332 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -133.76 138.87 46.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.299 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.18 14.26 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 75.3 -33.12 0.23 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.63 1.972 . . . . 0.0 113.48 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -113.78 -44.95 3.13 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -172.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -129.35 154.16 47.16 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.267 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -126.84 147.47 50.03 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.556 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 26.6 p -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.113 -1.035 . . . . 0.0 113.107 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.7 p -115.36 112.81 43.54 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-N 114.392 -1.277 . . . . 0.0 107.942 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -85.47 132.84 4.39 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.359 2.039 . . . . 0.0 112.538 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -151.97 99.87 2.9 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.2 Cg_exo -78.6 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 124.407 -1.08 . . . . 0.0 112.116 -4.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.84 -51.13 10.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.48 139.56 30.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.009 0.433 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -153.12 -177.49 26.73 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.4 mt -112.12 165.49 12.09 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 117.716 0.758 . . . . 0.0 110.743 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 m -89.19 135.8 33.37 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.304 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.35 128.95 24.69 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.71 123.97 11.01 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.086 1.857 . . . . 0.0 111.715 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -83.61 -36.0 24.23 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.417 -2.076 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.63 -179.649 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -52.09 135.34 51.89 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 123.122 2.548 . . . . 0.0 112.465 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -123.88 -171.34 2.3 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 m -85.67 -58.47 2.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 59.42 21.92 10.34 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.725 1.21 . . . . 0.0 111.127 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -80.16 126.84 78.48 Favored Pre-proline 0 N--CA 1.426 -1.649 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.32 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -74.03 -27.31 12.11 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.125 1.884 . . . . 0.0 111.846 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 45.7 p90 -164.62 179.6 6.53 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 18.5 t -174.24 162.11 3.61 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.3 p -156.88 -179.77 8.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -75.48 -20.19 58.93 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.647 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 58.1 m-85 -86.24 -34.78 20.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 5.5 mpt_? -121.37 87.42 2.75 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 36.4 pt -97.02 -7.6 9.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.875 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.66 -19.15 62.44 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.163 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.94 -37.84 87.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.252 0.549 . . . . 0.0 110.094 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.09 -23.16 35.89 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.914 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.33 56.56 6.15 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.434 -1.257 . . . . 0.0 115.793 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 71.9 -23.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.183 1.393 . . . . 0.0 113.672 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -81.65 -28.74 33.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 111.27 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 60.7 m -133.65 169.21 17.35 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.369 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -131.22 124.43 30.58 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 25.6 p -94.14 138.04 32.64 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.635 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -98.99 107.31 43.2 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.1 Cg_exo -79.09 127.91 7.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.713 2.276 . . . . 0.0 111.322 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.8 pt? -134.16 90.21 26.37 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.874 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.6 Cg_endo -90.78 -21.68 9.32 Favored 'Cis proline' 0 C--N 1.357 1.015 0 C-N-CA 124.399 -1.084 . . . . 0.0 111.704 -7.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 49.1 mm -108.85 -57.28 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.183 0.516 . . . . 0.0 110.296 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 58.9 t80 -88.45 146.15 25.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.46 -169.03 15.46 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.67 -1.729 . . . . 0.0 113.722 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 23.2 t -99.05 120.25 39.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -111.17 132.7 21.6 Favored Pre-proline 0 C--O 1.257 1.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.0 Cg_endo -54.51 119.62 6.7 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.172 2.582 . . . . 0.0 112.074 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.501 ' H ' ' HA ' ' A' ' 21' ' ' CYS . 17.0 t70 -88.91 -34.84 16.8 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.641 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.432 -1.373 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.622 175.408 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.8 139.37 79.83 Favored 'Trans proline' 0 C--O 1.25 1.089 0 C-N-CA 123.678 2.919 . . . . 0.0 111.767 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.412 ' NH1' ' HG3' ' A' ' 34' ' ' PRO . 26.9 mmt180 -129.62 126.84 39.35 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.132 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.2 m -128.38 -50.44 1.29 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 60.88 18.62 8.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.102 0.961 . . . . 0.0 113.319 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -54.33 125.49 51.31 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.307 0.643 . . . . 0.0 109.307 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.44 -44.4 14.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.751 2.301 . . . . 0.0 113.36 -172.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.82 145.74 51.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 t -158.29 163.46 37.35 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.0 m -151.37 178.6 9.11 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -77.22 -22.66 51.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 109.707 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -81.14 -45.21 16.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.908 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -112.52 89.06 2.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.877 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.5 pt -95.99 -5.97 9.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.698 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.19 6.92 32.88 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.53 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.97 -14.17 56.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.251 0.548 . . . . 0.0 110.081 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -134.43 107.59 7.67 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.48 100.03 1.1 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.864 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 t70 74.25 -29.47 0.2 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.293 2.237 . . . . 0.0 113.518 171.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -77.75 -50.11 13.04 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.811 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.3 m -130.75 171.06 13.54 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -133.81 144.03 48.74 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -98.33 144.83 27.31 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.494 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.572 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.3 p -108.31 100.48 37.59 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.262 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 10.0 Cg_exo -72.77 128.86 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.618 2.212 . . . . 0.0 111.339 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -135.99 89.5 20.48 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-O 120.897 0.38 . . . . 0.0 112.02 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.2 Cg_endo -89.45 -19.39 15.19 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.479 -1.05 . . . . 0.0 111.405 -7.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 70.6 mt -107.77 -59.68 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.98 146.18 24.08 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.32 178.24 32.92 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.922 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.37 165.03 12.98 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 124.15 0.559 . . . . 0.0 110.49 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 19.3 t -103.23 112.46 25.34 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.07 137.69 27.78 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.302 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HG3' ' NH1' ' A' ' 3' ' ' ARG . 30.5 Cg_endo -67.96 113.76 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.126 1.217 . . . . 0.0 109.321 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -86.35 -6.69 58.88 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.113 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--N 1.276 -2.599 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.706 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.55 169.57 15.51 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.199 1.933 . . . . 0.0 110.525 174.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -71.46 0.8 7.5 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.048 0.928 . . . . 0.0 113.05 -175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.1 -17.77 54.52 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.115 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 74.03 -0.42 3.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.548 1.539 . . . . 0.0 110.471 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -85.95 118.0 69.71 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.616 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.64 -26.58 9.8 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.86 1.706 . . . . 0.0 112.383 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -157.92 -179.94 8.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.9 t -166.91 169.82 12.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.9 m -155.91 171.31 20.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.07 -24.36 61.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.364 0.602 . . . . 0.0 111.667 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -85.89 -59.11 2.4 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -81.48 80.08 7.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.9 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -98.13 -2.78 9.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.627 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.38 4.44 72.6 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.609 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.28 -31.69 33.54 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.902 -0.175 . . . . 0.0 111.316 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.0 m -114.11 105.5 13.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.81 127.01 6.2 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.745 -1.217 . . . . 0.0 113.099 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.0 t70 76.94 -36.21 0.25 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 126.851 2.06 . . . . 0.0 113.074 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' A' ' 36' ' ' VAL . 47.1 mmtm -97.39 -40.83 8.51 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.46 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.763 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 62.3 m -139.4 168.69 19.26 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.047 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 m -135.97 148.92 48.68 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -106.58 143.62 34.43 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.018 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.22 102.41 18.1 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.8 Cg_exo -73.67 126.27 10.68 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.615 2.21 . . . . 0.0 112.691 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -156.88 97.27 2.11 Favored Pre-proline 0 N--CA 1.425 -1.701 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.692 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -81.85 -62.09 0.03 OUTLIER 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.624 -0.99 . . . . 0.0 112.097 -3.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.17 -43.6 14.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.979 0.418 . . . . 0.0 110.481 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -83.5 154.77 23.7 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -137.46 156.07 23.33 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.608 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 31' ' ' LEU . 4.1 pp -85.79 139.96 30.87 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.2 t -91.98 119.72 31.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -112.03 130.79 22.9 Favored Pre-proline 0 C--O 1.25 1.084 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.763 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 18.7 Cg_endo -58.31 126.55 21.8 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.686 2.257 . . . . 0.0 112.226 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -91.36 -56.91 2.96 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.216 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 20' ' ' LYS . 16.6 m . . . . . 0 C--N 1.311 -1.082 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.027 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.63 129.63 14.86 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.048 2.499 . . . . 0.0 112.754 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.6 mtm105 -109.27 171.04 7.67 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.5 m -92.66 -22.52 19.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t70 69.82 28.87 4.21 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.535 1.534 . . . . 0.0 108.811 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -97.56 109.55 50.98 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.852 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -73.14 -24.47 16.99 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.826 1.684 . . . . 0.0 112.142 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -157.49 -179.87 8.59 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.2 t -160.27 169.34 23.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 m -155.7 169.55 24.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.2 pt? -71.32 -30.15 65.88 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.06 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.44 -16.97 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.079 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -125.29 78.97 1.76 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.5 pt -99.71 -1.25 10.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.435 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.04 -15.81 69.96 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.69 -44.61 81.29 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -126.87 89.91 3.07 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.583 0.706 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.99 136.72 7.94 Favored Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t70 74.87 -25.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.242 1.417 . . . . 0.0 113.498 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -113.55 -39.44 4.07 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 p -148.86 169.66 20.02 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -122.53 144.4 49.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.8 139.83 52.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.782 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.12 107.9 60.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.576 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 57.5 Cg_endo -75.81 134.78 16.87 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.646 2.231 . . . . 0.0 112.246 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -150.09 90.95 4.33 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.797 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -86.0 -40.41 0.64 Allowed 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.619 -0.992 . . . . 0.0 111.829 -7.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.464 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 48.7 mm -98.48 -53.91 7.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.76 138.87 46.75 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -136.26 156.72 23.14 Favored Glycine 0 N--CA 1.41 -3.062 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.596 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.5 143.0 27.91 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.6 t -98.23 146.01 26.05 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.89 129.04 7.12 Favored Pre-proline 0 N--CA 1.425 -1.683 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.0 116.84 4.71 Favored 'Trans proline' 0 C--O 1.254 1.313 0 C-N-CA 121.8 1.667 . . . . 0.0 109.361 172.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.61 -50.3 8.92 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.734 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.295 -1.771 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.804 -179.65 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.82 154.94 48.89 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.922 2.415 . . . . 0.0 111.364 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 43.9 mtp180 -103.95 170.21 8.05 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.649 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.2 m -85.1 -40.06 17.21 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 17.68 9.13 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.73 1.212 . . . . 0.0 113.893 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.4 m -148.07 137.96 12.52 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.17 -60.03 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.561 2.174 . . . . 0.0 112.043 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -139.38 175.35 9.63 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 p -129.72 -165.47 1.53 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 m -148.5 163.92 35.76 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.95 -23.87 67.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.704 0.764 . . . . 0.0 110.848 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -80.78 -54.31 5.72 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.054 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -105.36 90.19 3.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.656 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 pt -97.21 -4.23 9.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.41 -5.19 41.83 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.199 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.47 -40.45 70.26 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.42 85.71 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.352 0.596 . . . . 0.0 109.919 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -134.97 126.45 4.06 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.4 t70 67.41 -6.58 0.62 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.684 1.194 . . . . 0.0 112.416 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 18' ' ' GLY . 54.0 mttp -101.81 -55.94 2.39 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.815 0.846 . . . . 0.0 109.229 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -147.66 -179.92 7.22 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 130.75 53.76 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 31.2 p -121.13 129.78 53.44 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.925 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.97 118.68 62.41 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 2.7 Cg_exo -76.81 120.61 5.55 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.256 1.97 . . . . 0.0 111.823 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 2.0 pt? -150.63 101.12 3.1 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.786 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 3.0 Cg_endo -83.67 -57.0 0.14 OUTLIER 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.652 -0.978 . . . . 0.0 111.897 -3.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.05 -44.17 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -83.69 151.88 25.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -126.34 144.65 15.24 Favored Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 119.07 -1.538 . . . . 0.0 114.055 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 88.9 mt -82.4 127.22 33.05 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.04 116.47 30.33 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.58 132.58 23.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.79 113.36 3.18 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.847 1.698 . . . . 0.0 110.094 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.86 -8.14 56.26 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.452 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 C--N 1.285 -2.23 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.576 -177.749 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.3 128.68 14.01 Favored 'Trans proline' 0 CA--C 1.511 -0.673 0 C-N-CA 122.642 2.228 . . . . 0.0 110.299 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -109.96 146.82 34.59 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.001 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -98.69 -5.81 30.86 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.517 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 70.94 14.14 6.93 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 125.233 1.413 . . . . 0.0 109.535 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 m -108.4 115.99 57.15 Favored Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.182 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.93 -22.13 17.7 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.826 1.684 . . . . 0.0 109.905 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -169.94 -179.94 3.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.8 t -152.47 164.04 38.35 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 m -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.19 -26.51 64.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.071 0.462 . . . . 0.0 111.137 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -105.54 1.14 27.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -140.1 78.92 1.68 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.33 -4.34 9.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.111 0.482 . . . . 0.0 110.378 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.66 -12.23 73.76 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.203 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.39 -46.66 79.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 m -85.94 94.4 9.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -79.66 69.13 3.08 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.435 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 70.84 -21.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.328 1.851 . . . . 0.0 112.772 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.2 mttt -65.76 -34.13 77.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.215 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.557 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 71.1 m -138.5 -179.94 6.1 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.328 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 m -124.67 146.88 48.88 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -116.83 133.11 56.41 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.506 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.409 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 5.6 p -97.91 113.62 63.98 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.017 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 96.1 Cg_endo -88.42 148.09 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.787 2.325 . . . . 0.0 112.188 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.3 pt? -142.85 88.01 8.65 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.181 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -91.22 -18.68 13.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.09 -1.212 . . . . 0.0 111.597 -9.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.9 mt -108.47 -46.59 7.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.214 0.53 . . . . 0.0 111.357 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -99.54 146.7 26.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 25' ' ' PRO . . . -160.12 -168.8 22.58 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.597 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.0 156.21 23.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.64 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 6.5 t -101.26 141.02 34.75 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.9 134.58 15.98 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -67.87 140.28 50.14 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.748 1.632 . . . . 0.0 109.551 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.72 -35.08 33.98 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.418 -2.03 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.132 178.964 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.67 133.59 46.13 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 122.45 2.1 . . . . 0.0 111.702 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -81.87 95.65 7.39 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.482 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.7 m -74.54 -45.37 46.07 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 16.5 t70 59.67 20.03 8.69 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.274 1.43 . . . . 0.0 110.762 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -82.86 112.65 39.5 Favored Pre-proline 0 N--CA 1.424 -1.748 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 5' ' ' ASP . 23.1 Cg_exo -64.07 -49.41 3.85 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 121.971 1.781 . . . . 0.0 108.745 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.419 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 77.0 m-85 -146.04 165.8 27.99 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.58 154.02 31.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.3 m -144.7 175.37 10.22 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.2 pt? -70.49 -23.27 62.64 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.38 0.61 . . . . 0.0 110.302 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -85.37 -56.9 3.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.03 79.74 6.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.023 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.8 pt -92.63 -13.92 8.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.796 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.15 -5.3 33.32 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.574 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 8' ' ' PHE . 3.4 mm? -77.34 -24.33 50.78 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.524 -0.398 . . . . 0.0 110.13 177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -115.61 87.35 2.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' LYS . . . -91.69 94.68 1.96 Allowed Glycine 0 N--CA 1.432 -1.615 0 C-N-CA 120.73 -0.748 . . . . 0.0 114.316 -172.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 74.11 -31.2 0.21 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.398 1.879 . . . . 0.0 114.051 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 56.1 mmtt -90.54 -26.09 19.91 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.518 -174.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.442 ' HA ' ' H ' ' A' ' 35' ' ' ASP . 32.8 m -137.54 165.06 27.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -136.45 141.62 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.1 p -103.33 135.73 44.4 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.357 0.599 . . . . 0.0 111.155 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 58.6 t -98.39 105.72 31.2 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.9 Cg_exo -78.21 135.79 13.9 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.73 2.286 . . . . 0.0 112.458 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.9 pt? -146.24 93.23 5.09 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-O 120.948 0.404 . . . . 0.0 112.074 177.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.5 Cg_exo -87.36 -27.64 5.06 Favored 'Cis proline' 0 C--N 1.354 0.865 0 C-N-CA 124.562 -1.016 . . . . 0.0 111.651 -7.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 48.1 mm -100.77 -57.32 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -100.6 158.33 16.02 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -156.22 -163.02 11.85 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.238 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 pp -101.3 154.39 18.82 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.76 0.329 . . . . 0.0 110.537 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -102.54 125.14 49.16 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.5 135.48 23.64 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.8 126.1 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.328 2.018 . . . . 0.0 111.128 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' H ' ' HA ' ' A' ' 21' ' ' CYS . 31.0 t70 -87.76 -40.01 14.44 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -175.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.299 -1.598 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.476 178.922 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.512 -0.484 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.73 150.5 35.18 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.134 1.89 . . . . 0.0 110.658 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -77.59 -23.6 49.87 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.5 m -114.35 -11.55 12.52 Favored 'General case' 0 C--N 1.254 -3.57 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.003 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 61.16 20.98 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.093 0.957 . . . . 0.0 112.269 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 t -120.59 121.28 29.21 Favored Pre-proline 0 N--CA 1.423 -1.816 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.71 -39.48 8.76 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.682 1.588 . . . . 0.0 110.884 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -170.62 164.07 8.24 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.7 -173.28 4.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -155.77 172.68 17.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.46 -27.4 68.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.932 0.787 . . . . 0.0 112.353 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.429 ' C ' ' HD2' ' A' ' 13' ' ' ARG . 91.6 m-85 -81.54 -21.36 38.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HD2' ' C ' ' A' ' 12' ' ' PHE . 9.4 mpt_? -130.74 82.15 2.04 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.64 -5.21 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.759 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -8.06 47.55 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.872 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.74 -34.03 77.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.834 0.35 . . . . 0.0 110.287 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.3 m -127.04 102.21 6.88 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.162 0.506 . . . . 0.0 110.855 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.45 146.61 18.58 Favored Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 74.84 -27.27 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 113.443 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -119.68 -43.83 2.57 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 63.6 m -135.88 165.56 25.34 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -125.53 141.26 52.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m -90.37 123.32 34.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.844 0.354 . . . . 0.0 110.922 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.91 100.16 19.26 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.513 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 9.8 Cg_exo -73.37 123.88 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.785 2.323 . . . . 0.0 111.678 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 pp -135.43 89.68 22.1 Favored Pre-proline 0 N--CA 1.417 -2.124 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.6 Cg_exo -88.03 -27.64 4.7 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.498 -1.043 . . . . 0.0 111.998 -6.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.0 mt -110.4 -48.43 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 O-C-N 122.191 -0.318 . . . . 0.0 111.258 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -75.27 144.51 42.48 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 25' ' ' PRO . . . -124.18 148.25 16.73 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 119.468 -1.349 . . . . 0.0 113.931 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.95 140.0 34.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.0 t -94.99 114.92 26.79 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.35 130.17 23.11 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.164 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.588 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 19.9 Cg_endo -61.04 118.1 4.94 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.81 2.34 . . . . 0.0 110.503 177.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -103.11 -43.84 5.37 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.42 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t . . . . . 0 C--N 1.304 -1.406 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.783 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.88 132.5 28.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.495 2.13 . . . . 0.0 110.571 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -92.11 76.95 5.35 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.5 m -126.07 -18.27 5.07 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.852 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 65.09 26.8 12.52 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.744 0.783 . . . . 0.0 109.593 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 m -114.81 109.42 47.57 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.211 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.72 -29.95 18.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.546 1.498 . . . . 0.0 111.138 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -163.06 -179.98 7.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 38.9 t -154.82 173.07 16.97 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.416 ' HB3' ' CD2' ' A' ' 29' ' ' PHE . 47.9 p -150.08 168.47 23.82 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.1 pt? -73.18 -25.22 60.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.38 0.61 . . . . 0.0 109.978 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -78.63 -46.57 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -118.45 95.48 4.89 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.941 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.629 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 32.6 pt -93.32 -3.92 10.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 0.7 22.27 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.648 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.21 -30.53 66.48 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -94.08 122.87 37.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.8 53.76 4.03 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.63 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 70.43 -18.47 0.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.642 1.577 . . . . 0.0 113.604 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -84.77 -17.86 36.9 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.993 0.902 . . . . 0.0 111.092 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.5 m -136.51 153.29 51.06 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.668 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 m -125.28 142.57 51.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 29.5 p -108.53 156.32 19.64 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.63 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.64 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 7.5 p -120.5 118.48 30.95 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -80.96 124.08 4.85 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 121.902 1.735 . . . . 0.0 111.428 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -139.8 92.12 10.15 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.863 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.5 Cg_exo -87.57 -35.9 1.14 Allowed 'Cis proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.73 -0.946 . . . . 0.0 112.973 -5.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mm -100.13 -52.6 8.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.118 0.485 . . . . 0.0 110.295 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 10' ' ' SER . 99.3 m-85 -101.44 150.2 23.28 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -154.03 -174.22 23.93 Favored Glycine 0 N--CA 1.415 -2.745 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.855 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.26 153.47 18.01 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.133 -0.534 . . . . 0.0 109.585 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 27.1 t -109.66 131.09 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.61 134.94 25.2 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.15 124.63 14.25 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.225 1.95 . . . . 0.0 110.224 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -73.25 -54.95 7.14 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 C--N 1.292 -1.902 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.89 175.827 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.98 135.82 49.6 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.17 1.913 . . . . 0.0 112.147 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -119.7 23.58 11.06 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 m -81.02 -57.57 3.47 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.007 -170.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 70.18 0.09 3.01 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.255 1.422 . . . . 0.0 113.008 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 m -68.3 121.46 80.49 Favored Pre-proline 0 N--CA 1.427 -1.615 0 C-N-CA 123.725 0.81 . . . . 0.0 108.871 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -72.67 -26.73 15.95 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.214 1.943 . . . . 0.0 112.569 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.78 -179.69 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 t -175.33 158.15 2.29 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 m -148.51 169.9 19.25 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 12' ' ' PHE . 3.3 pp -66.47 -24.45 66.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.633 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' N ' HD12 ' A' ' 11' ' ' LEU . 75.4 m-85 -78.81 -64.72 1.11 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.96 87.35 5.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.537 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 pt -92.71 -3.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.409 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.7 -0.44 87.79 Favored Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.476 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.29 -34.66 78.86 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.196 0.522 . . . . 0.0 110.115 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 23' ' ' CYS . 57.4 m -97.64 116.5 29.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.21 128.45 5.8 Favored Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.177 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 79.07 -38.01 0.2 Allowed 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 127.023 2.129 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -119.87 -22.35 6.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -132.6 164.38 26.81 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.953 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -136.74 137.16 39.6 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 27.2 p -95.59 142.83 27.46 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.05 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 61.6 t -105.11 101.41 30.19 Favored Pre-proline 0 C--N 1.293 -1.849 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 23' ' ' CYS . 14.7 Cg_exo -69.25 128.01 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.501 2.134 . . . . 0.0 110.773 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.1 pp -134.42 88.49 29.66 Favored Pre-proline 0 N--CA 1.423 -1.813 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -87.88 -21.97 12.07 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.449 -1.063 . . . . 0.0 111.626 -8.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.5 -57.42 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.717 0.294 . . . . 0.0 110.772 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.62 145.84 24.12 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -148.79 -175.19 21.07 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 118.427 -1.844 . . . . 0.0 114.553 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.4 151.44 21.52 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.09 -1.055 . . . . 0.0 109.222 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.2 119.84 39.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.58 139.1 29.3 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.1 118.61 5.49 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.292 1.995 . . . . 0.0 109.897 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -104.35 -46.91 4.27 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.076 0.465 . . . . 0.0 109.971 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.277 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 36' ' ' VAL . 96.1 mt . . . . . 0 C--O 1.244 0.778 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.24 137.32 30.97 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.655 2.903 . . . . 0.0 114.218 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -121.36 107.21 12.23 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.933 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 20' ' ' LYS . 61.9 m -78.77 -36.8 42.41 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 53.7 34.01 17.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.57 1.148 . . . . 0.0 111.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.4 m -83.85 121.26 75.93 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.651 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.05 -33.15 32.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 111.34 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -143.79 166.11 25.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.785 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 46.1 t -156.24 167.24 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 13' ' ' ARG . 20.0 m -147.06 168.59 21.19 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.4 -26.23 64.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.514 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -81.82 -53.17 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.647 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 10' ' ' SER . 8.4 mpt_? -96.22 85.29 3.95 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.481 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.401 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 26.0 pt -99.68 -6.34 9.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.435 0.635 . . . . 0.0 109.504 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.43 -15.69 59.58 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 114.823 -1.08 . . . . 0.0 113.56 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.31 -36.87 84.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.776 0.798 . . . . 0.0 109.828 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -111.39 13.2 21.54 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.715 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -40.77 96.27 0.01 OUTLIER Glycine 0 N--CA 1.466 0.681 0 C-N-CA 125.364 1.459 . . . . 0.0 115.618 -173.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t70 71.09 -19.98 0.23 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.497 2.319 . . . . 0.0 113.177 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.8 mmtp -79.26 -50.96 10.1 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.712 0.805 . . . . 0.0 111.23 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.5 m -128.76 -179.12 4.9 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 m -123.72 137.68 54.66 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 29.1 p -118.57 147.55 43.58 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.166 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.52 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 43.5 t -112.67 99.29 47.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 21.8 Cg_exo -70.86 122.99 9.34 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.567 2.178 . . . . 0.0 110.574 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -132.0 92.65 29.04 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-O 120.97 0.414 . . . . 0.0 111.961 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 94.7 Cg_endo -92.28 -7.76 38.08 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.057 -1.226 . . . . 0.0 111.737 -6.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 73.1 mt -121.09 -49.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.998 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.69 148.34 26.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -155.42 -175.84 26.92 Favored Glycine 0 N--CA 1.422 -2.253 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.685 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.58 165.15 11.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.5 t -114.65 136.0 53.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 130.3 22.95 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.932 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.64 131.28 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.577 1.518 . . . . 0.0 109.842 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -100.11 -37.89 8.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.402 ' O ' HD22 ' A' ' 1' ' ' LEU . 3.9 p . . . . . 0 N--CA 1.42 -1.947 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.475 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 26.2 tp . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.15 131.26 44.13 Favored 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.356 2.037 . . . . 0.0 110.347 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -105.58 150.59 25.26 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.966 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m -77.97 -39.05 43.71 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.1 t70 73.89 6.0 4.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.857 1.663 . . . . 0.0 111.887 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -148.31 133.48 9.24 Favored Pre-proline 0 C--N 1.289 -2.031 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.29 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.46 -45.51 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.256 1.971 . . . . 0.0 111.411 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -117.96 171.49 8.04 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.502 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.551 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 43.3 t -166.81 175.6 7.66 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.2 m -147.11 165.11 30.95 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.86 -28.11 67.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.144 0.497 . . . . 0.0 110.774 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.85 -31.49 40.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.386 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -126.24 88.13 2.79 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.551 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 23.2 pt -99.43 -0.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.601 0.715 . . . . 0.0 110.799 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -8.09 87.17 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.33 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.45 -51.88 63.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.1 m -64.77 127.16 30.4 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.865 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.03 40.88 1.23 Allowed Glycine 0 CA--C 1.535 1.344 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.1 t70 71.07 -25.76 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.546 1.938 . . . . 0.0 114.145 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -88.02 1.46 54.15 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.328 1.061 . . . . 0.0 110.201 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 34' ' ' PRO . 58.6 m -144.1 155.43 43.95 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -130.39 147.92 52.15 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.1 p -103.04 144.85 30.74 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.61 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 42.5 t -105.13 100.23 23.87 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.43 118.78 5.01 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.479 2.119 . . . . 0.0 111.787 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -139.42 97.57 8.38 Favored Pre-proline 0 N--CA 1.416 -2.134 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 2.8 Cg_exo -84.91 -26.49 7.5 Favored 'Cis proline' 0 C--N 1.35 0.637 0 C-N-CA 124.551 -1.02 . . . . 0.0 111.618 -6.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -111.34 -54.95 4.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -93.2 151.47 19.8 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -158.32 176.17 35.33 Favored Glycine 0 C--N 1.28 -2.567 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.78 155.78 18.01 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.298 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -98.58 119.54 37.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.39 127.5 26.77 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 12.8 Cg_endo -61.23 134.18 50.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.482 2.122 . . . . 0.0 112.708 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.79 -13.0 32.23 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.768 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.307 -1.256 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.994 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.507 -0.698 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.54 123.13 10.7 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.565 2.177 . . . . 0.0 113.464 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -116.45 -9.98 11.36 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.406 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 m -102.29 -34.32 9.26 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.439 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 61.66 30.81 18.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.435 1.094 . . . . 0.0 112.099 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.3 m -132.98 116.68 14.63 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.19 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.88 -35.1 27.97 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.71 2.274 . . . . 0.0 113.224 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.69 160.15 28.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 58.1 m -130.63 -177.76 4.49 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -142.94 170.35 15.86 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt -51.9 -43.44 63.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.488 0.661 . . . . 0.0 111.167 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -84.51 -37.8 20.84 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.081 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.9 88.02 2.64 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.195 0.521 . . . . 0.0 110.642 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.7 pt -109.29 -0.39 9.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.74 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.04 2.73 68.33 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.183 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.4 -27.52 69.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.333 0.587 . . . . 0.0 109.876 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -121.35 90.6 3.35 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.93 86.73 1.55 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.624 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t70 73.69 -20.88 0.28 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.631 1.972 . . . . 0.0 113.4 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.29 -39.91 88.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.721 0.772 . . . . 0.0 109.31 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.628 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.9 m -153.6 179.03 9.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -122.72 133.77 54.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 9' ' ' CYS . 66.7 m -82.3 129.34 34.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 96.5 44.29 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 10.4 Cg_exo -74.86 129.48 12.51 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.26 2.64 . . . . 0.0 112.828 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.3 pt? -153.75 105.71 2.51 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.301 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.7 Cg_exo -83.37 -29.29 5.5 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.603 -0.999 . . . . 0.0 111.619 -7.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt -110.94 -54.59 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -87.96 144.28 26.63 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.966 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . -132.22 167.81 22.81 Favored Glycine 0 N--CA 1.402 -3.596 0 C-N-CA 119.546 -1.311 . . . . 0.0 114.666 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 mt -92.38 160.78 14.94 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 42.3 t -117.57 118.01 30.98 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.85 134.31 26.17 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.998 -176.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 42.6 Cg_endo -74.17 136.56 22.42 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.086 1.858 . . . . 0.0 112.744 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.95 -44.59 39.3 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.431 -1.417 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.028 179.272 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.238 0.486 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.86 173.12 15.0 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.901 2.401 . . . . 0.0 112.032 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -93.43 111.75 23.49 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' A' ' 34' ' ' PRO . 59.4 m -66.88 -35.5 80.17 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.575 -177.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 64.03 21.36 12.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.663 1.22 . . . . 0.0 109.24 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -105.24 113.09 64.87 Favored Pre-proline 0 N--CA 1.429 -1.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.978 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.39 -37.3 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.768 1.645 . . . . 0.0 111.718 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.18 -179.81 7.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.2 t -160.94 162.16 31.89 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.0 m -154.64 169.91 22.77 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.3 pt? -72.86 -22.7 60.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.549 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -88.71 -14.02 38.24 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.694 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -136.22 79.61 1.78 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.1 pt -102.81 -4.24 9.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.19 0.519 . . . . 0.0 110.92 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.55 -0.95 64.29 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.247 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.39 -27.68 67.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.958 0.503 . . . . 0.0 110.427 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.49 128.66 55.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.46 103.14 0.39 Allowed Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.069 -177.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.9 t70 76.94 -31.29 0.18 Allowed 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.67 1.988 . . . . 0.0 114.27 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -101.88 -42.06 6.27 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.487 0.661 . . . . 0.0 111.488 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.3 m -116.29 161.9 18.31 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.963 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -139.22 143.87 38.23 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 p -113.72 158.44 20.91 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.646 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 4.2 p -119.83 106.21 41.93 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.869 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.12 115.45 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.287 1.992 . . . . 0.0 110.357 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.1 pt? -133.36 98.34 15.41 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.252 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 Cg_exo -89.09 -20.44 13.53 Favored 'Cis proline' 0 C--N 1.353 0.787 0 C-N-CA 124.724 -0.948 . . . . 0.0 111.785 -7.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 45.7 mm -108.72 -58.26 3.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.269 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.17 156.94 16.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . -162.87 -176.69 35.19 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -106.4 155.84 19.14 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -103.32 130.47 50.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.42 136.87 29.57 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 28.7 Cg_endo -65.38 115.57 3.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.391 2.061 . . . . 0.0 109.912 175.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.98 -20.06 11.18 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.223 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 C--O 1.254 1.313 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.76 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 CA--C 1.514 -0.423 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.14 177.35 3.16 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.715 2.277 . . . . 0.0 110.757 172.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -79.36 92.08 5.14 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.023 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 83.5 m -127.49 -0.54 6.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.05 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.74 -0.59 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.633 1.173 . . . . 0.0 112.943 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.7 m -118.69 133.72 23.58 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.608 -0.682 . . . . 0.0 110.862 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.91 -36.69 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.799 2.332 . . . . 0.0 112.361 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -147.18 160.56 42.31 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 30.8 p -139.88 -168.31 2.48 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.0 p -141.97 166.25 25.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.88 -21.76 64.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.447 0.642 . . . . 0.0 110.996 175.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -76.49 -59.77 2.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.35 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.45 92.04 4.03 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.341 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 37.9 pt -91.6 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.25 -7.39 57.13 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.636 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 3.9 mm? -67.73 -25.67 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.55 0.69 . . . . 0.0 109.524 174.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 52.9 m -98.1 100.18 11.48 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.97 72.93 0.87 Allowed Glycine 0 C--N 1.312 -0.765 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 72.31 -33.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.653 2.381 . . . . 0.0 113.909 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -83.19 -22.69 33.12 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-O 122.207 1.004 . . . . 0.0 110.2 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 1.6 p -124.21 149.33 46.51 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.716 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.9 m -112.14 154.33 25.64 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.398 1.079 . . . . 0.0 108.629 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 61.0 m -88.28 129.14 35.45 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.24 95.64 8.5 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.95 124.3 4.39 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 121.899 1.733 . . . . 0.0 112.048 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 1.7 pt? -135.5 89.82 21.56 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.039 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 3.4 Cg_exo -87.82 -29.94 3.15 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 124.309 -1.121 . . . . 0.0 111.191 -7.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 52.6 mt -110.1 -49.4 6.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.919 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -71.73 132.08 44.02 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.54 16.57 Favored Glycine 0 N--CA 1.415 -2.737 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.993 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -117.53 150.2 39.35 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.0 m -78.11 113.48 16.09 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.516 0.51 . . . . 0.0 110.394 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.69 134.96 20.23 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.15 112.99 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.694 1.596 . . . . 0.0 110.666 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.3 -38.64 11.39 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.426 -1.644 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.895 175.754 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.22 143.74 17.86 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 122.074 1.849 . . . . 0.0 110.499 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -130.24 -177.48 4.33 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.5 m -110.89 -50.47 2.94 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.002 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 67.26 29.22 7.73 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.559 1.171 . . . . 0.0 109.566 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 m -91.58 116.04 65.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.129 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.36 -47.85 3.95 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.697 2.264 . . . . 0.0 113.099 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -145.21 -179.75 6.84 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 14' ' ' ILE . 16.3 t -156.17 162.75 40.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.0 p -145.09 170.29 16.49 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 28' ' ' ILE . 4.0 pp -68.72 -20.04 64.38 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.629 0.728 . . . . 0.0 110.534 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.22 -59.08 2.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.865 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.84 90.73 4.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.444 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 38.0 pt -100.38 -0.14 10.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 109.643 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.86 64.92 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.243 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.85 -33.59 75.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 m -128.72 83.84 2.19 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 20' ' ' LYS . . . -110.31 99.55 1.19 Allowed Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.939 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 72.63 -22.92 0.21 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.147 1.779 . . . . 0.0 112.685 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 18' ' ' GLY . 97.8 mttt -79.77 -29.96 40.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.548 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 p -163.0 177.75 8.92 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.044 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 m -134.49 148.71 50.61 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.6 p -124.7 139.86 53.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -113.84 102.7 55.06 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.47 142.34 65.01 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.897 2.398 . . . . 0.0 110.88 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 2.0 pt? -149.33 92.22 4.31 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-O 120.706 0.289 . . . . 0.0 111.75 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 5.0 Cg_exo -87.62 -28.48 4.2 Favored 'Cis proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.592 -1.003 . . . . 0.0 111.95 -6.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.44 ' HA ' HD23 ' A' ' 11' ' ' LEU . 58.1 mt -101.99 -47.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -109.05 154.02 22.82 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.36 177.51 33.33 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.772 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.6 163.97 12.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 t -108.3 140.22 41.88 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.05 138.85 24.25 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.63 132.06 45.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.89 1.727 . . . . 0.0 109.421 173.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.71 -43.64 12.42 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -173.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.405 -2.675 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.317 178.161 . . . . . . . . 0 0 . 1 stop_ save_